97. 潰瘍性大腸炎 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
( L ) ASCORBATO DI CALCIO
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
(-)-3-(4-Aminophenyl)-2-methoxypropionic acid
GIULIANI
2012 - EUCTR2011-003283-78-IT Italy;
(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid
PPM SERVICES SA
2017 Phase 2 EUCTR2016-001684-36-LV Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2017 Phase 2 EUCTR2016-001684-36-ES Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2016 Phase 2 EUCTR2016-001684-36-SK Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-HU Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-BG Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben
Celgene International II Sàrl
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride
CELGENE INTERNATIONAL II SàRL
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
-aminosalicylic acid
National Center for Research Resources (NCRR)
1996 Phase 2 NCT00004810 -
1.Remicade
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
100
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
15N2-tofacitinib
Theravance Biopharma
2017 Phase 1 NCT03103412 United States;
2 x 10 mg Natura-alpha capsules
Natrogen Therapeutics International, Inc
2010 Phase 2 NCT01216280 United States;
2'-Fucosyllactose
Children's Hospital Medical Center, Cincinnati
2019 Phase 1/Phase 2 NCT03847467 United States;
23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)
Cedars-Sinai Medical Center
2005 - NCT00829595 United States;
2L polyethylene glycol/ascorbic acid
American University of Beirut Medical Center
2018 Phase 4 NCT03581149 Lebanon;
3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)
Iron Therapeutics (Switzerland) AG
2012 - EUCTR2010-023588-16-DE Austria;Germany;Hungary;United Kingdom;
2011 Phase 3 EUCTR2010-023588-16-GB Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-HU Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-AT Austria;Germany;Hungary;United Kingdom;
331731-18-1
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2013-001682-16-DK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2017 Phase 3 EUCTR2015-001346-29-CZ Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-HU Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-GB Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-ES Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-BE Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2013-001682-16-BE Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-003032-77-IT Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-HU Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-GB Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001682-16-SK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-PL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-HU Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-ES Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-DE Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-AT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
- Phase 3 EUCTR2015-001346-29-SE Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-AT Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
AbbVie Inc.
- - EUCTR2014-004559-29-Outside-EU/EEA Japan;
Abbvie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2013-003032-77-PL Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-BE Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2013-003032-77-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
42942019
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-002061-54-IT Italy;
5 ASA, enemas, suppositories, corticosteroids
Bausch Health Americas, Inc.
2005 Phase 3 NCT00269438 United States;
5-ASA
Bausch Health Americas, Inc.
2012 Phase 3 NCT01532648 Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
Center for Diagnostic and Therapeutic Endoscopy,Keio University
2015 - JPRN-UMIN000018075 Japan;
Centre Hospitalier Universitaire de Saint Etienne
2016 Phase 3 NCT02665845 France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
2015 - JPRN-UMIN000019310 Japan;
Department of Gastroenterology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
2014 Phase 1 study ChiCTR-TRC-14004153 -
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
2017 - JPRN-UMIN000026175 Japan;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
Friendship Hospital of Capital Medical University
2008 Phase 1 study ChiCTR-TRC-08000145 China;
5-ASA (5-Aminosalicylate)
Ferring Pharmaceuticals
2007 Phase 3 NCT00603733 Canada;
5-ASA MMx
GIULIANI
2004 - EUCTR2004-000916-25-IT Italy;
5-Aminosalicyclic acid
Asian Institute of Gastroenterology, India
2016 Phase 3 NCT02683759 India;
5-Aminosalicylic acid (5-ASA)
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
5-HTP
University Hospital, Ghent
2018 Phase 2 NCT03574948 Belgium;
5-amino salicylic acid
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-amino salicylic acid (5-ASA)
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
5-amino-2-hydroxybenzoic acid
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
5-aminosalicylate (Pentasa, Ferring)
VU University Medical Center
2005 Phase 4 NCT00167882 Netherlands;
5-aminosalicylic acid
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
2010 Phase 3 JPRN-UMIN000003785 Japan;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
2012 Phase 2 EUCTR2012-002023-15-AT Austria;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Sheba Medical Center
2011 Phase 3 NCT01320436 Israel;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-aminosalicylic acid (5-ASA)
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
549-0261/F02-01
F. Hoffmann-La Roche Ltd
2018 Phase 1 EUCTR2017-003649-10-GB Belgium;Germany;Poland;Spain;United Kingdom;
2018 Phase 1 EUCTR2017-003649-10-DE Belgium;Germany;Poland;Spain;United Kingdom;United States;
2018 Phase 1 EUCTR2017-003649-10-BE Belgium;Germany;Poland;Spain;United Kingdom;
- Phase 1 EUCTR2017-003649-10-PL Belgium;Germany;Poland;Spain;United Kingdom;United States;
6 mercaptopurine
Indiana University
2015 - NCT02413047 United States;
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
A multistrain probiotic product (DSF)
Xijing Hospital of Digestive Diseases
2019 - NCT04006977 China;
A07DA03
Department of surgery, Odense University Hospital
2014 Phase 4 EUCTR2014-004740-35-DK Denmark;
A: 1 dosis
AB Biotics, SA
2018 - NCT03444311 Spain;
AB (antibiotics)
Shaare Zedek Medical Center
2014 - NCT02033408 Canada;Finland;Israel;Italy;Poland;Spain;
ABBV-006
ABBVIE DEUTSCHLAND GMBH & CO. KG
2018 Phase 3 EUCTR2016-004676-22-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2021 Phase 3 EUCTR2016-004676-22-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-066
ABBVIE DEUTSCHLAND GMBH & CO. KG
2018 Phase 3 EUCTR2016-004676-22-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2021 Phase 3 EUCTR2016-004676-22-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2016-004677-40-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-NL Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-DK Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-BE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-CZ Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-323
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 2 EUCTR2018-000930-37-IT Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 2 EUCTR2018-000930-37-HU Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-GB Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-FR Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-ES Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-DE Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000930-37-NL Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose A
AbbVie
2019 Phase 2 NCT03695185 Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose B
AbbVie
2019 Phase 2 NCT03695185 Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABI-M201
Assembly Biosciences
2019 Phase 1 NCT03923478 Canada;United States;
ABT-494
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2016-000642-62-IT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-IT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 3 EUCTR2016-000642-62-SE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2016-000642-62-FR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-SK Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-NL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-LT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-IE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-HR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GB Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-ES Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-DE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-CZ Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-AT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-NO Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-LV Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-HU Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-FI Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-000641-31-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-LV Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-HU Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-ES Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-LV Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-HU Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-ES Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
ABT-Humira
AbbVie Deutschland GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
Abbott GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
ABX464
ABIVAX
2022 Phase 2 EUCTR2021-004398-30-SI Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2021 Phase 2 EUCTR2021-004398-30-SK Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2021 Phase 2 EUCTR2021-004398-30-HU Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2020 Phase 2 EUCTR2019-000733-39-GB Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-FR Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-DE Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-AT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2018-003558-26-GB Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2019-000733-39-SK Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-SI Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-PL Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-ES Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-SK Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-SI Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-PL Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-HU Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-FR Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-DE Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-CZ Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-BE Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003284-35-PL Belgium;Hungary;Poland;Spain;
2018 Phase 2 EUCTR2017-003284-35-HU Belgium;Hungary;Poland;Spain;
2018 Phase 2 EUCTR2017-003284-35-ES Hungary;Spain;
2018 Phase 2 EUCTR2017-000937-30-AT Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-003284-35-BE Belgium;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-PL Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-FR Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-ES Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-DE Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-BE Austria;Belgium;Germany;Hungary;Poland;Spain;
Abivax
2021 Phase 2 EUCTR2021-004398-30-IT Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2020 Phase 2 EUCTR2019-000733-39-IT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-IT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
Abivax S.A.
2021 Phase 2 NCT05177835 Belgium;Czechia;Hungary;Poland;
2020 Phase 2 NCT04023396 Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 NCT03760003 Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03368118 Belgium;
2017 Phase 2 NCT03093259 Belgium;
Owada Yasuko
2021 Phase 1 JPRN-jRCT2051210087 Japan;
ACETATO DI AMMONIO
Protagonist Therapeutics, Inc.
2020 Phase 2 EUCTR2019-004469-41-IT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States;
AEB071
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Novartis Pharmaceuticals
2010 Phase 2 NCT00572585 Denmark;Germany;Poland;United States;
AEB071A
Novartis Pharma Services AG
2007 - EUCTR2007-002542-38-DE Denmark;Germany;
AG011
ActoGeniX N.V.
2008 Phase 1/Phase 2 NCT00729872 Belgium;Canada;Netherlands;Sweden;
AG011 - Capsules
ActoGeniX N.V
2008 - EUCTR2008-000967-40-BE Belgium;Netherlands;Sweden;
ActoGeniX NV.
2008 - EUCTR2008-000967-40-SE Belgium;Netherlands;Sweden;
2008 - EUCTR2008-000967-40-NL Belgium;Netherlands;Sweden;
AG011 - Enema
ActoGeniX N.V
2008 - EUCTR2008-000967-40-BE Belgium;Netherlands;Sweden;
ActoGeniX NV.
2008 - EUCTR2008-000967-40-SE Belgium;Netherlands;Sweden;
2008 - EUCTR2008-000967-40-NL Belgium;Netherlands;Sweden;
AJG501
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2-3 JPRN-JapicCTI-101144 -
AJG511
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2 JPRN-JapicCTI-132294 -
EA Pharma Co.,Ltd.
2014 Phase 3 JPRN-JapicCTI-142704 -
AJM300
EA Pharma Co., Ltd.
2018 Phase 3 NCT03531892 Japan;
ALTH12-1:4
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
ALTH12-2:4
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
AMG 181
Amgen
2011 Phase 1 NCT01290042 Australia;United States;
Amgen Inc
2014 Phase 2 EUCTR2011-005251-13-LV Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2014 Phase 2 EUCTR2011-005251-13-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2013 Phase 2 EUCTR2011-005251-13-PL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2013 Phase 2 EUCTR2011-005251-13-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-GR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
AMG 592
AMGEN INC.
2021 Phase 2 EUCTR2021-002537-41-IT Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
Amgen Inc.
2022 Phase 2 EUCTR2021-002537-41-ES Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States;
2022 Phase 2 EUCTR2021-002537-41-BG Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-NL Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-HU Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-DE Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
AMG181
AMGEN INC.
2012 Phase 2 EUCTR2011-005251-13-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Poland;Switzerland;United Kingdom;United States;
AMGEVITA
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
AMGEVITA (Adalimumab biosimilar )
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
AMGEVITA®
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
AMT-101
Applied Molecular Transport
2019 Phase 1 NCT04224857 Georgia;Germany;Moldova, Republic of;Ukraine;
Applied Molecular Transport Inc.
2021 Phase 2 EUCTR2020-002833-13-PL Georgia;Netherlands;Poland;Ukraine;
2021 Phase 2 EUCTR2020-002833-13-NL Georgia;Netherlands;Poland;Ukraine;
2021 Phase 2 EUCTR2020-000047-31-PL Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-000047-31-DE Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-HU Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-GB Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-FR Belarus;Belgium;Bulgaria;Canada;Czech Republic;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-BG Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
AMT-101 (oral)
Applied Molecular Transport
2020 Phase 2 NCT04583358 Bulgaria;Canada;France;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Switzerland;Ukraine;United Kingdom;United States;
AND (Andrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA (ethanol extract)
Hutchison MediPharma Enterprises Limited
2008 - EUCTR2007-005166-12-DE Germany;
AODG (Apigenin-7-O-glucuronide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
APD334
ARENA PHARMACEUTICALS, INC.
2021 Phase 2 EUCTR2020-003507-34-IT Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2019 Phase 3 EUCTR2018-003987-29-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003797-40-DE Belgium;Germany;United States;
2017 Phase 2 EUCTR2016-003797-40-BE Belgium;Germany;United States;
2017 Phase 2 EUCTR2015-001942-28-FR Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2015-001942-28-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-LT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-BG Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-BE Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-PL Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-BE Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-LT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-ES Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
APD334 L-arginine
ARENA PHARMACEUTICALS, INC.
2019 Phase 3 EUCTR2018-003986-33-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
APRISO 375 mg extended-release capsules
Bausch Health Americas, Inc.
2017 Phase 1 NCT03327558 United States;
APVO210
Aptevo Therapeutics
2019 Phase 1 NCT03768219 Australia;
AR401959 L-arginine
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
AS INN
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
ASACOL
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
ASC
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
ASP015K
Janssen-Cilag International NV
2014 Phase 2 EUCTR2013-000263-88-RO Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-DE Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-BG Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-PL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-NL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-HU Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-BE Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
ASP3291
Telsar Pharma Inc.
2012 Phase 2 NCT01612039 United States;
2010 Phase 1 NCT01320332 United States;
AST-120
Ocera Therapeutics, Inc.
2007 - EUCTR2005-005363-28-HU Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2007 - EUCTR2005-005363-28-AT Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 Phase 3 EUCTR2005-005363-28-GB Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-DE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-CZ Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-BE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
ATL-2502
ALIZYME
2006 - EUCTR2004-005032-35-IT Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Alizyme Therapeutics Limited
2007 - EUCTR2004-005032-35-BE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-SE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-HU Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-DK Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-CZ Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
AVX 470
Avaxia Biologics, Incorporated
2013 Phase 1 NCT01759056 Belgium;Canada;Hungary;United States;
AZA
Dipartimento di Pediatria Università Federico II di Napoli
2013 - EUCTR2012-001653-13-IT Italy;
AZAFOR
Dipartimento di Pediatria Università Federico II di Napoli
2013 - EUCTR2012-001653-13-IT Italy;
AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL
IRCCS ISTITUTO CLINICO HUMANITAS
2017 Phase 4 EUCTR2016-002707-25-IT Italy;
AZATHIOPRINE BP
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
AbGn-168H
AbGenomics International, Inc.
2018 Phase 2 NCT03298022 Puerto Rico;United States;
Abalimumab
AbbVie GK
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
Abatacept
Bristol-Myers Squibb International Corporation
2008 - EUCTR2006-003604-19-PL Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-FR Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IT Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Abatacept (ABA)
Bristol-Myers Squibb
2006 Phase 3 NCT00410410 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;South Africa;Spain;Switzerland;United Kingdom;United States;
Abrilumab
Amgen
2012 Phase 2 NCT01694485 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
Accelerated 1 hour-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Accelerated 30 minutes-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Acetic acid
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2015 - JPRN-UMIN000021460 Japan;
Acidophilus
Odense University Hospital
2003 - NCT00374725 Denmark;
Adalimumab
AbbVie
2016 - NCT02750800 Hungary;
2015 Phase 3 NCT02632175 Japan;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 NCT02065622 Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT02065557 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2013 - NCT01768858 Austria;
AbbVie (prior sponsor, Abbott)
2012 Phase 3 NCT01550965 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 NCT00853099 Japan;
2007 Phase 3 NCT00573794 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;United States;
AbbVie Deutschland GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
AbbVie GK
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
2014 Phase 3 JPRN-JapicCTI-142648 Japan, North America, Europe;
2009 Phase 2-3 JPRN-JapicCTI-090718 -
Abbott
2006 Phase 3 NCT00408629 Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United States;
2006 Phase 3 NCT00385736 Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Puerto Rico;Slovakia;Sweden;United States;
Abbott GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-IT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 - EUCTR2006-002782-40-DE Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002782-40-AT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002781-20-SE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2008 - EUCTR2006-002781-20-AT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 Phase 3 EUCTR2006-002782-40-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 Phase 3 EUCTR2006-002781-20-SK Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
2007 - EUCTR2006-002782-40-PT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-HU Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-DK Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-CZ Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002781-20-HU Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-DE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-CZ Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-BE Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
Clalit Health Services
2012 Phase 3 NCT01494857 Israel;
Fukuyama Medical Center
2016 - JPRN-UMIN000020840 Japan;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2020 Phase 4 NCT04183608 France;
Hoffmann-La Roche
2014 Phase 3 NCT02171429 Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 NCT02163759 Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
Iwate Medical UniversityKochi Medical School HospitalKeio University School of Medicine
2016 - JPRN-UMIN000019958 Japan;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Mayo Clinic
2006 Phase 1 NCT00421642 United States;
McMaster University
2018 Phase 4 NCT03059849 -
Odense University Hospital
2012 Phase 3 NCT01670240 Denmark;
Osaka Medical College
2014 - JPRN-UMIN000015912 Japan;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
Sakura Medical Center, Toho university
2018 - JPRN-UMIN000030988 Japan;
Sakura Medical Center,Toho university
2015 - JPRN-UMIN000019066 Japan;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Takeda
2015 Phase 3 NCT02497469 Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
University of Western Ontario, Canada
2014 Phase 4 NCT01960426 United States;
2013 Phase 4 NCT01716039 -
Adipose derived, autologous mesenchymal stem cells
Mayo Clinic
2020 Phase 1 NCT04312113 United States;
Adipose tissue-derived mesenchymal stem cells
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
Adipose-cord mesenchymal stromal cells (A-MSCs)
Liaocheng People's Hospital
2018 Phase 1/Phase 2 NCT03609905 China;
Algin
Ishikawa Dai
2020 - JPRN-jRCTs031200103 Japan;
Alicaforsen
Isis Pharmaceuticals
2003 Phase 2 NCT00063830 United States;
2003 Phase 2 NCT00063414 United States;
Allogeneic adipose tissue-derived mesenchymal stem cells
Instituto de Investigación Hospital Universitario La Paz
2013 Phase 1/Phase 2 NCT01914887 Spain;
Allopurinol
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
AloASC
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
Aloe Barbadensis Miller
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
2012 Phase 0 NCT01783119 Mexico;
Aloe vera gel
Ospedale Sandro Pertini, Roma
2010 - NCT04753775 -
Also referred to as 'MEDI2070'
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
AstraZeneca AB
2022 Phase 2 EUCTR2021-001644-10-HU Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-001644-10-ES Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Also referred to as MEDI2070
AstraZeneca AB
2021 Phase 2 EUCTR2018-001605-93-HU Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-DE Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-CZ Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Amg 181
Amgen
2010 Phase 1 NCT01164904 Australia;New Zealand;United States;
Amgevita
IRCCS ISTITUTO CLINICO HUMANITAS
2021 Phase 4 EUCTR2020-003420-16-IT Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-ES Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Amgevita 40 mg Injektionslösung im Fertigpen
Universitätsklinikum Erlangen
2019 Phase 4 EUCTR2019-003662-40-DE Germany;
Amgevita 40 mg Injektionslösung in einer Fertigspritze
Universitätsklinikum Erlangen
2019 Phase 4 EUCTR2019-003662-40-DE Germany;
Amgevita 40Mg Solution for Injection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
2019 Phase 4 NCT04131322 Spain;
Amiselimod
Salix Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-005232-30-SK Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-HU Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-EE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-DE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-BG Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
Amitriptyline hydrochloride
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Amoxicillin
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Juntendo university school of medicine Department of gastroenterology
2015 - JPRN-UMIN000018642 Japan;
2014 - JPRN-UMIN000014152 Japan;
Juntendo university school of medicineDepartment of gastroenterology
2017 - JPRN-UMIN000025846 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
Amoxicillin and doxycyclin
Wolfson Medical Center
2019 Phase 2 NCT03986996 Israel;
Amoxicillin, metronidazole and doxycycline
Wolfson Medical Center
2019 Phase 2 NCT03986996 Israel;
Anakinra
Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
2017 Phase 2 EUCTR2017-001389-10-GB United Kingdom;
Andecaliximab
Gilead Sciences
2015 Phase 2/Phase 3 NCT02520284 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;Iceland;Ireland;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AndoSan
Oslo University Hospital
2011 Phase 2/Phase 3 NCT01496053 Norway;
Anrukinzumab
Pfizer
2011 Phase 2 NCT01284062 Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Anti Beta7
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
Anti CD3 monoclonal antibody
PDL BioPharma, Inc
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
Anti TNF therapy including infliximab
Janssen Biotech, Inc.
2007 - NCT00606346 Canada;United States;
Anti-CD3 monoclonal antibody
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Anti-IP-10 Antibody
Bristol-Myers Squibb
2011 Phase 2 NCT01294410 Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2022 Phase 2 EUCTR2021-001644-10-HU Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-001644-10-ES Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2018-001605-93-HU Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-DE Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-CZ Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-MAdCAM antibody
Baxalta Innovations GmbH
- Phase 3 EUCTR2017-000573-37-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
2014 - EUCTR2012-002030-37-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Pfizer Inc.
2013 - EUCTR2012-002030-37-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom;
Shire Human Genetic Therapie, Inc.
2013 Phase 2 EUCTR2012-002031-28-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2019 Phase 3 EUCTR2017-000574-11-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-FR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-ES Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000573-37-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-GR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2013 Phase 2 EUCTR2012-002031-28-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Anti-TL1A
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-SK Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-PL Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-HU Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-GB Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-FR Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-ES Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-DE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BG Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Anti-TNF Drug
HaEmek Medical Center, Israel
2009 - NCT03747068 -
Anti-TNF Therapy
Takeda
2017 - NCT03090139 Argentina;China;Colombia;Korea, Republic of;Mexico;Russian Federation;Saudi Arabia;Singapore;Taiwan;Turkey;
Anti-TNF discontinuation: Physiological saline solution
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Anti-TNF: Infliximab (Infusion)
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Anti-TNF:Adalimumab (Subcutaneus)
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Antibiotic cocktail
Prof. Arie Levine
2015 Phase 4 NCT02345733 Canada;Israel;United States;
2014 - NCT02217722 Israel;
Apixaban 2.5 milligram
McMaster University
2021 Early Phase 1 NCT03935451 Canada;
Apremilast
Amgen
2015 Phase 2 NCT02289417 Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Ukraine;United States;
Apriso 0.375G ER CAP
Bausch Health Americas, Inc.
2017 Phase 1 NCT03327558 United States;
Aquamin
James Varani
2021 Phase 2 NCT04855799 United States;
Aquamin®
James Varani
2019 Phase 2 NCT03869905 United States;
Asacol
Annette Langseder
2006 - NCT00349388 United States;
Procter & Gamble Pharmaceuticals
- Phase 3 EUCTR2007-005702-49-PL Poland;
Shire
2005 Phase 3 NCT00151892 Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States;
Tillotts Pharma AG
2015 Phase 3 EUCTR2013-000366-11-RO Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-SK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;
2014 Phase 3 EUCTR2013-000366-11-LV Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-LT Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-HU Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-BG Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 NCT01903252 Netherlands;Switzerland;
2013 Phase 3 EUCTR2013-000366-11-SE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-PL Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine;
2013 Phase 3 EUCTR2013-000366-11-IE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-GB Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-FI Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-DK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-CZ Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-BE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2013-000366-11-ES Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine;
Warner Chilcott
2009 Phase 3 NCT01004185 Canada;Croatia;Poland;Romania;Russian Federation;United States;
2008 Phase 3 NCT00713310 Canada;Croatia;Poland;Romania;United States;
Asacol (mesalamine)
University of Chicago
2006 Phase 3 NCT00343850 United States;
University of Washington
2003 Phase 4 NCT00194818 United States;
Asacol (mesalamine) Delayed-release Tablets
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
Asacol 400 mg (mesalamine)
Warner Chilcott
2000 Phase 3 NCT00073021 Canada;Puerto Rico;United States;
Asacol 400 mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 400mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800 mg (mesalamine)
Warner Chilcott
2000 Phase 3 NCT00073021 Canada;Puerto Rico;United States;
Asacol 800 mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol Delayed Release Tablets
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Asacol Delayed-Release Tablets
EMET Pharmaceuticals LLC
2008 - EUCTR2007-004732-23-LV Estonia;Latvia;Poland;
2007 - EUCTR2007-004732-23-EE Estonia;Latvia;Poland;
EMET Pharmaceuticals, LLC
2008 - EUCTR2007-004732-23-PL Estonia;Latvia;Poland;
Asacol tablet
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
Asacol®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
Copenhagen University Hospital Hvidovre
2019 Phase 4 EUCTR2019-002070-31-DK Denmark;
Otsuka Pharmaceutical Development & Commercialization, Inc.
2004 Phase 3 NCT00092508 United States;
Tillotts Pharma AG
2010 Phase 3 NCT01257399 China;
2010 Phase 3 NCT01257386 China;
Aspergillus oryzae
Graduate School of Medical Science, KyotoPrefectural University of Medicine
2012 Phase 2 JPRN-UMIN000009364 Japan;
Atorvastatin Calcium
National Cancer Institute (NCI)
2021 Phase 2 NCT04767984 United States;
Avonex
Biogen Idec Ltd
2009 Phase 2 EUCTR2007-004867-22-SK Czech Republic;Hungary;Slovakia;
2008 - EUCTR2007-004867-22-HU Czech Republic;Hungary;
2008 - EUCTR2007-004867-22-CZ Czech Republic;Hungary;
Azathioprine
Affiliated Hospital of Nanjing University of Chinese Medicine
2015 Phase 1 study ChiCTR-IPR-15005760 China;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Indiana University
2015 - NCT02413047 United States;
Istituto Clinico Humanitas
2017 Phase 4 NCT03151525 Italy;
Kyungpook National University Hospital
2016 Phase 4 NCT02579733 Korea, Republic of;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
Sakura Medical Center, Toho university
2018 - JPRN-UMIN000030988 Japan;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
Azathioprine (AZA)
Merck Sharp & Dohme Corp.
2007 Phase 3 NCT00537316 Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Azathioprine (AZA) or 6-mercaptopurine (6-MP)
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
Azathioprine (Imuran) 50 mg Overencapsulated Tablet
Schering-Plough Research Institute, a division of Schering Corporation
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
Azathioprine and Allopurinol
Hvidovre University Hospital
2016 Phase 3 NCT03101800 Denmark;
Azathioprine or 6-mercaptopurine
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
B2-ASmedic
Novartis Pharma Services AG
2007 - EUCTR2007-002542-38-DE Denmark;Germany;
B: 2 dosis
AB Biotics, SA
2018 - NCT03444311 Spain;
BBT-401-1S
Bridge Biotherapeutics, Inc.
2021 Phase 2 NCT04596293 Korea, Republic of;New Zealand;Poland;Ukraine;United States;
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
2021 Phase 1 NCT04478825 New Zealand;
2019 Phase 2 NCT03800420 United States;
BBT-401-1S, Multiple doses
Bridge Biotherapeutics, Inc.
2018 Phase 1 NCT03482648 United States;
BBT-401-1S, Single dose
Bridge Biotherapeutics, Inc.
2018 Phase 1 NCT03482648 United States;
BG9418 (Interferon beta-1a)
Biogen
2008 Phase 2 NCT00616434 Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia;United States;
BG9924
Biogen Idec Ltd.
2011 Phase 2 EUCTR2010-019558-42-SK Belgium;Czech Republic;Hungary;Slovakia;
2011 - EUCTR2010-019558-42-HU Belgium;Czech Republic;Hungary;
2011 - EUCTR2010-019558-42-CZ Belgium;Czech Republic;Hungary;
2010 - EUCTR2010-019558-42-BE Belgium;Czech Republic;Hungary;
BGP-014
BioGaia Pharma AB
2022 Phase 1/Phase 2 NCT05118919 Sweden;
BGP-014 Capsules
BioGaia Pharma AB
2021 Phase 1;Phase 2 EUCTR2019-004578-25-SE Sweden;
BI 655130
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim BV Netherlands
2017 Phase 2 EUCTR2016-004572-21-NL Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim España, S.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-ES Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-ES Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-ES Denmark;Germany;Netherlands;Norway;Spain;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-GR Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-CZ Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-GB Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-GB Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-NO Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-DE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-DE Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DK Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DE Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000334-35-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim bv
2018 Phase 2;Phase 3 EUCTR2017-004230-28-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim bv Netherlands
2019 Phase 2 EUCTR2018-000334-35-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2;Phase 3 EUCTR2017-004230-28-BE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-BE Belgium;Germany;United Kingdom;
BITTER CANDYTUFT FRESH PLANT EXTRACT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
BL-7040
BioLineRx, Ltd.
2012 Phase 2 NCT01506362 Israel;
BMS-188667
Bristol-Myers Squibb International Corporation
2008 - EUCTR2006-003604-19-PL Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-FR Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
BMS-936557
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-IT Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
BMS-986165
BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
2021 Phase 2 EUCTR2020-004461-40-IT Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-IT Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
Bristol-Myers Squibb
2021 Phase 2 NCT04877990 Australia;Brazil;China;Germany;Hungary;Italy;Japan;Poland;Romania;Russian Federation;United Kingdom;United States;
2019 Phase 2 NCT03934216 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2020 Phase 2 EUCTR2018-004694-27-FR Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-PL Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-HU Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-GB Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-DE Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-CZ Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BMS-986165 Dose 1
Bristol-Myers Squibb
2021 Phase 2 NCT04613518 Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986165 Dose 2
Bristol-Myers Squibb
2021 Phase 2 NCT04613518 Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986166
Bristol-Myers Squibb
2017 Phase 1 NCT03038711 United States;
BMS-986184
Bristol-Myers Squibb
2016 Phase 1 NCT02864264 Australia;Georgia;Moldova, Republic of;Romania;
BMS986165
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2020 Phase 2 EUCTR2018-004694-27-FR Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-PL Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-HU Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-GB Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-DE Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-CZ Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BT-11
Landos Biopharma Inc.
2020 Phase 2 EUCTR2018-005086-39-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HU Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (1000 mg)
Landos Biopharma Inc.
2019 Phase 2 NCT03861143 Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (500 mg)
Landos Biopharma Inc.
2019 Phase 2 NCT03861143 Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 Active
Landos Biopharma Inc.
2018 Phase 1 NCT03860571 United States;
BT051 up to
Bacainn Therapeutics, Inc.
2021 Phase 1 NCT05084261 Georgia;Moldova, Republic of;Poland;Ukraine;United States;
Bacteriotherapy
David Suskind
2012 Phase 1 NCT01757964 United States;
Balsalazide
Roxane Laboratories
2005 - NCT00618202 United States;
2004 - NCT00618228 United States;
Balsalazide Disodium
Bausch Health Americas, Inc.
2006 Phase 3 NCT00486031 United States;
Balsalazide disodium
Bausch Health Americas, Inc.
2006 Phase 3 NCT00408174 United States;
Baminercept
Biogen Idec Ltd.
2011 Phase 2 EUCTR2010-019558-42-SK Belgium;Czech Republic;Hungary;Slovakia;
2011 - EUCTR2010-019558-42-HU Belgium;Czech Republic;Hungary;
2011 - EUCTR2010-019558-42-CZ Belgium;Czech Republic;Hungary;
2010 - EUCTR2010-019558-42-BE Belgium;Czech Republic;Hungary;
Bascial prescription plus or minus herbs depend on symptoms
Shanghai University of Traditional Chinese Medicine
2009 - NCT00963287 China;
Basiliximab
Cerimon Pharmaceuticals
2007 Phase 2 NCT01061996 United Kingdom;
2007 Phase 2 NCT00430898 Belgium;Czech Republic;India;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
Cerimon Pharmaceuticals, Inc.
2007 Phase 2 EUCTR2006-006319-54-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-CZ Belgium;Czech Republic;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 - EUCTR2006-006319-54-BE Belgium;United Kingdom;
2007 - EUCTR2006-004303-19-CZ Belgium;Czech Republic;United Kingdom;
2007 - EUCTR2006-004303-19-BE Belgium;Czech Republic;United Kingdom;
Beclometasone
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
Beclomethasone diproprionate
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
Berberine
Xijing Hospital of Digestive Diseases
2016 Phase 4 NCT02962245 -
Berberine Chloride
National Cancer Institute (NCI)
2016 Phase 1 NCT02365480 China;United States;
Bertilimumab
Immune Pharmaceuticals
2015 Phase 2 NCT01671956 Israel;
Beta-1,3/1,6-D-Glucan
Fakultas Kedokteran Universitas Indonesia
2019 Phase 2/Phase 3 NCT04029649 Indonesia;
Bezlotoxumab
David Binion, MD
2021 Phase 4 NCT04626947 United States;
Bifidobacterium breve
Public Health Research foundation
2012 - JPRN-UMIN000007593 Japan;
Bifidobacterium infantis 35624
University College Cork
2002 Phase 2/Phase 3 NCT00510978 Ireland;
Bimekizumab
UCB Biopharma SPRL
2017 Phase 2 EUCTR2016-000420-26-PL Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-000420-26-BG Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-ES Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-CZ Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
Bio-enhanced Curcumin Soft Gelatin Capsule
Asian Institute of Gastroenterology, India
2016 Phase 3 NCT02683759 India;
2016 Phase 3 NCT02683733 India;
Biological Drug
Assiut University
2021 - NCT04818788 -
Biologically active human fecal microbiota
Virginia O. Shaffer
2014 Phase 2 NCT02049502 United States;
Biopsies
Centre Hospitalier Universitaire de Saint Etienne
2019 - NCT04030676 France;
2017 - NCT03172195 France;
Biosimilar
McGill University Health Centre/Research Institute of the McGill University Health Centre
2018 - NCT03729674 Canada;
Biosimilar infliximab
Diakonhjemmet Hospital
2014 Phase 4 NCT02148640 Norway;
Biospecimen Collection
National Cancer Institute (NCI)
2021 Phase 2 NCT04767984 United States;
Bitterschleifenblume-ganzpflanze 1,5ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Blood sample
Centre Hospitalier Universitaire de Saint Etienne
2017 - NCT03172195 France;
Blood samples
Centre Hospitalier Universitaire de Saint Etienne
2019 - NCT04030676 France;
2017 Phase 2 NCT03182166 France;
University Hospital, Bordeaux
2020 - NCT04272307 France;
Blood sampling, endoscopy
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Boulardii
University Clinic Dr Dragisa Misovic-Dedinje
2019 - NCT03941418 -
Bovine intestinal alkaline phosphatase (BIAP)
AM-Pharma
2006 Phase 2 NCT00727324 Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase (BIAP)
AM-Pharma B.V.
2006 - EUCTR2006-000197-69-CZ Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase BIAP
AM PHARMA B.V.
2006 - EUCTR2006-000197-69-IT Italy;
Brazikumab
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
AstraZeneca
2018 Phase 2 NCT04718818 Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States;
2018 Phase 2 NCT03616821 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Hibi Kazushige
2021 Phase 2 JPRN-jRCT2011210047 Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 JPRN-jRCT2011210030 Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Induction Dose
AstraZeneca
2020 Phase 2 NCT04277546 Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Maintenance Dose
AstraZeneca
2020 Phase 2 NCT04277546 Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brepocitinib
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Broccoli
University of Tsukuba
2020 - JPRN-UMIN000041972 Japan;
Budenofalk
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-SK Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 Phase 3 EUCTR2006-005377-22-ES Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 - EUCTR2006-005377-22-LV Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-LT Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-DE Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-CZ Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
- Phase 3 EUCTR2006-005377-22-PL Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Budenofalk 2mg rectal foam
University Hospital Birmingham NHS Foundation Trust
2009 Phase 4 EUCTR2009-015077-12-GB United Kingdom;
Budenofalk rectal foam
University Hospital Birmingham NHS Foundation Trust
2009 Phase 4 EUCTR2009-015077-12-GB United Kingdom;
Budenofalk® suppositories (BUS)
Dr. Falk Pharma GmbH
2021 Phase 3 EUCTR2019-003334-16-BG Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
2020 Phase 3 EUCTR2019-003334-16-DE Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
Budesonide
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2 JPRN-JapicCTI-132294 -
Bausch Health Americas, Inc.
2010 Phase 3 NCT01100112 India;
Dr. Falk Pharma GmbH
2015 Phase 2 NCT02550418 Germany;
2007 Phase 3 NCT00747110 Germany;
EA Pharma Co.,Ltd.
2018 - JPRN-JapicCTI-183858 Japan;
2014 Phase 3 JPRN-JapicCTI-142704 -
Hyogo College of Medicine
2018 - JPRN-UMIN000034016 Japan;
Matsuoka Katsuyoshi
2021 - JPRN-jRCTs031210326 Japan;
Budesonide (6 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Budesonide (9 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg capsules, hard (BUX-PV)
Dr. Falk Pharma GmbH
2015 Phase 2 EUCTR2014-005635-14-LV Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-LT Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-HU Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-DE Germany;Hungary;Latvia;Lithuania;
Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide MMX
COSMO TECHNOLOGIES LTD
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide MMX 6 mg Tablet
Bausch Health Americas, Inc.
2008 Phase 3 NCT00801723 Canada;United States;
Budesonide MMX®
Bausch Health Americas, Inc.
2012 Phase 3 NCT01532648 Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Ferring Pharmaceuticals
2015 - NCT02586259 Canada;Germany;Ireland;Israel;Italy;Netherlands;Poland;Sweden;Switzerland;United Kingdom;
Budesonide-MMX
COSMO TECHNOLOGIES LTD
2009 - EUCTR2008-003913-28-IT Italy;
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide-MMX®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
Santarus, Inc.
2012 - EUCTR2011-005115-82-PL Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-LV Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-LT Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-HU Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-EE Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-CZ Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-BG Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
Budesonide-MMX™
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Butyrate
Children's Hospital Los Angeles
2022 Phase 1 NCT05218850 United States;
By demand
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
CARVI EXTRACTUM FLUIDUM
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
CAT-354
ASTRAZENECA
2011 - EUCTR2011-004812-40-IT Czech Republic;Germany;Italy;Netherlands;United Kingdom;
AstraZeneca AB
2012 Phase 2 EUCTR2011-004812-40-GB Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-NL Czech Republic;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-DE Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-CZ Czech Republic;Italy;Netherlands;United Kingdom;
CB-01-02
COSMO TECHNOLOGIES LTD
2009 - EUCTR2008-003913-28-IT Italy;
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
CB-01-05-MMX
COSMO TECHNOLOGIES LTD
2006 - EUCTR2006-001782-42-IT Hungary;Italy;United Kingdom;
Cosmo Technologies Ltd
2006 Phase 2 EUCTR2006-001782-42-GB Hungary;Italy;United Kingdom;
2006 - EUCTR2006-001782-42-HU Hungary;Italy;United Kingdom;
CBP-307
Suzhou Connect Biopharmaceuticals, Ltd.
2019 Phase 2 NCT04700449 China;Pakistan;Ukraine;United States;
CC-10004
CELGENE CORPORATION
2015 Phase 2 EUCTR2014-002981-64-IT Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Celgene Corporation
2016 Phase 2 EUCTR2014-002981-64-BG Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 Phase 2 EUCTR2014-002981-64-NL Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;United Kingdom;United States;
2015 Phase 2 EUCTR2014-002981-64-DE Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 Phase 2 EUCTR2014-002981-64-CZ Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 - EUCTR2014-002981-64-HU Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Turkey;Ukraine;United Kingdom;United States;
CD7 CAR T-cells
Zhejiang University
2022 Early Phase 1 NCT05239702 China;
CGMP protein
University of Aarhus
2012 - NCT01534312 Denmark;
CLA (Chlorogenic acid)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
CLIPPER*30CPR 5MG R.M.
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
CNTO 148
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
CNTO-148
University Medical Centre Ljubljana, Department of gastroenterology
2020 Phase 4 EUCTR2019-003987-37-SI Slovenia;
CNTO1275
JANSSEN CILAG INTERNATIONAL NV
2015 Phase 3 EUCTR2014-005606-38-IT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 3 EUCTR2020-004457-76-PL Argentina;France;Japan;Poland;Russian Federation;Turkey;United States;
2021 Phase 3 EUCTR2019-004224-38-DE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004224-38-HU Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2020-004457-76-FR Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-PL Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-Outside-EU/EEA Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-GB Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-BE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
CNTO148
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2015 Phase 2 EUCTR2013-002042-36-FR Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-PL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-BG Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-NL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-HU Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-DE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-CZ Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-BE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO1959
JANSSEN CILAG INTERNATIONAL NV
2019 Phase 3 EUCTR2018-004002-25-IT Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 2;Phase 3 EUCTR2018-004002-25-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2018-004002-25-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-PT Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-ES Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-SE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-HU Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-GB Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-FR Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO312
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
COFFEE COAL
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
COLAL PRED
ALIZYME
2006 - EUCTR2004-005032-35-IT Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
COLAL-PRED®
Alizyme
2006 Phase 3 NCT00299013 Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom;
CP- 690 550
Pfizer
2008 Phase 2 NCT00787202 Belgium;Brazil;Chile;Czech Republic;Denmark;France;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Slovakia;South Africa;Spain;Sweden;Turkey;United Kingdom;
CP-690, 550-10
PFIZER INC
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
CP-690,500
Pfizer
2017 Phase 4 NCT03281304 Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
CP-690,550
PFIZER
2009 - EUCTR2008-004564-40-IT Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
Pfizer
2017 Phase 4 NCT03281304 Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01470612 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01458574 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer S.A
2008 Phase 2 EUCTR2008-004564-40-ES Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
Pfizer limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2009 Phase 2 EUCTR2008-004564-40-FR Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-SE Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-NL Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-GB Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-CZ Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-BE Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2008-004564-40-SK Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-004564-40-HU Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
CP-690,550-10
PFIZER INC
2018 Phase 3;Phase 4 EUCTR2017-002274-39-IT Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
PFIZER INC.
2013 - EUCTR2011-004578-27-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
PFIZER LIMITED
2013 Phase 3 EUCTR2011-004580-79-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-IT Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc
2012 Phase 3 EUCTR2011-004580-79-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 3;Phase 4 EUCTR2017-002274-39-NL Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-CZ Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-BE Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002274-39-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-002274-39-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-004580-79-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004579-35-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-AT Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004581-14-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2022 Phase 3 EUCTR2018-002378-30-HU Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-SK Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-SK Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-PL Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-DE Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-BE Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CP690,550
Pfizer
2012 Phase 3 NCT01458574 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CS (corticosteroids) Only
Shaare Zedek Medical Center
2014 - NCT02033408 Canada;Finland;Israel;Italy;Poland;Spain;
CT-P13
Celltrion
2016 Phase 1 NCT02883452 Korea, Republic of;
Pfizer
2015 - NCT02539368 Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom;
CT-P13 SC (Infliximab)
Celltrion
2020 Phase 3 NCT04205643 Poland;
CYCLOSPORINE VS INFLIXIMAB
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2007 Phase 4 NCT00542152 Belgium;Finland;France;Italy;Spain;
Caffeine
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Calcitonin nasal spray (salmon)
Children's Hospital Boston
2004 - NCT00114803 United States;
Caltrate
Second Affiliated Hospital of Wenzhou Medical University
2015 - NCT04276649 China;
Cannabidiol
Meir Medical Center
2010 Phase 1/Phase 2 NCT01037322 Israel;
Cannabis, Medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Carbon
Hyogo College of Medicine, Department of Internal medicine, Division of Lower GI disease
2007 Phase 2,3 JPRN-UMIN000004401 Japan;
Carbon dioxide
Osaka University, Graduate School of Medicine,Department of Gastroenterology and Hepatology
2015 - JPRN-UMIN000018801 Japan;
Carrageenan
University of Illinois at Chicago
2010 - NCT01065571 United States;
Casein glycomacropeptide (CGMP)
University of Aarhus
2016 - NCT02825914 Denmark;
Catridecacog
Novo Nordisk A/S
2013 - EUCTR2011-001568-22-HU Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 Phase 2 NCT01706159 Bulgaria;Croatia;Denmark;Hungary;Poland;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-DK Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-BG Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
Ceftriaxone
Postgraduate Institute of Medical Education and Research
2019 Phase 2 NCT03794765 India;
Cefuroxime
University of Dundee
2006 - NCT00355602 United Kingdom;
Cholecalciferol
Boston Children’s Hospital
2008 - NCT00621257 United States;
Medical clinic, University Hospital of North Norway
2009 - EUCTR2009-015649-21-NO Norway;
Ciclosporin
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
Ciclosporina
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Cimzia
University of Washington
2010 Phase 2 NCT01090154 United States;
Ciprofloxacin
Hvidovre University Hospital
2011 Phase 4 NCT01772615 Denmark;
University of Dundee
2006 - NCT00355602 United Kingdom;
Clarithromycin
University of Dundee
2006 - NCT00355602 United Kingdom;
Clipper
CHIESI ESPAÑA S.A.U.
2017 Phase 3 EUCTR2017-000330-61-ES Spain;
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
2007 - EUCTR2006-004230-32-ES Belgium;Italy;Poland;Spain;
Clipper 30 cpr 5mg R.M.
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Clotrimazole
Paul Rufo
2002 Phase 1/Phase 2 NCT00061282 United States;
Coamoxiclav
University of Dundee
2006 - NCT00355602 United Kingdom;
Cobitolimod
INDEX PHARMACEUTICALS AB
2021 Phase 3 EUCTR2021-002549-13-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2016-004217-26-IT Czech Republic;France;Germany;Hungary;Italy;Montenegro;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
InDex Pharmaceuticals
2021 Phase 3 NCT04985968 Hungary;
2017 Phase 2 NCT03178669 Czechia;France;Germany;Hungary;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;
InDex Pharmaceuticals AB
2021 Phase 1;Phase 2 EUCTR2021-003023-14-SE Sweden;
2017 Phase 2 EUCTR2016-004217-26-SE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-HU Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-FR Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-ES Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-DE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-CZ Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
Colectomy
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Colonoscopy
London North West Healthcare NHS Trust
2006 - NCT00292175 United Kingdom;
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Colorectal biopsies
University Hospital, Bordeaux
2020 - NCT04272307 France;
Coltect
Tel-Aviv Sourasky Medical Center
2008 - NCT00793130 Israel;
Combination Oral Budesonide and Rectal Hydrocortisone
University of Maryland, Baltimore
2008 Phase 2 NCT00805285 United States;
Combination Product: Beclomethasone dipropionate in addition to MC-EVOO
Casa Sollievo della Sofferenza IRCCS
2017 - NCT03408847 Italy;
Combination Product: Beclomethasone dipropionate in addition to refined oil
Casa Sollievo della Sofferenza IRCCS
2017 - NCT03408847 Italy;
Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator
Cristcot LLC
2020 Phase 3 NCT04469686 Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States;
Companion Diagnostic (CDx) Testing
Prometheus Biosciences, Inc.
2021 Phase 2 NCT04996797 United States;
Corticosteroid
Sixth Affiliated Hospital, Sun Yat-sen University
2021 - NCT04879966 China;
Tampere University Hospital
2015 - NCT04564638 -
Corticosteroids
Centre Hospitalier Universitaire de Saint Etienne
2016 Phase 3 NCT02665845 France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Children's Hospital of Fudan University
2021 Phase 4 NCT04999228 -
Jinling Hospital, China
2013 Phase 1/Phase 2 NCT02922374 China;
Corticosteroids only
Sheba Medical Center
2013 Phase 4 NCT01941589 China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
CortimentMMX
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
CosmoFer 50mg/ml solution for infusion or injection
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Cotrimoxazole
University of Dundee
2006 - NCT00355602 United Kingdom;
Curcumin
Chinese University of Hong Kong
2017 - NCT03122613 Hong Kong;
Schneider Children's Medical Center, Israel
2020 Phase 3 NCT02277223 Israel;
Seattle Children's Hospital
2009 Phase 1 NCT00889161 United States;
Sheba Medical Center
2011 Phase 3 NCT01320436 Israel;
Tianjin Medical University General Hospital
2019 Phase 0 ChiCTR1900022243 China;
CyCol
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
CyCol™
Sigmoid Pharma
2010 Phase 2 NCT01033305 Ireland;United Kingdom;
Cyclosporine
Chiba University Hospital
2013 - JPRN-UMIN000010776 Japan;
Postgraduate Institute of Medical Education and Research
2021 - NCT05112263 -
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Cyclosporine (USAN)
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
Cytochrome P450 (CYP) Substrates
AbbVie
2020 Phase 1 NCT04254783 Germany;Israel;United States;
D.3.6.2.1 - valore: 45 / 0.45 mg/ml
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
D.3.6.2.1 - valore: 5 o
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
DACORTIN
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2007 - EUCTR2007-003815-30-ES Portugal;Spain;
DAND (14-Deoxyandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DDAND (14-deoxy-11,12-didehydroandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DELTACORTENE FORTE*10CPR
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
DELTACORTENE*20CPR
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
DEXTRAN 1 FOR INJECTION
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
DIMS0150
INDEX PHARMACEUTICALS
2012 - EUCTR2011-003130-14-IT Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals AB
2021 Phase 1;Phase 2 EUCTR2021-003023-14-SE Sweden;
2017 Phase 2 EUCTR2016-004217-26-SE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-HU Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-FR Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-ES Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-DE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-CZ Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2012 - EUCTR2011-003130-14-CZ Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 Phase 3 EUCTR2011-003130-14-GB Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-PL Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-HU Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-DE Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2006 - EUCTR2006-001846-15-SE Sweden;
Daclizumab
Facet Biotech
2003 Phase 2 NCT00073047 Belgium;Canada;United States;
Dacortin
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2009 - EUCTR2007-003815-30-PT Portugal;Spain;
Decortin H
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Dekavil
PFIZER INC
2018 Phase 2 EUCTR2017-002108-28-IT Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
Dekristol
Medical clinic, University Hospital of North Norway
2009 - EUCTR2009-015649-21-NO Norway;
Delayed and extended release mesalazine
Shire
2003 Phase 3 NCT00503243 United States;
Deligoparin
Incara Pharmaceuticals
2001 Phase 2/Phase 3 NCT00033943 United States;
Delmitide acetate
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
Deltacortene
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
2007 - EUCTR2006-004230-32-ES Belgium;Italy;Poland;Spain;
Deltacortene 10 cpr
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Deltacortene 20 cpr
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Dersalazina sodica
Palau Pharma S.A.
2008 - EUCTR2008-004610-27-ES Belgium;Hungary;Spain;
Dersalazine sodium
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 Phase 2 NCT00808977 Belgium;Hungary;Slovakia;Spain;
2008 - EUCTR2008-004610-27-ES Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Deucravacitinib
BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
2021 Phase 2 EUCTR2020-004461-40-IT Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
Dexamethasone 21-phosphate
Casa Sollievo della Sofferenza IRCCS
2003 Phase 2 NCT01171807 Italy;
Dextromethorphan
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Diet
Assiut University
2020 - NCT04332328 -
Doxycycline
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
University of Dundee
2006 - NCT00355602 United Kingdom;
E. coli Nissle
Hvidovre University Hospital
2011 Phase 4 NCT01772615 Denmark;
E. coli Nissle 1917 (Mutaflor®)
Kangbuk Samsung Hospital
2018 Phase 4 NCT04969679 Korea, Republic of;
E6007
EA Pharma Co., Ltd.
2016 Phase 2 NCT03018054 Japan;
EGF enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
EMEA/H/C/000240
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
EMEA/H/C/000481
Odense University Hospital
2011 Phase 3 EUCTR2011-004268-31-DK Denmark;
EN
Friendship Hospital of Capital Medical University
2008 Phase 1 study ChiCTR-TRC-08000145 China;
ENTOCORT CR
COSMO TECHNOLOGIES LTD
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
2016 Phase 4 EUCTR2015-003270-32-IT Italy;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Ecologic 825
Wageningen University
2014 - NCT02361957 Netherlands;
Efavaleukin alfa
Amgen
2022 Phase 2 NCT04987307 Austria;Bulgaria;Japan;Korea, Republic of;Poland;United States;
Efmarodocokin alfa
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-IE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Eicosapentaenoic acid
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
2014 - NCT02179372 Italy;
Empagliflozin
Sadat City University
2021 Phase 2 NCT05058417 Egypt;
Encapsulated Mesalamine Granules (eMG)
Bausch Health Americas, Inc.
2005 Phase 3 NCT00326209 United States;
Encapsulated faecal microbiota filtrate
Jena University Hospital
2021 Phase 2/Phase 3 NCT03843385 -
Enema
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Entecavir
Saitama Medical University
2016 - JPRN-UMIN000020029 Japan;
Entocort EC®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Entocort® CR
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Entyvio
ALIMENTIV INC.
2021 Phase 4 EUCTR2019-002485-12-IT Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Academic Medical Center, Gastroenterology
2017 Phase 4 EUCTR2014-005443-40-HU Belgium;Hungary;Netherlands;
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-NL Belgium;Hungary;Netherlands;
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
Alimentiv Inc.
2021 Phase 4 EUCTR2019-002485-12-PL Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 4 EUCTR2019-002485-12-NL Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Alimentiv Inc. (formerly Robarts Clinical Trials)
2020 Phase 4 EUCTR2019-002485-12-GB Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Eli Lilly and Company
2021 Phase 3 EUCTR2019-001653-99-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001653-99-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe Limited
2017 Phase 4 EUCTR2016-000678-40-BG Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-LV Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-HU Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-EE Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
Epaxal Berna (virosomal hepatitis A vaccine)
Asan Medical Center
2011 Phase 4 NCT01341808 Korea, Republic of;
Epidermal growth factor enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Ergocalciferol
Boston Children’s Hospital
2008 - NCT00621257 United States;
Etrasimod
Arena Pharmaceuticals
2022 Phase 2 NCT05287126 -
2021 Phase 2 NCT05061446 Japan;
2021 Phase 2 NCT04607837 Australia;Belarus;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States;
2020 Phase 3 NCT04706793 Japan;
2020 Phase 3 NCT03996369 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 NCT03950232 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 NCT03945188 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 NCT02536404 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 NCT02447302 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Everstar Therapeutics Limited
2019 Phase 3 NCT04176588 China;
IQVIA Services Japan K.K. ICCC:
2021 Phase 3 JPRN-jRCT2071200081 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea;Lebanon;Mexico;Moldova;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;
2020 Phase 3 JPRN-jRCT2071200080 Japan;
Tanabe Masakazu
2021 Phase 2 JPRN-jRCT2071210052 Japan;
Etrasimod L-arginine
ARENA PHARMACEUTICALS, INC.
2021 Phase 2 EUCTR2020-003507-34-IT Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2019 Phase 3 EUCTR2018-003987-29-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
Etrolizumab
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Genentech, Inc.
2011 Phase 2 NCT01461317 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
Hoffmann-La Roche
2018 Phase 1 NCT03478956 Belgium;Germany;Poland;Spain;United Kingdom;United States;
2014 Phase 3 NCT02171429 Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 NCT02165215 Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Hungary;India;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 NCT02163759 Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 NCT02136069 Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 NCT02118584 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Etrozulimab
Hoffmann-La Roche
2014 Phase 3 NCT02100696 Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
ExoFlo
Direct Biologics, LLC
2022 Phase 1 NCT05176366 -
Exposure to golimumab
University of Zurich
2018 - NCT03394586 Switzerland;
F8IL10
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
FE 999301
University Hospital Schleswig-Holstein (UKSH)
2016 Phase 2 EUCTR2016-000205-36-DE Germany;
FMT
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Yanling Wei
2015 Phase 2 NCT02335281 China;
FMT enema
University of British Columbia
2020 Phase 2 NCT04202211 Canada;
FMT infusions
The University of New South Wales
2013 Phase 2 NCT01896635 Australia;
FMT oral
University of British Columbia
2020 Phase 2 NCT04202211 Canada;
FP-110
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
FP-CYA-050
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
FP-CYA-053
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Faecal Microbiota Transplant
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Faecal Microbiota Transplantation
St Vincent's Hospital Melbourne
2018 - NCT03477032 Australia;
Faecal matter
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Faecal microbiota transplantation
Torkell Ellingsen
2022 Phase 2 NCT04924270 -
Fecal Microbial Transplant
Children's Hospital Los Angeles
2016 Phase 1 NCT02291523 United States;
Fecal Microbial Transplantation
Stony Brook University
2013 Early Phase 1 NCT03268213 United States;
Fecal Microbiota
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Fecal Microbiota Enema
McMaster Children's Hospital
2015 Phase 1 NCT02487238 Canada;
Fecal Microbiota Transplant
Baylor College of Medicine
2014 Phase 1 NCT01947101 United States;
Children's Hospital of Philadelphia
2015 - NCT02636517 United States;
University of Alberta
2014 Phase 1/Phase 2 NCT02227342 Canada;
University of Vermont
2015 Early Phase 1 NCT02390726 United States;
Fecal Microbiota Transplant (FMT)
Stacy A. Kahn
2015 Phase 1/Phase 2 NCT02330653 United States;
Fecal Microbiota Transplantation
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
Dayanand Medical College and Hospital
2018 Phase 3 NCT03716388 India;
Jun Liu
2015 Phase 2/Phase 3 NCT02435160 -
Weill Medical College of Cornell University
2020 Phase 2 NCT03998488 United States;
2016 Phase 1 NCT02516384 United States;
Fecal Microbiota Transplantation (FMT)
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03483246 France;
Children's Mercy Hospital Kansas City
2014 Phase 1 NCT02108821 United States;
Fecal Microbiota Transplantation (FMT), OpenBiome
Najwa Elnachef
2017 Phase 1 NCT03006809 United States;
Fecal microbiota
University of Minnesota
2019 Phase 1 NCT03948919 United States;
Fecal microbiota capsule
Zhongshan Hospital Xiamen University
2020 Phase 1 NCT04521205 China;
Fecal microbiota transplantation
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
Gulhane Military Medical Academy
2015 Phase 3 NCT02575040 Turkey;
Helsinki University Central Hospital
2018 Phase 2 NCT03378921 Finland;
McMaster University
2021 Phase 4 NCT04231110 Canada;
The Second Hospital of Nanjing Medical University
2016 Phase 4 NCT02998112 China;
University of Chicago
2013 Phase 1 NCT02058524 United States;
Ferric carboxymaltose
Vifor Inc.
2008 Phase 3 NCT00810030 Austria;Russian Federation;
Ferrous sulphate
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Queen Mary University of London
2011 Phase 4 NCT01991314 United Kingdom;
Filgotinib
GILEAD SCIENCES INCORPORATED
2018 Phase 3 EUCTR2016-002765-58-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001392-78-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences
2018 Phase 1 NCT03417778 Germany;New Zealand;United States;
2017 Phase 3 NCT02914535 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 NCT02914522 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Film-coated tablet
LG Chem
2020 Phase 1 NCT04360343 Korea, Republic of;
Flagyl
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
Flaxseed lignan-enriched complex (FLC)
University of Saskatchewan
2018 Phase 2 NCT02201758 Canada;
Flixabi
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
UMC Amsterdam location AMC
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
University Southampton Hospital NHS Foundation Trust
2018 Phase 4 EUCTR2018-001546-33-GB United Kingdom;
Fluorescein
Fujita Health University School of Medicine, Department of Gastroenterology
2017 - JPRN-UMIN000032250 Japan;
Ohmiya Naoki
2017 - JPRN-jRCTs041180035 Japan;
Flupentixol
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Fosfomycin
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Freeze-dried black raspberry powder
UConn Health
2013 Phase 1 NCT02267694 United States;
G1567970
Galapagos NV
2020 Phase 2 EUCTR2020-000659-11-PL Georgia;Moldova, Republic of;Poland;Ukraine;
G321605
Galapagos NV
2015 Phase 2 EUCTR2014-001893-32-CZ Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2015 - EUCTR2014-001893-32-PL Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-HU Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-DE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-BE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GB004
GB004, Inc.
2020 Phase 2 NCT04556383 Australia;Georgia;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
2019 Phase 1 NCT03860896 Georgia;Moldova, Republic of;United States;
GB004-HCl
GB004, Inc.
2021 Phase 2 EUCTR2020-002306-12-PL Australia;Belarus;Georgia;Italy;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
GED-0301
Celgene
2015 Phase 2 NCT02601300 Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
Celgene Corporation
2016 Phase 2 EUCTR2015-003364-36-SK Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-HU Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-BG Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
GED-0507-34-Levo
GIULIANI
2012 - EUCTR2011-003283-78-IT Italy;
PPM Services S.A.
2016 Phase 2 NCT02808390 Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine;United States;
GED0507
PPM SERVICES SA
2017 Phase 2 EUCTR2016-001684-36-LV Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2017 Phase 2 EUCTR2016-001684-36-ES Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2016 Phase 2 EUCTR2016-001684-36-SK Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-HU Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-BG Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
GI-270384
GlaxoSmithKline
2004 Phase 1 NCT00457171 Netherlands;
GLPG0974
Galapagos NV
2013 Phase 2 NCT01829321 Belgium;Czech Republic;Latvia;Slovakia;
2013 Phase 2 EUCTR2012-005521-73-BE Belgium;Czech Republic;Latvia;
2013 - EUCTR2012-005521-73-LV Czech Republic;Latvia;
2013 - EUCTR2012-005521-73-CZ Belgium;Czech Republic;Latvia;
GLPG1205
Galapagos NV
2015 Phase 2 EUCTR2014-001893-32-CZ Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2015 - EUCTR2014-001893-32-PL Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 Phase 2 NCT02337608 Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-HU Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-DE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-BE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GLPG3970
Galapagos NV
2020 Phase 2 NCT04577794 Georgia;Moldova, Republic of;Poland;Ukraine;
2020 Phase 2 EUCTR2020-000659-11-PL Georgia;Moldova, Republic of;Poland;Ukraine;
GLYCYRRHIZA GLABRA ROOT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
GM-CSF, fosfomycin and metronidazole
Zealand University Hospital
2021 Phase 1/Phase 2 NCT04979832 Denmark;
GS-4875
GILEAD SCIENCES INCORPORATED
2020 Phase 2 EUCTR2019-001430-33-IT Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
Gilead Sciences, Inc.
2020 Phase 2 EUCTR2019-001430-33-PL Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-GB Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-DE Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-AT Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
GS-5745
Gilead Sciences
2013 Phase 1 NCT01831427 Belgium;Canada;Hungary;Moldova, Republic of;Netherlands;Romania;United States;
Gilead Sciences, Inc
2016 Phase 2;Phase 3 EUCTR2014-005217-24-SE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-IS Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-HR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-BG Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-BE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-SK Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-NL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-LV Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-IE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-GB Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-CZ Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-AT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
GS-5745 IV
Gilead Sciences
2014 Phase 1 NCT02209987 New Zealand;
GS-5745 SC
Gilead Sciences
2014 Phase 1 NCT02209987 New Zealand;
GS-6034
GILEAD SCIENCES INCORPORATED
2018 Phase 3 EUCTR2016-002765-58-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001392-78-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Galapagos NV
2017 Phase 3 EUCTR2016-002765-58-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences, Inc
2017 Phase 3 EUCTR2016-002765-58-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences, Inc.
2018 Phase 2 EUCTR2017-000402-38-SE Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-PT Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-NL Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-GB Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-DE Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-BE Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-AT Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-IS Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-IS Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-002765-58-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-001392-78-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
GSK1399686
GlaxoSmithKline
2009 Phase 2 NCT01036022 Belgium;Canada;Germany;Norway;Sweden;
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
GSK1605786
GlaxoSmithKline
2013 Phase 2 NCT01658605 Belgium;Netherlands;United Kingdom;
GSK1605786A
GlaxoSmithKline Research & Development Ltd
2012 Phase 2 EUCTR2011-002818-37-BE Belgium;Netherlands;United Kingdom;
2012 - EUCTR2011-002818-37-NL Netherlands;United Kingdom;
2012 - EUCTR2011-002818-37-GB Netherlands;United Kingdom;
GSK2586184
GlaxoSmithKline
2013 Phase 1 NCT02000453 Netherlands;
GSK2831781
GlaxoSmithKline Research & Development Limited
2020 Phase 2 EUCTR2018-003278-28-BG Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-PL Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-NL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-HU Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-GB Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-FR Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-CZ Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Double Blind Phase
GlaxoSmithKline
2019 Phase 2 NCT03893565 Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Open Label phase
GlaxoSmithKline
2019 Phase 2 NCT03893565 Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2982772
GlaxoSmithKline
2016 Phase 2 NCT02903966 Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
GlaxoSmithKline Research & Development Ltd
2017 Phase 2 EUCTR2016-001833-29-PL Germany;Netherlands;Poland;Sweden;United Kingdom;
2017 Phase 2 EUCTR2016-001833-29-NL Germany;Netherlands;Poland;Sweden;United Kingdom;
2016 Phase 2 EUCTR2016-001833-29-SE Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001833-29-GB Germany;Netherlands;Poland;Sweden;United Kingdom;
GSK2982772A, where A denotes the free base
GlaxoSmithKline Research & Development Ltd
2017 Phase 2 EUCTR2016-001833-29-PL Germany;Netherlands;Poland;Sweden;United Kingdom;
2017 Phase 2 EUCTR2016-001833-29-NL Germany;Netherlands;Poland;Sweden;United Kingdom;
2016 Phase 2 EUCTR2016-001833-29-SE Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001833-29-GB Germany;Netherlands;Poland;Sweden;United Kingdom;
GWP42003
GW Pharma Ltd.
2013 Phase 2 EUCTR2011-003208-19-CZ Czech Republic;United Kingdom;
2011 Phase 2 EUCTR2011-003208-19-GB Czech Republic;United Kingdom;
GW Research Ltd
2012 Phase 2 NCT01562314 Czech Republic;United Kingdom;
Ganciclovir
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2016 - JPRN-UMIN000022588 Japan;
Graduate School of Medicine, Kyoto University, Gastroenterology and Hepatology
2007 - JPRN-UMIN000013925 Japan;
Gastro-resistant phosphatidylcholine granules
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Gastroscopy
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Glutamine
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Gold
Peking University First Hospital
2018 - ChiCTR1800019676 China;
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
2012 - ChiCTR1900023689 China;
Golimumab
Guy's and St Thomas' NHS Foundation Trust
2017 Phase 4 NCT03124121 United Kingdom;
2017 Phase 4 EUCTR2017-001374-42-GB United Kingdom;
Hospital San Carlos, Madrid
2019 - NCT03773445 Spain;
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
2016 - NCT03018925 Spain;
Istituto Clinico Humanitas
2015 Phase 4 NCT02412085 Italy;
JANSSEN PHARMACEUTICAL K.K
2008 Phase 3 JPRN-JapicCTI-090740 -
2008 Phase 2-3 JPRN-JapicCTI-090739 -
Janssen Biologics B.V.
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Janssen Pharmaceutical K.K.
2013 Phase 3 NCT01863771 Japan;
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
2018 Phase 3 NCT03596645 Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2013 Phase 2 NCT01988961 Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Russian Federation;Ukraine;United States;
2013 Phase 1 NCT01900574 Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2007 Phase 3 NCT00488631 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 2/Phase 3 NCT00487539 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
Janssen Scientific Affairs, LLC
2013 Phase 4 NCT01804166 United States;
Kliniken im Naturpark Altmuehltal
2014 Phase 4 NCT02186886 Germany;
MSD
2014 Phase 4 EUCTR2013-004583-56-GB United Kingdom;
Merck Sharp & Dohme Corp.
2015 Phase 4 NCT02318667 Portugal;
2014 Phase 4 NCT02092285 United Kingdom;
Golimumab (GLM)
University College Dublin
2016 Phase 4 NCT02687724 Ireland;
Golimumab (Optimization)
Centre Hospitalier Universitaire de Saint Etienne
2017 Phase 2 NCT03182166 France;
Golimumab 1 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 2 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 4 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg
Hospital de Manises
2018 Phase 4 NCT03669029 Spain;
Golimumab Dose 1
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Dose 2
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Liquid in Vial
Centocor BV
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Golimumab Liquid in prefilled syringe
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Golimumab Prefilled Syringe
David Drobne
2020 Phase 4 NCT04156984 Slovenia;
Golimumab treatment optimization.
Hospital de Manises
2018 Phase 4 NCT03669029 Spain;
Gralise
Shirley Ryan AbilityLab
2012 Phase 4 NCT01678911 United States;
Granulated mesalamine
Bausch Health Americas, Inc.
2004 Phase 3 NCT00767728 United States;
2004 Phase 3 NCT00744016 United States;
Grapefruit
Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
2014 - JPRN-UMIN000013546 Japan;
Group 1- Control Diet
Prof. Arie Levine
2020 - NCT03980405 Israel;
Group 2- UCD Diet
Prof. Arie Levine
2020 - NCT03980405 Israel;
Guaiazulene
Mie University Graduate School of Medicine, Gastrointestinal and Pediatric Surgery
2013 - JPRN-UMIN000013266 Japan;
Guselkum
Janssen-Cilag International NV
2020 Phase 2;Phase 3 EUCTR2018-004002-25-ES Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-FR Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Guselkumab
Janssen Pharmaceutical K.K.
2020 Phase 2-3 JPRN-JapicCTI-194980 Japan, Asia except Japan, North America, Europe;
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
2019 Phase 2/Phase 3 NCT04033445 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 2;Phase 3 EUCTR2018-004002-25-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2018-004002-25-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-GB Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 1
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 2
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
H02AB
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2009 - EUCTR2007-003815-30-PT Portugal;Spain;
HE3286
Harbor Therapeutics
2008 Phase 1/Phase 2 NCT00628433 United States;
HF2
Sheba Medical Center
2019 Phase 1/Phase 2 NCT03720002 Israel;
HGS1025
Human Genome Sciences Inc.
2011 Phase 1 NCT01434576 -
HM201
Syneos Health
2021 Early Phase 1 NCT05088369 -
HMPL-004
Hutchison MediPharma Enterprises Limited
2008 - EUCTR2007-005166-12-DE Germany;
Hutchison Medipharma Limited
2013 Phase 3 NCT01882764 United States;
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
HMPL-004 1800 mg/day
Hutchison Medipharma Limited
2013 Phase 3 NCT01805791 United States;
HMPL-004 2400 mg/day
Hutchison Medipharma Limited
2013 Phase 3 NCT01805791 United States;
HMPL-004 high dose
Hutchison Medipharma Limited
2008 Phase 2 NCT00659802 United States;
HMPL-004 low dose
Hutchison Medipharma Limited
2008 Phase 2 NCT00659802 United States;
HMPL004-6599
Nutrition Science Partners Limited
2018 Phase 1 NCT03597971 Australia;
HUMIRA
Abbott GmbH Co. KG
2007 - EUCTR2006-002781-20-IT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
GETAID
2019 Phase 4 EUCTR2018-003490-10-FR France;
HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
HUMIRA 40Mg Solution for Injection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
2019 Phase 4 NCT04131322 Spain;
HUMIRA ®
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
Hemay007
Tianjin Hemay Pharmaceutical Co.,Ltd
2019 Phase 2 NCT03977480 China;
Herbal treatment (SA100)
Stanford University
2014 Phase 1 NCT02442960 United States;
Hextend
Spectrum Health Hospitals
2007 Phase 3 NCT00467922 United States;
Hgd40
sterna biologicals GmbH & Co. KG
2014 Phase 2 EUCTR2013-004599-36-DE Germany;
High Dose Budesonide
Bausch Health Americas, Inc.
2022 Phase 4 NCT04314375 -
High Dose MT-1303
Bausch Health Americas, Inc.
2021 Phase 2 NCT04857112 United States;
High Protein and Low Fiber Diet
Mayo Clinic
2021 - NCT04933162 United States;
High dose
Holy Stone Healthcare Co., Ltd
2016 Phase 2 NCT02493712 Italy;Taiwan;
HuM291
Facet Biotech
2007 Phase 3 NCT00502294 -
PDL BioPharma , Inc.
2006 - EUCTR2005-003482-17-IT Greece;Ireland;Italy;Spain;United Kingdom;
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Hulio
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Human Anti-TNF IgG1 Monoclonal Antibody
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human Anti-TNFalfa
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human anti-IP10 monoclonal antibody
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-IT Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Human anti-TNF-alpha monoclonal antibody
Janssen Biologics B.V.
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Humanized recombinant IgG4 monoclonal antibody against CD-127
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-LV Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Humira
Abbott GmbH & Co. KG
2008 - EUCTR2006-002782-40-DE Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002782-40-AT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002781-20-SE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2008 - EUCTR2006-002781-20-AT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 Phase 3 EUCTR2006-002782-40-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 Phase 3 EUCTR2006-002781-20-SK Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
2007 - EUCTR2006-002782-40-PT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-HU Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-DK Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-CZ Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002781-20-HU Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-DE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-CZ Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-BE Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
F. Hoffmann-La Roche Ltd
2019 Phase 3 EUCTR2013-004279-11-FR Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-HU Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-CZ Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2013-004279-11-BG Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2015 Phase 3 EUCTR2013-004277-27-BG Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-SK Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-EE Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LV Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LT Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-HR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-GR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Humira (adalimumab original)
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringe
ABBOTT GMBH & Co. KG
2012 - EUCTR2011-002411-29-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
AbbVie Deutschland GmbH & Co. KG
2013 - EUCTR2011-002411-29-SK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2013 - EUCTR2011-002411-29-PL Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2013 - EUCTR2011-002411-29-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-SE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-IE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-DE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-BE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
Abbott GmbH & Co. KG
2012 - EUCTR2011-002411-29-GR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
Abbvie Deutschland GmbH & Co. KG
2012 - EUCTR2011-002411-29-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringes
Odense University Hospital
2011 Phase 3 EUCTR2011-004268-31-DK Denmark;
Humira 40 mg/0.8 ml solution for injection
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2013-001682-16-DK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2015 Phase 3 EUCTR2013-001682-16-BE Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-SK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-PL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-HU Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-ES Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-DE Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-AT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
AbbVie Inc.
- - EUCTR2014-004559-29-Outside-EU/EEA Japan;
Humira 40 mg/0.8 ml solution for injection for paediatric use
AbbVie Deutschland GmbH & Co. KG
2017 Phase 3 EUCTR2015-001346-29-CZ Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-HU Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-GB Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-ES Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-BE Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-IT Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-HU Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-GB Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-SE Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-AT Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
Abbvie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2013-003032-77-PL Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-BE Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2013-003032-77-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira®
Samsung Bioepis Co., Ltd.
2014 Phase 3 EUCTR2013-005013-13-BG Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-PL Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-LT Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-CZ Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
Hydrocortisone
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Hydrogen
411th Hospital of PLA
2013 - ChiCTR-TRC-13003530 China;
Juntendo University Hospital
2020 - JPRN-UMIN000042017 Japan;
Hydroxocobalamin with Butyrate
Joshua Korzenik
2020 Phase 2 NCT04259060 United States;
Hydroxychloroquine
Icahn School of Medicine at Mount Sinai
2022 Phase 1/Phase 2 NCT05119140 United States;
Hyperbaric oxygen
Dartmouth-Hitchcock Medical Center
2013 Phase 2/Phase 3 NCT02144350 United States;
IBD98-M Delayed-release Capsules
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
IDOFORM®Travel
Oslo University Hospital
2020 Phase 1 NCT04241029 Norway;
IM90838
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
IMU-838
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03341962 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
INCB039110
Incyte Corporation
2020 Phase 2 EUCTR2018-004491-35-RO Czechia;Germany;Poland;Romania;United States;
2019 Phase 2 EUCTR2018-004491-35-PL Czech Republic;Germany;Poland;Romania;United States;
ITACITINIB ADIPATE
Incyte Corporation
2020 Phase 2 EUCTR2018-004491-35-RO Czechia;Germany;Poland;Romania;United States;
2019 Phase 2 EUCTR2018-004491-35-PL Czech Republic;Germany;Poland;Romania;United States;
IV Corticosteroid
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Iberogast N
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Imolope
Department of surgery, Odense University Hospital
2014 Phase 4 EUCTR2014-004740-35-DK Denmark;
Impact
Hospices Civils de Lyon
2018 - NCT03504930 France;
Lawson Health Research Institute
2016 - NCT02742597 Canada;
Imuran
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Imurek 25mg Filmtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Imurek 50mg Filmtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Imurel
Hvidovre Hospital
2016 Phase 3 EUCTR2016-002433-30-DK Denmark;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
Infectofos
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Inflectra
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Celltrion, Inc.
2020 Phase 3 EUCTR2019-003849-15-HR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-GR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-FR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-ES Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-CZ Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-BG Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-AT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Erasmus Medical Center
2019 Phase 4 EUCTR2018-004587-61-NL Netherlands;
Pfizer
2018 - NCT03801928 Canada;United States;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Inflectra 100 mg powder for concentrate for solution for infusion
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
Infliximab
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2019 Phase 4 NCT03937609 Netherlands;
Alimentiv Inc.
2018 - NCT03765450 Canada;United States;
Austin Health
2016 Phase 4 NCT02770040 Australia;
CENTOCOR
2007 - EUCTR2006-000410-20-IT Belgium;Denmark;Italy;Netherlands;
Centocor BV
2007 - EUCTR2006-000410-20-DK Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-BE Belgium;Denmark;Italy;Netherlands;
Centocor, Inc.
2006 Phase 3 NCT00336492 Belgium;Canada;Denmark;Netherlands;United States;
2002 Phase 3 NCT00096655 -
2002 Phase 3 NCT00036439 Belgium;United States;
Chiba University Hospital
2012 Phase 2 JPRN-UMIN000015297 Japan;
2012 Phase 2 JPRN-UMIN000007806 Japan;
Children's Hospital of Fudan University
2021 Phase 4 NCT04999228 -
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2011 - JPRN-UMIN000006141 Japan;
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
2013 Phase 4 JPRN-UMIN000010612 Japan;
Department of Internal Medicine,Juntendo University
2014 - JPRN-UMIN000013033 Japan;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Fukuoka University Chikushi Hospital
2021 - JPRN-UMIN000043165 Japan;
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Grupo de Estudo da Doença Inflamatória Intestinal
2011 Phase 4 NCT01408810 Portugal;
Hikma Pharmaceuticals LLC
2018 - NCT03452501 Saudi Arabia;
Hiroshima University Hospital, Department of Endoscopy
2014 - JPRN-UMIN000015068 Japan;
Hoffmann-La Roche
2014 Phase 3 NCT02136069 Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Hyogo College of Medicine
2014 Phase 1 JPRN-UMIN000014275 Japan;
Hyogo college of medicine
2013 - JPRN-UMIN000013371 Japan;
Inflammatory bowel disease center, Hyogo college of medicine
2013 Phase 1 JPRN-UMIN000013370 Japan;
Istituto Clinico Humanitas
2017 Phase 4 NCT03151525 Italy;
Janssen Research & Development, LLC
2018 Phase 3 NCT03596645 Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2004 - NCT00207688 Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Israel;Netherlands;New Zealand;Switzerland;United Kingdom;United States;
Janssen Scientific Affairs, LLC
2013 Phase 4 NCT01804166 United States;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
2007 - NCT00705484 Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Nagoya University Graduate School of Medicine, Department of Gastroentrology and hepatology
2015 - JPRN-UMIN000018745 Japan;
Rennes University Hospital
2019 Phase 4 NCT03679546 France;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schneider Children's Medical Center, Israel
2018 - NCT03209232 Israel;
Sixth Affiliated Hospital, Sun Yat-sen University
2021 - NCT04879966 China;
Tohoku University Graduate School of Medicine (Tohoku University Hospital)
2012 - JPRN-UMIN000007341 Japan;
University Hospitals Cleveland Medical Center
2008 - NCT00791557 United States;
University Southampton Hospital NHS Foundation Trust
2018 Phase 4 EUCTR2018-001546-33-GB United Kingdom;
University of California, San Francisco
2013 Phase 1 NCT01971814 United States;
University of Toyama
2017 - JPRN-UMIN000027465 Japan;
University of Western Ontario, Canada
2014 Phase 4 NCT01960426 United States;
Xian-Janssen Pharmaceutical Ltd.
2012 Phase 3 NCT01551290 China;
Yokohama City University Medical Center
2014 Phase 2 JPRN-UMIN000013716 Japan;
Infliximab (IFX)
Merck Sharp & Dohme Corp.
2007 Phase 3 NCT00537316 Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Infliximab [infliximab biosimilar 3]
Pfizer
2019 - NCT03884439 Japan;
Infliximab and adalimumab
Regionshospitalet Viborg, Skive
2009 - NCT02322008 -
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2019 Phase 4 NCT03885713 Spain;
Infliximab therapeutic drug monitoring
Imelda GI Clinical Research Center
2018 Phase 4 NCT04775732 Belgium;
Infliximab, adalimumab, certolizumab pegol
Oslo University Hospital
2013 - NCT02073526 Norway;
Infusion of Saline
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
Innovator infliximab
Diakonhjemmet Hospital
2014 Phase 4 NCT02148640 Norway;
Inositol
National Cancer Institute (NCI)
2010 Phase 1/Phase 2 NCT01111292 United States;
Interferon-beta-1a, 44 microgram
EMD Serono
2001 Phase 2 NCT00303381 Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interferon-beta-1a, 66 microgram
EMD Serono
2001 Phase 2 NCT00303381 Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interleukin-2 (aldesleukin).
Scott Snapper
2015 Phase 1 NCT02200445 United States;
Intestinal flora capsule
Third Military Medical University
2021 - NCT05030064 China;
Iron sulphate 200mg coated tablets
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Iron supplement 300-600 mg/day
University Health Network, Toronto
2002 Phase 2 NCT00152841 Canada;
Iron(III)- hydroxide dextran complex
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Itacitinib
Incyte Corporation
2018 Phase 2 NCT03627052 United States;
JNJ-54781532 150 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 25 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg twice daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532-AAD-
Janssen-Cilag International NV
2014 Phase 2 EUCTR2013-000263-88-RO Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-DE Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-BG Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-PL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-NL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-HU Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-BE Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-66525433
Janssen Research & Development, LLC
2020 Phase 1 NCT04457960 Georgia;Germany;Moldova, Republic of;
JNJ-72537634
Vedanta Biosciences, Inc.
2021 Phase 2 EUCTR2021-001280-24-LT Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-001280-24-HU Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
JNJ-78934804
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
Janus Kinase Inhibitor
Alimentiv Inc.
2020 - NCT04576000 Belgium;Canada;Italy;Netherlands;Spain;United States;
Janus kinase Inhibitor
Alimentiv Inc.
2020 Phase 4 EUCTR2019-003780-21-NL Belgium;Canada;Italy;Netherlands;Spain;United States;
K(D)PT
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
Dr. August Wolff GmbH & Co. KG Arzneimittel
2011 Phase 2 EUCTR2010-023494-19-SE Sweden;
KBL697
KoBioLabs
2021 Phase 2 NCT04898348 -
KHK4083
Kyowa Kirin Co., Ltd.
2016 Phase 1 NCT02985593 Japan;
Kyowa Kirin Pharmaceutical Development, Inc.
2016 Phase 2 NCT02647866 Czech Republic;Czechia;Hungary;Poland;Puerto Rico;Romania;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-PL Czech Republic;Hungary;Poland;Romania;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-HU Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-CZ Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
KRP203
Novartis Pharmaceuticals
2010 Phase 2 NCT01375179 Belgium;Germany;Hungary;Sweden;Switzerland;United Kingdom;
Novartis Services AG
2010 - EUCTR2010-019970-33-SE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-DE Belgium;Germany;Hungary;Sweden;United Kingdom;
KRP203A
Novartis Services AG
2011 - EUCTR2010-019970-33-GB Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019970-33-BE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-SE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-HU Belgium;Germany;Hungary;Sweden;United Kingdom;
Kamillenblüten 3ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Kappaproct
INDEX PHARMACEUTICALS
2012 - EUCTR2011-003130-14-IT Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals
2011 Phase 3 NCT01493960 Czech Republic;France;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals AB
2012 - EUCTR2011-003130-14-CZ Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 Phase 3 EUCTR2011-003130-14-GB Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-PL Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-HU Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-DE Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2006 - EUCTR2006-001846-15-SE Sweden;
KdPT
Dr August Wolff GmbH & Co KG Arzneimittel
2012 - EUCTR2011-002462-20-SK Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
2011 - EUCTR2011-002462-20-PL Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-HU Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-DE Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-CZ Czech Republic;Germany;Hungary;Italy;Poland;
Kremezin®, Spherical Adsorptive Carbon
Ocera Therapeutics, Inc.
2007 - EUCTR2005-005363-28-HU Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2007 - EUCTR2005-005363-28-AT Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 Phase 3 EUCTR2005-005363-28-GB Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-DE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-CZ Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-BE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
Kyo-Dophilus
University of California, Irvine
2007 Phase 1 NCT00578799 United States;
Kümmel 2ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
L-Lysyl-D-Prolyl-L-Threonine Acetate
Dr August Wolff GmbH & Co KG Arzneimittel
2012 - EUCTR2011-002462-20-SK Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
2011 - EUCTR2011-002462-20-PL Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-HU Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-DE Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-CZ Czech Republic;Germany;Hungary;Italy;Poland;
L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
LC51-0255
LG Chem
2020 Phase 2 NCT04096573 -
LDP-02
Millennium Pharmaceuticals, Inc.
2009 - EUCTR2008-002782-32-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
LT-02
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 NCT02280629 Germany;
2014 Phase 3 NCT02142725 Germany;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Lipid Therapeutics GmbH
2009 Phase 2 NCT01011322 Germany;Lithuania;Romania;
Prometheus Laboratories
2016 Phase 3 NCT02849951 United States;
LT-02 (modified-release PC pellets)
Lipid Therapeutics GmbH
2009 - EUCTR2008-007952-90-LT Germany;Lithuania;
2009 - EUCTR2008-007952-90-DE Germany;Lithuania;
LX1606
Lexicon Pharmaceuticals, Inc.
2012 - EUCTR2011-003532-32-LT Belgium;Lithuania;Poland;Slovakia;United States;
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
LY3074828
ELI LILLY & COMPANY, LILLY CORPORATE CENTER
2019 Phase 3 EUCTR2017-004092-31-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
Eli Lilly Cork Limited
2018 Phase 3 EUCTR2017-003229-14-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-DK Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Eli Lilly Japan K.K.
2018 Phase 3 JPRN-JapicCTI-184062 Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Eli Lilly and Company
2021 Phase 3 EUCTR2019-001653-99-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001653-99-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-004092-31-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-004092-31-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-003238-96-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-003229-14-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-LT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-HU Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-DE Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-CZ Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-AT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-SK Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-LT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-DE Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-CZ Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-AT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-PL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-NL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-HU Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-GB Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-DK Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-CZ Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-BE Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-003123-57-LT Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Lilly S.A.
2019 Phase 3 EUCTR2017-004092-31-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
LY3471851
Eli Lilly and Company
2021 Phase 2 NCT04677179 Argentina;Australia;Belgium;Brazil;Canada;China;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-SK Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-HU Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-CZ Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-BE Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
LYC-30937
Lycera Corp.
2016 Phase 1 NCT02818543 Hungary;
LYC-30937-EC
Lycera Corp.
2017 Phase 2 EUCTR2016-003633-26-PL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2017 Phase 2 EUCTR2016-003633-26-NL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2017 Phase 2 EUCTR2016-003633-26-CZ Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 NCT02764229 Czechia;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 NCT02762500 Canada;Czech Republic;Czechia;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-003633-26-HU Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-PL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-NL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-HU Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-CZ Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
LYS006
Novartis Pharma AG
2021 Phase 2 EUCTR2019-003113-34-SK Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-NO Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-HU Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-DE Czech Republic;Germany;Hungary;Norway;United States;
Novartis Pharmaceuticals
2020 Phase 2 NCT04074590 Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United Kingdom;United States;
Lactated Ringers
Spectrum Health Hospitals
2007 Phase 3 NCT00467922 United States;
Lactobacillus GG
Children's Hospital Medical Center, Cincinnati
2011 Phase 2 NCT00895336 United States;
Lactobacillus casei
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
Lactobacillus casei DG
University of Padova
2016 - NCT03136419 Italy;
Lactobacillus plantarum
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
Lactobacillus reuteri
Uppsala University
2017 Phase 2 NCT03798210 Sweden;
Lactobacillus rhamnosus GG ATCC 53103
San Giovanni Addolorata Hospital
2019 Phase 1/Phase 2 NCT04102852 Italy;
Lactobacillus salivarius UCC118
University College Cork
2002 Phase 2/Phase 3 NCT00510978 Ireland;
Lactobacilus acidophilus & bifidobacterium animalis/lactis
Hvidovre University Hospital
2004 Phase 2 NCT00268164 Denmark;
Lactose in water
University Hospitals, Leicester
2007 - NCT00403923 United Kingdom;
Leucine
Showa Inan General Hospital
2020 - NCT04535882 Japan;
Levocarnitine
SIGMA-TAU
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
Levocarnitine propyl hydrochloride
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
Linaclotide
University of Virginia
2015 Phase 4 NCT02465385 United States;
Lixacol
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Loperamide
Odense University Hospital
2014 Phase 3 NCT02266849 Denmark;
Loperamide hydrochloride
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Losartan
Takeda
2016 Phase 4 NCT02760615 United States;
Low Dose Budesonide
Bausch Health Americas, Inc.
2022 Phase 4 NCT04314375 -
Low Dose MT-1303
Bausch Health Americas, Inc.
2021 Phase 2 NCT04857112 United States;
Low FODMAP
Vendsyssel Hospital
2018 - NCT02469220 Denmark;
Low Protein and High Fiber Diet
Mayo Clinic
2021 - NCT04933162 United States;
Low dose
Holy Stone Healthcare Co., Ltd
2016 Phase 2 NCT02493712 Italy;Taiwan;
Low dose naltrexone
Santa Barbara Cottage Hospital
2013 Phase 2 NCT01810185 United States;
Lumbar puncture
Shire
2012 Phase 1 NCT01387594 Austria;Belgium;France;Germany;Netherlands;
Lusvertikimab
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Lysine-D-Proline-Threonine
Dr. August Wolff GmbH & Co. KG Arzneimittel
2011 Phase 2 EUCTR2010-023494-19-SE Sweden;
Lysine-D-proline-threonine
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
MATRICARIA RECUTITA L. FLOS
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MD-0901
MOCHIDA PHARMACEUTICAL CO., LTD
2018 Phase 2-3 JPRN-JapicCTI-173803 Japan;
2018 Phase 2-3 JPRN-JapicCTI-173802 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
2010 Phase 3 JPRN-JapicCTI-101381 -
2010 Phase 3 JPRN-JapicCTI-101380 -
MDX-1100
Bristol-Myers Squibb
2008 Phase 2 NCT00656890 Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States;
Bristol-Myers Squibb Company
2008 - EUCTR2007-002544-25-LV Czech Republic;Hungary;Latvia;
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2008 - EUCTR2007-002544-25-HU Czech Republic;Hungary;Latvia;
2008 - EUCTR2007-002544-25-CZ Czech Republic;Hungary;Latvia;
MDX-1100 (anti-CXCL10 human monoclonal antibody)
Bristol-Myers Squibb
2006 Phase 1 NCT00295282 United States;
MEDI7183 high dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MEDI7183 low dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MEDI7183 medium dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MELISSAE FOLII DRY AQUEOUS EXTRACT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MENTHA × PIPERITA L. FOLIUM
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MESENCHYMAL CELLS
Leiden University Medical Center
2018 Phase 2 EUCTR2017-003524-75-NL Netherlands;
MET-2
NuBiyota
2019 Phase 1 NCT03832400 Canada;
METHOTREXATE DISODIUM
UMC Amsterdam location AMC
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
METHYLPREDNISOLONE SODIUM HEMISUCCINATE
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
2017 Phase 4 EUCTR2016-001170-15-ES Spain;
MEZAVANT
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
MH002
MRM Health NV
2021 Phase 1;Phase 2 EUCTR2020-004355-33-CZ Belgium;Czech Republic;
2021 Phase 1;Phase 2 EUCTR2020-004355-33-BE Belgium;
MK-6194
Merck Sharp & Dohme Corp.
2021 Phase 1 NCT04924114 Georgia;Germany;Moldova, Republic of;Ukraine;United Kingdom;United States;
MK-8259
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
MLN0002
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
MILLENNIUM PHARMACEUTICALS, INC.
2009 Phase 3 EUCTR2008-002784-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002782-32-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
Millennium Pharmaceuticals, Inc.
2009 Phase 3 EUCTR2008-002784-14-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-IE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-EE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002782-32-IS Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-GB Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002784-14-MT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002783-33-MT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002783-33-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
2009 - EUCTR2008-002782-32-PT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-MT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-IE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-GR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-EE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-DE Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;
2009 - EUCTR2008-002782-32-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2008 - EUCTR2008-002782-32-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Center Americas, Inc.
2021 Phase 3 EUCTR2020-004300-34-SK Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-LT Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HU Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HR Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-GR Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-ES Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-CZ Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-BE Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe Ltd
2009 Phase 3 EUCTR2008-002784-14-IS Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Takeda Development Centre Europe Ltd.
2010 Phase 3 EUCTR2008-002784-14-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2008-002784-14-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-CZ Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2008-002784-14-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe ltd.
2009 Phase 3 EUCTR2008-002784-14-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
MLN0002 (Vedolizumab)
TAKEDA PHARMACEUTICAL COMPANY LTD.
2014 Phase 3 JPRN-JapicCTI-142403 Japan;
MLN0002 SC
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000482-31-IT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000482-31-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BG Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
MLN002
Takeda Development Centre Europe Limited
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
MMX Mesalamine
Shire
2010 Phase 1 NCT01130844 Australia;Poland;Slovakia;United Kingdom;United States;
2007 Phase 4 NCT00446849 United States;
MMX Mesalamine/Mesalazine
Shire Development Inc
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
MMX Mesalamine/Mesalazine (High Dose)
Shire
2014 Phase 3 NCT02093663 Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX Mesalamine/Mesalazine (Low Dose)
Shire
2014 Phase 3 NCT02093663 Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX mesalamine/ mesalazine
Shire
2010 Phase 4 NCT01124149 Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Ireland;Poland;Romania;South Africa;Spain;United Kingdom;United States;
MONOCLONAL ANTIBODY ANTI-IGG1
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim BV Netherlands
2017 Phase 2 EUCTR2016-004572-21-NL Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim España, S.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-ES Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-ES Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-ES Denmark;Germany;Netherlands;Norway;Spain;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-GR Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-CZ Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-GB Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-GB Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-NO Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-DE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-DE Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DK Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DE Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000334-35-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim bv
2018 Phase 2;Phase 3 EUCTR2017-004230-28-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim bv Netherlands
2019 Phase 2 EUCTR2018-000334-35-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2;Phase 3 EUCTR2017-004230-28-BE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-BE Belgium;Germany;United Kingdom;
MS-20 oral solution
National Taiwan University Hospital
2021 - NCT04908644 -
MSB11022
Fresenius Kabi SwissBioSim GmbH
2019 Phase 1 NCT04018599 United States;
MSC
Leiden University Medical Center
2018 Phase 2 EUCTR2017-003524-75-NL Netherlands;
MT-1303
Salix Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-005232-30-SK Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-HU Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-EE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-DE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-BG Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
MTX 12.5
University of Western Ontario, Canada
2013 Phase 4 NCT01716039 -
MTX 25
University of Western Ontario, Canada
2013 Phase 4 NCT01716039 -
Maltodextrin
Capital Medical University
2020 Phase 0 ChiCTR2000032498 China;
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
University of Alberta
2016 - NCT02865707 Canada;
Maltose
Honda Takashi
2018 - JPRN-jRCTs041190010 Japan;
Mango polyphenolics
Texas A&M University
2014 - NCT02227602 United States;
Mare´s milk
University of Jena
2000 - NCT00940576 Germany;
Maximal oral 5ASA
University of Aarhus
2012 - NCT01534312 Denmark;
Melatonin
Emory University
2009 Phase 2 NCT00790478 United States;
Melissenblätter 15ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Melitracen
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Mercaptopurine (Puri-Nethol)
Academic Medical Centre
2016 Phase 3 EUCTR2015-005260-41-NL Netherlands;
Mercaptopurine (Purinethol)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
Mesalamin
Tillotts Pharma AG
2009 Phase 3 NCT01059344 Belarus;India;Turkey;Ukraine;
Mesalamine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
Beijing Friendship Hospital, Capital Medical University
2019 - ChiCTR1900021229 China;
Department of Gastroenterology, Jinan Central Hospital
2018 - ChiCTR2100043797 China;
Dr. Falk Pharma GmbH
2014 Phase 3 NCT02280629 Germany;
EMET Pharmaceuticals, LLC
2008 Phase 3 NCT01045018 -
2008 - EUCTR2007-004732-23-PL Estonia;Latvia;Poland;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
2016 Phase 3 NCT02522780 Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 NCT02522767 Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
Icahn School of Medicine at Mount Sinai
2022 Phase 1/Phase 2 NCT05119140 United States;
James Lewis
2008 Phase 4 NCT00652145 United States;
VSL Pharmaceuticals
2017 - NCT03415711 Italy;
Warner Chilcott
2006 Phase 3 NCT00350415 Belarus;Canada;Croatia;Czech Republic;Estonia;Former Serbia and Montenegro;Hungary;Latvia;Lithuania;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Ukraine;United States;
2005 Phase 1 NCT00254618 United States;
2001 Phase 3 NCT00577473 United States;
Wolfson Medical Center
2010 Phase 4 NCT01201122 Israel;
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
2020 Phase 0 ChiCTR2000037261 China;
Mesalamine Delayed Release Tablets
EMET Pharmaceuticals LLC
2008 - EUCTR2007-004732-23-LV Estonia;Latvia;Poland;
2007 - EUCTR2007-004732-23-EE Estonia;Latvia;Poland;
Mesalamine Enema
Altheus Therapeutics, Inc.
2012 Phase 2 NCT01586533 United States;
Mesalamine Granules
Dayanand Medical College and Hospital
2018 Phase 3 NCT03716388 India;
Mesalamine Once-Daily
Warner Chilcott
2007 Phase 3 NCT00505778 Canada;Puerto Rico;United States;
Mesalamine Twice-Daily
Warner Chilcott
2007 Phase 3 NCT00505778 Canada;Puerto Rico;United States;
Mesalamine granules
Dr. Falk Pharma GmbH
2005 Phase 3 NCT00746447 Germany;
Mesalamine, 5-ASA
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
Mesalamine, 5-aminosalicylic acid [5-ASA]
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002558-11-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2015-002557-35-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002558-11-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002557-35-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Mesalazine
Affiliated Hospital of Inner Mongolia Medical University
2017 - ChiCTR-IPR-17010306 China;
Affiliated Hospital of Jiangnan University
2021 - ChiCTR2100046446 China;
Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Province Traditional Chinese Medicine Hospital)
2014 - ChiCTR1800016668 China;
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University
2020 Phase 2 ChiCTR2000028869 China;
Cardiff and Vale NHS Trust
2006 Phase 3 EUCTR2005-002784-91-GB United Kingdom;
Chengdu University of Traditional Chinese Medicine
2020 Phase 0 ChiCTR2000039161 China;
2020 Phase 0 ChiCTR2000038888 China;
Chiba University Hospital
2013 Phase 2 JPRN-UMIN000010906 Japan;
Chinese University of Hong Kong
2015 - NCT02537210 China;Hong Kong;
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2013 - JPRN-UMIN000010127 Japan;
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
2017 - JPRN-UMIN000026175 Japan;
Department of anorectal surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine
2014 - ChiCTR-IOR-15006812 China;
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine
2011 - JPRN-UMIN000011236 Japan;
Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
2014 - ChiCTR-OCH-14004615 China;
Dongfang Hospital of Beijing University of Chinese Medicine
2019 Phase 0 ChiCTR1900023159 China;
Dongfang hospital, Beijing univetsity of Chinese Medicine
2015 - ChiCTR-IOR-15007194 China;
Dr. Falk Pharma GmbH
2007 Phase 3 NCT00747110 Germany;
2005 Phase 3 NCT00449722 Germany;
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-FI Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-DK Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
- - EUCTR2004-004565-15-DE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Ferring Pharmaceuticals
2015 - NCT02368743 France;
2015 - NCT02261636 Netherlands;
2012 - NCT01517607 Germany;
Flemming Bendtsen
2019 Phase 4 NCT04133194 Denmark;
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
2004 - EUCTR2004-000916-25-IT Italy;
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Hyogo College of Medicine
2018 - JPRN-UMIN000034016 Japan;
Jiangsu Province Hospital of Chinese Medicine
2020 Phase 0 ChiCTR2000035099 China;
2019 Phase 4 ChiCTR1900023158 China;
Kitasato University Kitasato Institute Hospital
2016 - JPRN-UMIN000022954 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD
2018 Phase 2-3 JPRN-JapicCTI-173803 Japan;
2018 Phase 2-3 JPRN-JapicCTI-173802 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
Nanjing Hospital of Chinese Medicine
2019 Phase 3 ChiCTR1900025900 China;
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 Phase 2 NCT00808977 Belgium;Hungary;Slovakia;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Peking University First Hospital
2019 Phase 0 ChiCTR1900024591 China;
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
Saitama Medical Center, Saitama Medical University
2013 - JPRN-UMIN000010340 Japan;
2012 - JPRN-UMIN000008352 Japan;
Shire Development Inc
2012 - EUCTR2011-000164-10-SK Slovakia;United Kingdom;United States;
Shire Development LLC
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100048176 China;
Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
2020 Phase 0 ChiCTR2000037220 China;
2020 Phase 0 ChiCTR2000035497 China;
Southern Medical University, Nanfang Hospital, Department of Gastroenterology
2015 - ChiCTR-ICR-15007188 China;
The 900th Hospital of PLA
2018 Phase 4 ChiCTR2000038316 China;
The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
2006 Phase 1 study ChiCTR-TRC-08000048 China;
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
2021 - ChiCTR2100048502 China;
2019 - ChiCTR1900024086 China;
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Tillotts Pharma AG
2010 Phase 3 NCT01257399 China;
2010 Phase 3 NCT01257386 China;
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
University Medical Center Groningen
2010 - EUCTR2010-018557-35-NL Netherlands;
Xiangya Hospital of Central South University
2020 - ChiCTR2000028767 China;
Yanling Wei
2015 Phase 2 NCT02335281 China;
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of TCM
2020 Phase 0 ChiCTR2000036950 China;
Zeria Pharmaceutical Co., Ltd.
2013 Phase 3 JPRN-JapicCTI-132135 -
- Phase 2 JPRN-JapicCTI-121943 -
Zeria Pharmaceutical Co.,LTD.
2005 Phase 3 JPRN-C000000289 Japan;
2005 Phase 3 JPRN-C000000288 Japan;
Mesalazine (3,600 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Mesalazine (Asacol®)
Cardiff and Vale University Health Board
2006 Phase 3 NCT00708656 United Kingdom;
Mesalazine - TID 2x
Dr. Falk Pharma GmbH
2013 Phase 3 NCT01745770 Germany;
Mesalazine 1000 mg gastro-resistant tablets
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
2015 Phase 1/Phase 2 NCT03441893 -
Mesalazine 4G Enema
Institute for Clinical and Experimental Medicine
2017 Phase 2 NCT03104036 Czech Republic;Czechia;
Mesalazine 500 mg gastro-resistant tablets (Salofa
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine Enema
Ferring Pharmaceuticals
2015 Phase 3 NCT02368717 China;
Mesalazine enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Mesalazine liquid enema
Ferring Pharmaceuticals
2008 Phase 3 NCT00737789 Belgium;France;Netherlands;United Kingdom;
Mesalazine slow-release granules
Ferring Pharmaceuticals
2008 Phase 3 NCT00737789 Belgium;France;Netherlands;United Kingdom;
Mesalazine tablet
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2-3 JPRN-JapicCTI-101144 -
MOCHIDA PHARMACEUTICAL CO., LTD.
2010 Phase 3 JPRN-JapicCTI-101381 -
2010 Phase 3 JPRN-JapicCTI-101380 -
Mesalazine with hydrocortisone sodium succinate
Xijing Hospital of Digestive Diseases
2017 Phase 4 NCT03110198 China;
Mesalazinum
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Metformin 500 mg TID Oral Tablet
National Hepatology & Tropical Medicine Research Institute
2021 Phase 2 NCT04750135 Egypt;
Methotrexate
Centre Hospitalier Universitaire de Besancon
2007 Phase 2 NCT00498589 Austria;Belgium;France;Israel;Italy;Netherlands;
GETAID, Jean Minjoz Hospital
2009 - EUCTR2006-003607-40-FI Austria;Belgium;Finland;Netherlands;
Indiana University
2015 - NCT02413047 United States;
University of North Carolina, Chapel Hill
2012 Phase 2 NCT01393405 United States;
Methotrexate bellon 25mg/ml
Besancon University Hospital
2008 - EUCTR2006-003607-40-NL Austria;Finland;Netherlands;
2008 - EUCTR2006-003607-40-BE Austria;Belgium;Finland;Netherlands;
Besancon University Hospitaö
2008 - EUCTR2006-003607-40-AT Austria;Finland;Netherlands;
Methotrexate injection
Amsterdam UMC location AMC
2019 Phase 4 EUCTR2018-003594-95-NL Netherlands;
Methylene blue 25mg tablets
COSMO TECHNOLOGIES LTD
2012 - EUCTR2011-005693-36-IT Italy;
Methylprednisolone
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
2018 Phase 4 NCT02921555 Spain;
Metoject
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
Metronidazole
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Juntendo university school of medicine Department of gastroenterology
2015 - JPRN-UMIN000018642 Japan;
2014 - JPRN-UMIN000014152 Japan;
Juntendo university school of medicineDepartment of gastroenterology
2017 - JPRN-UMIN000025846 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Postgraduate Institute of Medical Education and Research
2019 Phase 2 NCT03794765 India;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
University of Dundee
2006 - NCT00355602 United Kingdom;
Metronidazole capsule
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
Mezavant 1200 mg magensaftresistente Retardtabletten
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
2012 Phase 2 EUCTR2012-002023-15-AT Austria;
Mezavant Gastro-resistant, prolonged release tablets
Shire Development LLC
2018 Phase 3 EUCTR2013-001744-65-DE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2018 Phase 3 EUCTR2013-001744-65-BE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
Shire Devlopment LLC
2014 Phase 3 EUCTR2013-001744-65-SK Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-PL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
Mezavant XL 1200 mg gastro-resistant prolonged release tablets
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.
Shire Pharmaceutical Development Ltd
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200mg gastro-resistant, prolonged release tablets
Shire Development LLC
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
Mezavant XL Gastro-resistant, prolonged release tablets
Shire Development Inc
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2014 Phase 3 EUCTR2013-001744-65-GB Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Devlopment LLC
2015 Phase 3 EUCTR2013-001744-65-NL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-HU Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
Microbiote fécal
AP-HP/DRCD
2022 Phase 2 EUCTR2020-000311-71-FR France;
Midazolam
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Mirikizumab
ELI LILLY & COMPANY, LILLY CORPORATE CENTER
2019 Phase 3 EUCTR2017-004092-31-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Eli Lilly Japan K.K.
2018 Phase 3 JPRN-JapicCTI-184062 Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Eli Lilly and Company
2021 Phase 3 NCT04844606 Israel;Japan;Korea, Republic of;United States;
2020 Phase 2 NCT04004611 Canada;Israel;Japan;Korea, Republic of;United States;
2018 Phase 3 NCT03524092 Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03519945 Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03518086 Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-PL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-DK Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-CZ Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-BE Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 NCT02589665 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-003123-57-LT Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Yoshimoto Yusuke
2021 Phase 3 JPRN-jRCT2031210210 Japan;United States;
Mirikizumab IV
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
Mirikizumab SC
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
MitoQ
University of Edinburgh
2021 Phase 2 NCT04276740 -
Modified Gegen Qinlian Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Early Phase 1 NCT04057547 China;
Modified-release phosphatidylcholine
Lipid Therapeutics GmbH
2009 - EUCTR2008-007952-90-LT Germany;Lithuania;
2009 - EUCTR2008-007952-90-DE Germany;Lithuania;
Molgramostim
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Mongersen
Celgene Corporation
2016 Phase 2 EUCTR2015-003364-36-SK Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-HU Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-BG Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
MultiStem high dose
Pfizer
2011 Phase 2 NCT01240915 Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
MultiStem low dose
Pfizer
2011 Phase 2 NCT01240915 Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
Multiple dose- Group B
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Multiple dose-Group B
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Mycodigest supplement
Tel-Aviv Sourasky Medical Center
2018 - NCT04329481 Israel;
Myrrhinil-Intest®
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
N.d.
IRCCS ISTITUTO CLINICO HUMANITAS
2021 Phase 4 EUCTR2020-003420-16-IT Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
NAND (Neoandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
NEORAL
GETAID
2008 - EUCTR2006-005299-42-BE Belgium;Finland;France;Spain;
2007 - EUCTR2006-005299-42-FR Belgium;Finland;France;Spain;
NO
Peking Union Medical College Hospital
2019 - ChiCTR2000029648 China;
University of Texas at Austin
2021 - NCT04898530 United States;
2021 - NCT04617184 United States;
NX-13
Landos Biopharma Inc.
2020 Phase 1 NCT04458805 Australia;
NX-13 250mg IR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
NX-13 500mg IR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
NX-13 500mg MR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
Nanocort
Enceladus Pharmaceuticals
2011 - EUCTR2010-020448-37-NL Belgium;Netherlands;
2010 Phase 2 EUCTR2010-020448-37-BE Belgium;Netherlands;
Narrow Band Imaging
London North West Healthcare NHS Trust
2006 - NCT00292175 United Kingdom;
Natura-alpha capsule
Natrogen Therapeutics International, Inc
2010 Phase 2 NCT01216280 United States;
Neomycin
University of Dundee
2006 - NCT00355602 United Kingdom;
Neoral Soft Gelatin Capsules
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
Niclosamide
First Wave Bio, Inc.
2018 Phase 1/Phase 2 NCT03521232 Italy;
Nicolon
S.L.A. PHARMA (UK) LTD
2007 - EUCTR2006-006052-35-IT Italy;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States;
Nolpitantium Besylate
SANOFI-SYNTHELABO
2005 - EUCTR2004-001677-26-IT Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Nolpitantium besylate
Sanofi
2005 Phase 2 NCT00232258 Argentina;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;France;Hungary;Italy;Russian Federation;Singapore;South Africa;Spain;Sweden;United States;
Sanofi-Synthelabo Recherche
2005 Phase 2 EUCTR2004-001677-26-HU Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-SE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-ES Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-EE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
sanofi-aventis recherche & developpement
2004 - EUCTR2004-001677-26-CZ Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Non as of yet
Lexicon Pharmaceuticals, Inc.
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
None
Bridge Biotherapeutics, Inc.
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
None given
Shire Pharmaceutical Development Ltd
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Normal Saline Enema
McMaster Children's Hospital
2015 Phase 1 NCT02487238 Canada;
Nutrition supplement
Baptist Memorial Health Care Corporation
2018 - NCT03594708 United States;
Nutritional dietary intervention
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
Nuvion®
Facet Biotech
2007 Phase 3 NCT00502294 -
PDL BioPharma, Inc.
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
OPC-6535
Otsuka Maryland Research Institute, Inc.
2005 Phase 3 EUCTR2005-003724-19-HU Czech Republic;Hungary;
2005 - EUCTR2005-003724-19-CZ Czech Republic;Hungary;
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
Otsuka Pharmaceutical Development & Commercialization, Inc.
2004 Phase 3 NCT00092508 United States;
OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.
2003 Phase 3 NCT00064454 United States;
2003 Phase 3 NCT00064441 United States;
OPC-6535(Tetomilast)
Otsuka Pharmaceutical Co., Ltd.
2006 Phase 2 NCT00317356 Japan;
OPRX-106
Protalix
2016 Phase 2 NCT02768974 Israel;
OPRX-106 (plant cells expressing TNFR-Fc)
Protalix Biotherapeutics Ltd.
2016 Phase 2 EUCTR2016-000509-35-BG Bulgaria;Israel;Serbia;
ORE1001
Ore Pharmaceuticals, Inc.
2009 Phase 1/Phase 2 NCT01039597 Canada;India;
OSE-127
OSE Immunotherapeutics
2020 Phase 2 NCT04882007 Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;South Africa;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-LV Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
OST-122
ONCOSTELLAE S.L.
2020 Phase 1;Phase 2 EUCTR2019-004090-50-ES Spain;
Oncostellae S.L
2020 Phase 1/Phase 2 NCT04353791 Spain;
Omeprazole
Brigham and Women's Hospital
2011 Phase 1/Phase 2 NCT01287195 United States;
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Ondansetron hydrochloride dihydrate
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Ontamalimab
SHIRE HUMAN GENETIC THERAPIES, INC
2018 Phase 3 EUCTR2017-000599-27-IT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Shire
2018 Phase 3 NCT03290781 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03283085 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03259334 Australia;Austria;Brazil;Croatia;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States;
2017 Phase 3 NCT03259308 Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;New Zealand;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000572-28-BG Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000599-27-NL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-LT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-HR Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-GB Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-DE Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-CZ Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-PT Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-HU Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-BE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000599-27-AT Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-SK Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
- Phase 3 EUCTR2017-000599-27-PL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000573-37-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000572-28-IE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
Sheba Medical Center
2013 Phase 4 NCT01941589 China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Oral Corticosteroids
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Oral Iron
American University of Beirut Medical Center
2019 Phase 3 NCT05225545 Lebanon;
Oral OKT3
Brigham and Women's Hospital
2011 Phase 1/Phase 2 NCT01287195 United States;
Orencia
Bristol-Myers Squibb International Corporation
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IT Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Originator (legacy) drug
McGill University Health Centre/Research Institute of the McGill University Health Centre
2018 - NCT03729674 Canada;
Oseltamivir
Xiangya Hospital of Central South University
2020 - ChiCTR2000028767 China;
Other Biologic Therapies
Janssen Scientific Affairs, LLC
2021 - NCT04372108 United States;
Overencapsulated Azathioprine (Imuran) 50 mg Tablet
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Overencapsulated mesalazine tablets
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
Oxygen
Dartmouth-Hitchcock Medical Center
2017 Phase 2 NCT03494764 United States;
Ozanimod
Bristol-Myers Squibb
2021 Phase 2/Phase 3 NCT05076175 France;Japan;United States;
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene
2019 Phase 3 NCT03915769 Japan;
2012 Phase 2 NCT01647516 Australia;Belgium;Bulgaria;Canada;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
PARNAPARIN SODIUM
Cosmo Technologies Ltd
2006 Phase 2 EUCTR2006-001782-42-GB Hungary;Italy;United Kingdom;
2006 - EUCTR2006-001782-42-HU Hungary;Italy;United Kingdom;
PBF-677
PaloBiofarma S.L.
2018 Phase 2 EUCTR2017-003228-54-ES Spain;
Palobiofarma SL
2018 Phase 2 NCT03773952 Spain;
PCT (PureCell Technologies Complex)
PurGenesis Techonologies Inc.
2010 - EUCTR2009-017839-18-DE Germany;
PEG
Gunma University Graduate School of Medicine
2013 Phase 4 JPRN-UMIN000013892 Japan;
PEG-liposomal prednisolone sodium phosphate
Enceladus Pharmaceuticals
2011 - EUCTR2010-020448-37-NL Belgium;Netherlands;
2010 Phase 2 EUCTR2010-020448-37-BE Belgium;Netherlands;
PF-00547659
Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
2014 - EUCTR2012-002030-37-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Pfizer Inc.
2013 - EUCTR2012-002030-37-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom;
Shire Human Genetic Therapie, Inc.
2013 Phase 2 EUCTR2012-002031-28-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2013 Phase 2 EUCTR2012-002031-28-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
PF-00547659 SC Injection
Shire
2012 Phase 2 NCT01620255 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
PF-05230917
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2012 Phase 2 EUCTR2010-023762-49-BE Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2012 - EUCTR2010-023762-49-PL Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-HU Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-BG Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-AT Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
2011 - EUCTR2010-023762-49-DE Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Pfizer, S.L.U.
2011 - EUCTR2010-023762-49-ES Belgium;Bulgaria;Germany;Hungary;Poland;Spain;
PF-05285401
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
PF-06480605
PFIZER INC
2020 Phase 2 EUCTR2019-002698-74-IT Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001158-16-IT Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
Pfizer
2016 Phase 2 NCT02840721 Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-PL Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-HU Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-GB Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-FR Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-ES Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-DE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BG Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Pfizer Inc. 235 East 42nd Street, New York, NY 10017
2017 Phase 2 EUCTR2016-001158-16-NL Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
2016 Phase 2 EUCTR2016-001158-16-PL Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
2016 Phase 2 EUCTR2016-001158-16-BE Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
PF-06480605 100 mg/ml
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-SK Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
PF-06651600
Pfizer
2017 Phase 2 NCT02958865 Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06651600-15
PFIZER INC
2017 Phase 2 EUCTR2016-003708-29-IT Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-NL Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-LT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-HU Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-AT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06687234
PFIZER INC
2018 Phase 2 EUCTR2017-002108-28-IT Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States;
Pfizer
2017 Phase 2 NCT03269695 Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;Turkey;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
PF-06700841
Pfizer
2017 Phase 2 NCT02958865 Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06700841-15
PFIZER INC
2017 Phase 2 EUCTR2016-003708-29-IT Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-NL Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-LT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-HU Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-AT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06826647
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2020 Phase 2 EUCTR2019-003999-39-NO Armenia;Australia;Belgium;Bosnia and Herzegovina;Brazil;China;Croatia;Czech Republic;France;Georgia;Germany;Hong Kong;India;Ireland;Italy;Jordan;Lebanon;Macedonia, the former Yugoslav Republic of;Malaysia;Mexico;Morocco;Norway;Oman;Poland;Puerto Rico;Qatar;Romania;Russian Federation;Saudi Arabia;Slovakia;Spain;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
PF-06826647 100 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-06826647 300 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-06826647 600 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-6826647 400 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PN-10884A
Protagonist Therapeutics, Inc
2017 Phase 2 EUCTR2016-003452-75-PL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-NL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-LV Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HU Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HR Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-CZ Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-BE Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
PN-943
Protagonist Therapeutics, Inc
2020 Phase 2 EUCTR2019-004469-41-DE Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-BG Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-AT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Protagonist Therapeutics, Inc.
2020 Phase 2 NCT04504383 Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-IT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States;
PRA023
Prometheus Biosciences Inc.
2021 Phase 2 EUCTR2021-000091-11-IT Australia;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Prometheus Biosciences, Inc.
2021 Phase 2 EUCTR2021-000091-11-PL Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-000091-11-HU Australia;Belarus;Belgium;Canada;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-000091-11-CZ Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
PRA023 IV
Prometheus Biosciences, Inc.
2021 Phase 2 NCT04996797 United States;
PRD5973697
CHU Nantes
2018 Phase 3 EUCTR2017-004967-11-FR France;
PRIM-DJ2727
The University of Texas Health Science Center, Houston
2020 Phase 2 NCT04373473 United States;
PRO145223
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
PRO145223 (RO5490261)
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-ES Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-000897-80-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-HU Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-GB Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-ES Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-DE Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-CZ Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
PROPIONYL L-CARNITINE
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
PROPIONYL L-CARNITINE HYDROCHLORIDE
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
PRV-300
Provention Bio, Inc.
2018 Phase 1 NCT03849599 Georgia;Moldova, Republic of;Ukraine;
PS-QD
Kyorin Pharmaceutical Co.,LTD
- Phase 3 JPRN-JapicCTI-090967 -
PS-SP
Kyorin Pharmaceutical Co.,LTD
- Phase 3 JPRN-JapicCTI-111421 -
PTG-100
Protagonist Therapeutics, Inc
2017 Phase 2 EUCTR2016-003452-75-PL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-NL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-LV Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HU Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HR Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-CZ Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-BE Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Protagonist Therapeutics, Inc.
2016 Phase 2 NCT02895100 Australia;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czechia;Germany;Hungary;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Ukraine;United States;
PUR 0110
PurGenesis Techonologies Inc.
2010 - EUCTR2009-017839-18-DE Germany;
PUR 0110 Rectal Enema
PurGenesis Technologies Inc.
2010 Phase 2 NCT01149707 Germany;
2009 Phase 1 NCT01149694 Germany;
Pending
Reistone Biopharma Company Limited
2019 Phase 2 EUCTR2018-003364-31-PL China;Poland;Ukraine;United States;
Pentasa
Children´s Hospital, University of Helsinki
2012 Phase 4 EUCTR2012-004851-35-FI Finland;Israel;
Ferring Pharmaceuticals
2005 Phase 3 NCT00209300 Belgium;Czech Republic;Denmark;Finland;Germany;Netherlands;Norway;Sweden;
Pentasa 2g sachet prolonged release granules ()
Ferring Pharmaceuticals Ltd.
2009 - EUCTR2008-000045-59-GB Belgium;France;Netherlands;United Kingdom;
Ferring SAS
2008 Phase 3 EUCTR2008-000045-59-FR Belgium;France;Netherlands;United Kingdom;
2008 Phase 3 EUCTR2008-000045-59-BE Belgium;France;Netherlands;United Kingdom;
2008 - EUCTR2008-000045-59-NL Belgium;France;Netherlands;United Kingdom;
Pentasa 500 mg Retardtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Pentasa Compact 2g, granulate with prolonged release
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002558-11-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002558-11-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Pentasa Compact 4g, granulate with prolonged release
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002557-35-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002557-35-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Pentasa Sachet
Ferring BV
2005 - EUCTR2004-004565-15-DK Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 1 g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 1g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 2 g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Pentasa prolonged release granules 2g
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-FI Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
- - EUCTR2004-004565-15-DE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa sachet 1g
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pfefferminzblätter 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Phentermine-Topiramate
University of California, San Diego
2020 Phase 2 NCT04721873 United States;
Photodynamic therapy with Gliolan
University of Zurich
2012 Phase 1 NCT01697670 Switzerland;
Placebo
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
2014 Phase 3 JPRN-JapicCTI-142648 Japan, North America, Europe;
2009 Phase 2-3 JPRN-JapicCTI-090718 -
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
EA Pharma Co.,Ltd.
2014 Phase 3 JPRN-JapicCTI-142704 -
Eli Lilly Japan K.K.
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Janssen Pharmaceutical K.K.
2020 Phase 2-3 JPRN-JapicCTI-194980 Japan, Asia except Japan, North America, Europe;
Otsuka Pharmaceutical Co., Ltd.
2007 Phase 2 JPRN-JapicCTI-070399 Japan;
TAKEDA PHARMACEUTICAL COMPANY LTD.
2014 Phase 3 JPRN-JapicCTI-142403 Japan;
Polaprezinc
The Jikei University School of MedicineDivision of Gastroenterology and Hepatology
2009 - JPRN-UMIN000008967 Japan;
Polyethylene glycol
Kyungpook National University
2013 - NCT01929668 Korea, Republic of;
Polyphenon E®
University of Louisville
2008 Phase 2 NCT00718094 United States;
Pomegranate
IRCCS Azienda Ospedaliero-Universitaria di Bologna
2017 - NCT03000101 Italy;
Prednisolon Jenapharm
4SC AG
2010 - EUCTR2008-005903-25-BG Bulgaria;Germany;
2009 - EUCTR2008-005903-25-DE Bulgaria;Germany;
Prednisolone
Alizyme
2006 Phase 3 NCT00299013 Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom;
Department of Inflammatory Bowel DiseaseHyogo College of Medicine
2018 Phase 1 JPRN-UMIN000030000 Japan;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Lower Gastroenterology, Hyogo College of Medicine
2011 Phase 2,3 JPRN-UMIN000005358 Japan;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Prednisolone Tablets B.P.
Alizyme Therapeutics Limited
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Prednisolone sodium metasulphobenzoate
Alizyme Therapeutics Limited
2007 - EUCTR2004-005032-35-BE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-SE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-HU Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-DK Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-CZ Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Prednisone
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
2018 Phase 4 NCT02921555 Spain;
Peking University First Hospital
2019 Phase 0 ChiCTR1900024591 China;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Southern Medical University, Nanfang Hospital, Department of Gastroenterology
2015 - ChiCTR-ICR-15007188 China;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
Prefilled Syringe delivery of Golimumab
Merck Sharp & Dohme Corp.
2014 Phase 4 NCT02155335 Belgium;
Previously referred to as MEDI2070 and AMG 139
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Probiotic
Postgraduate Institute of Medical Education and Research
2011 Phase 4 NCT01479660 India;
Probiotic Formula Capsule
University of Jordan
2020 Phase 2/Phase 3 NCT04223479 Jordan;
Probiotic Mixture
Massachusetts General Hospital
2017 - NCT03266484 United States;
Probiotics
The Baruch Padeh Medical Center, Poriya
2012 Phase 4 NCT01078935 -
Products containing aminosalicylate
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Products containing azathioprine or 6-mercaptopurine
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Promiten
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
Propionyl-L-carnitine
SIGMA-TAU
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
Propionylcarnitinhydrochlorid
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
Psyllium Husk Powder
Weill Medical College of Cornell University
2020 Phase 2 NCT03998488 United States;
Puri-Nethol
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
Puri-nethol
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
QBECO SSI
Qu Biologics Inc.
2015 Phase 2 NCT02426372 Canada;
RDP58
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
RECTABUL2mg rectal form
EA Pharma Co.,Ltd.
2018 - JPRN-JapicCTI-183858 Japan;
REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO
IRCCS ISTITUTO CLINICO HUMANITAS
2017 Phase 4 EUCTR2016-002707-25-IT Italy;
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-002061-54-IT Italy;
RO5490261 / F02
Genentech, Inc.
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
RO5490261/F02
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
RO5490261/F04-02
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
RO7021610
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
RO7049665
Hoffmann-La Roche
2019 Phase 1 NCT03943550 Georgia;Hungary;Moldova, Republic of;Ukraine;United States;
RO7246311
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
ROSUVASTATIN CALCIUM
UZ Leuven
2020 Phase 3 EUCTR2019-004208-37-BE Belgium;
RPC103
CELGENE INTERNATIONAL II SàRL
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene
2015 Phase 3 NCT02531126 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 NCT02435992 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2 EUCTR2012-003123-38-PL Belgium;Bulgaria;Czech Republic;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 Phase 2 EUCTR2012-003123-38-BE Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II).
2013 Phase 2 EUCTR2012-003123-38-SK Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-NL Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-HU Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-BG Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Receptos, Inc.
2013 Phase 2 EUCTR2012-003123-38-GR Australia;Belgium;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;United States;
RTNV148B IgG
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
RYAH-Medtech Inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Ravagalimab
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 2 EUCTR2018-000930-37-IT Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 2 EUCTR2018-000930-37-HU Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-GB Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-DE Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000930-37-NL Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
Rebamipide
Otsuka Pharmaceutical Co., Ltd.
2007 Phase 2 NCT00463151 Japan;
2007 Phase 2 JPRN-JapicCTI-070399 Japan;
Recombinant Factor XIII (rFXIII)
Novo Nordisk A/S
2013 - EUCTR2011-001568-22-HU Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-DK Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-BG Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
Rectal dialysis
NorthShore University HealthSystem
2012 Phase 2 NCT04032652 -
Rectal tacrolimus
The University of Western Australia
2012 Phase 4 NCT01418131 Australia;
Rectosigmoidoscopy
Centre Hospitalier Universitaire de Saint Etienne
2017 - NCT03172195 France;
Regular treatment
Xijing Hospital of Digestive Diseases
2016 Phase 4 NCT02962245 -
Regulatory T cells
University of Erlangen-Nürnberg Medical School
2021 Phase 1 NCT04691232 Germany;
Remestemcel-L
The Cleveland Clinic
2020 Phase 1/Phase 2 NCT04543994 United States;
Remicade
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Centocor BV
2007 - EUCTR2006-000410-20-NL Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-DK Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-BE Belgium;Denmark;Italy;Netherlands;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-004282-14-PT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-NL Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-NO Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-FR Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-DE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-CZ Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-BE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-004282-14-IT Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
GEDII - Grupo de Estudo da Doença inflamatória Intestinal
2010 - EUCTR2009-013890-16-PT Portugal;
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2009 - EUCTR2008-005237-30-NL Canada;Netherlands;Sweden;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Katholieke Universiteit Leuven
2011 Phase 4 EUCTR2011-002061-38-BE Belgium;
Pfizer
2015 - NCT02539368 Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004282-14-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
University of Leuven Hospitals, Division of Gastroenterology
2009 - EUCTR2008-007519-34-SE Sweden;
Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
2013 - EUCTR2011-001332-29-AT Austria;
Remicade (infliximab)
Zon MW
2014 Phase 4 EUCTR2013-002651-15-NL Netherlands;
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Remicade 100 mg powder for concentrate for solution for infusion.
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning
Diakonhjemmet Hospital AS
2014 - EUCTR2014-002056-40-NO Norway;
Remsima
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Taina Sipponen
2016 Phase 4 EUCTR2016-001278-13-FI Finland;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Remsima (CT-P13)
CELLTRION INC.
2020 Phase 3 EUCTR2019-003849-15-IT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Celltrion, Inc.
2020 Phase 3 EUCTR2019-003849-15-HR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-GR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-FR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-ES Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-CZ Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-BG Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-AT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Remsima (infliximab)
Mundipharma Pharmaceuticals B.V.
2016 Phase 4 EUCTR2014-004904-31-BE Belgium;Netherlands;
2015 Phase 4 EUCTR2014-004904-31-NL Netherlands;
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning
Diakonhjemmet Hospital AS
2014 - EUCTR2014-002056-40-NO Norway;
Remsima and Inflectra
Janssen Biologics B.V.
2009 - EUCTR2008-005237-30-NL Canada;Netherlands;Sweden;United States;
Repomol
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Retarded Release Phosphatidylcholine (rPC)
Heidelberg University
2003 Phase 2 NCT00259545 Germany;
Retarded release phosphatidylcholine
Heidelberg University
2003 Phase 2/Phase 3 NCT00259571 Germany;
2003 Phase 2 NCT00259558 Germany;
2000 - NCT00463619 Germany;
RhIL-11
Wyeth is now a wholly owned subsidiary of Pfizer
1994 Phase 1 NCT00038922 United States;
RhuMAb Beta7
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 NCT01336465 Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-ES Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-000897-80-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-HU Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-GB Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-ES Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-DE Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-CZ Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2008 Phase 1 NCT00694980 Belgium;Canada;Germany;Netherlands;United Kingdom;United States;
RhuMAb Beta7, Anti Beta 7, PRO145223
F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004278-88-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
RhuMAb Beta7, Anti Beta7, PRO145223
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2013-004278-88-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004435-72-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004278-88-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
RhuMab Beta7, Anti Beta7, PRO145223
F. Hoffmann-La Roche Ltd
2015 Phase 3 EUCTR2013-004435-72-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Riboflavin
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Rifaximin
University of Dundee
2006 - NCT00355602 United Kingdom;
Risankizumab
AbbVie
2020 Phase 1 NCT04254783 Germany;Israel;United States;
2019 - NCT03914261 Belgium;Israel;Spain;Switzerland;United States;
2018 Phase 3 NCT03398135 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Risankizumab (Genetical Recombination)
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184008 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa;
2018 Phase 2-3 JPRN-JapicCTI-183997 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa;
Risankizumab IV
AbbVie
2018 Phase 2/Phase 3 NCT03398148 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Risankizumab SC
AbbVie
2018 Phase 2/Phase 3 NCT03398148 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Ritlecitinib
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Rituximab
Royal Liverpool University Hospital
2004 Phase 2/Phase 3 NCT00261118 United Kingdom;
Rivenprost (drug)
Kyoto University, Graduate School of Medicine
2006 Phase 2 NCT00296556 Japan;
Ro 549-0261/F04
F. Hoffmann-La Roche Ltd
2019 Phase 3 EUCTR2013-004279-11-FR Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-HU Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-CZ Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2013-004278-88-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2016 Phase 3 EUCTR2013-004280-31-SK Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2016 Phase 3 EUCTR2013-004280-31-PL Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2015 Phase 3 EUCTR2013-004435-72-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-PT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-NL Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004279-11-BG Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2015 Phase 3 EUCTR2013-004277-27-BG Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2015 - EUCTR2013-004435-72-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-NO Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-FR Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-DE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-CZ Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-BE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004280-31-HU Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004280-31-DK Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Poland;Slovakia;South Africa;United States;
2014 Phase 3 EUCTR2013-004280-31-DE Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004280-31-CZ Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-SK Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-EE Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004278-88-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-GR Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004277-27-LV Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LT Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-HR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-GR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 - EUCTR2013-004435-72-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 - EUCTR2013-004282-14-IT Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004278-88-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004282-14-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 - EUCTR2013-004435-72-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Rosiglitazone
Herlev Hospital
2005 Phase 1/Phase 2 NCT00309660 Denmark;
James Lewis
2002 Phase 2 NCT00065065 United States;
Rosuvastatin
Universitaire Ziekenhuizen Leuven
2020 Phase 2/Phase 3 NCT04883840 Belgium;
Rosuvastatine EG
UZ Leuven
2020 Phase 3 EUCTR2019-004208-37-BE Belgium;
SANDINUM
GETAID
2008 - EUCTR2006-005299-42-BE Belgium;Finland;France;Spain;
2007 - EUCTR2006-005299-42-FR Belgium;Finland;France;Spain;
SAR339658
Sanofi
2013 Phase 2 NCT01861249 Canada;United States;
2012 Phase 2 NCT01659138 Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi aventis Recherche&Développement
2013 Phase 2 EUCTR2012-002013-19-BE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-PL Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-IT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-DE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-AT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi-aventis recherche & développement
2014 - EUCTR2013-001012-30-DE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 Phase 2 EUCTR2013-001012-30-BE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-PL Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-IT Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-AT Austria;Canada;Germany;Italy;Poland;United States;
SB-656933
GlaxoSmithKline
2009 Phase 2 NCT00748410 Netherlands;
SB-656933 Tablets
GlaxoSmithKline R&D Ltd
2008 - EUCTR2007-005520-32-NL Netherlands;
SB012
Sterna Biologicals GmbH & Co. KG
2014 Phase 1/Phase 2 NCT02129439 Germany;
sterna biologicals GmbH & Co. KG
2014 Phase 2 EUCTR2013-004599-36-DE Germany;
SB5
Samsung Bioepis Co., Ltd
2015 - EUCTR2014-004887-39-PL Poland;
Samsung Bioepis Co., Ltd.
2014 Phase 3 EUCTR2013-005013-13-BG Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-PL Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-LT Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-CZ Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
SC12267
4SC AG
2010 - EUCTR2008-005903-25-BG Bulgaria;Germany;
2009 - EUCTR2008-005903-25-DE Bulgaria;Germany;
SC12267 (4SC-101)
4SC AG
2009 Phase 2 NCT00820365 Bulgaria;Germany;Romania;
SCH 900050
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
SER-287
Seres Therapeutics, Inc.
2018 Phase 2 NCT03759041 Canada;United States;
2016 Phase 1 NCT02618187 United States;
SF257 C59
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
SHP647
Baxalta Innovations GmbH
- Phase 3 EUCTR2017-000573-37-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
SHIRE HUMAN GENETIC THERAPIES, INC
2018 Phase 3 EUCTR2017-000599-27-IT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000572-28-BG Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2019 Phase 3 EUCTR2017-000574-11-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-NL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-LT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-HR Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-GB Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-DE Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-CZ Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-PT Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-HU Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-FR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-ES Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-BE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000599-27-AT Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-SK Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2017-000572-28-GR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
- Phase 3 EUCTR2017-000599-27-PL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000573-37-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000572-28-IE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
SHP647 (PF-00547659)
Shire
2013 Phase 2 NCT01771809 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;United States;
SHR0302
Reistone Biopharma Company Limited
2021 Phase 3 NCT05181137 China;Georgia;Poland;Ukraine;United States;
2019 Phase 2 NCT03675477 China;Poland;Puerto Rico;Ukraine;United States;
2019 Phase 2 EUCTR2018-003364-31-PL China;Poland;Ukraine;United States;
SHR0302 tablets
Reistone Biopharma Company Limited
2021 Phase 3 EUCTR2021-001940-86-PL China;Georgia;Poland;Ukraine;United States;
SODIUM HYALURONATE
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
SOYBEAN PHOSPHATIDYLCHOLINE
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
SPD476
Shire
2005 Phase 3 NCT00151892 Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States;
Shire Development Inc
2012 - EUCTR2011-000164-10-SK Slovakia;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2018 Phase 3 EUCTR2013-001744-65-DE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2018 Phase 3 EUCTR2013-001744-65-BE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-GB Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Devlopment LLC
2015 Phase 3 EUCTR2013-001744-65-NL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-SK Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-PL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-HU Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
SPD476 (mesalazine)
Shire
2003 Phase 3 NCT00151944 -
SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
Shire
2003 Phase 3 NCT00548574 Belgium;
2003 Phase 2 NCT00545389 Belgium;
SPH3127
Shanghai Pharma Biotherapeutics USA Inc.
2021 Phase 2 NCT05019742 United States;
SR140333B
SANOFI-SYNTHELABO
2005 - EUCTR2004-001677-26-IT Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Sanofi-Synthelabo Recherche
2005 Phase 2 EUCTR2004-001677-26-HU Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-SE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-ES Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-EE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
sanofi-aventis recherche & developpement
2004 - EUCTR2004-001677-26-CZ Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
SRT2104
Sirtris, a GSK Company
2012 Phase 1 NCT01453491 United States;
ST 261
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
ST-0529
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics Holdco Limited
2019 Phase 2 NCT03844932 Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
ST10-021
Iron Therapeutics (Switzerland) AG
2012 - EUCTR2010-023588-16-DE Austria;Germany;Hungary;United Kingdom;
2011 Phase 3 EUCTR2010-023588-16-GB Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-HU Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-AT Austria;Germany;Hungary;United Kingdom;
Shield Therapeutics
2011 Phase 3 NCT01340872 Austria;United Kingdom;
ST261
SIGMA-TAU
2008 - EUCTR2005-003471-20-LT Italy;Lithuania;
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
JANSSEN CILAG INTERNATIONAL NV
2015 Phase 3 EUCTR2014-005606-38-IT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
STELARA®
Janssen-Cilag International NV
2021 Phase 3 EUCTR2020-004457-76-PL Argentina;France;Japan;Poland;Russian Federation;Turkey;United States;
2021 Phase 3 EUCTR2019-004224-38-DE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004224-38-HU Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2020-004457-76-FR Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-PL Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-Outside-EU/EEA Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-GB Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-BE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
STNM01
STELIC INSTITUTE & CO.
2013 Phase 2 EUCTR2012-004768-23-DE Germany;
STW5-II
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
STW5-II (Iberogast N, BAY98-7410)
Bayer
2014 Phase 2 NCT02246686 Germany;
SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML
ParaTech A/S
2018 Phase 2 EUCTR2017-004772-65-DK Denmark;
Saffron 100
Shiraz University of Medical Sciences
2022 Phase 2 NCT05117749 -
Saffron 50
Shiraz University of Medical Sciences
2022 Phase 2 NCT05117749 -
Saffron supplement for IBD
Howard University
2020 - NCT04749576 United States;
Saline
The Second Hospital of Nanjing Medical University
2016 Phase 4 NCT02998112 China;
Salmon
Institute of Food Research
2004 - NCT00145015 Netherlands;United Kingdom;
Salofalk
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
University Medical Center Groningen
2010 - EUCTR2010-018557-35-NL Netherlands;
Salofalk 1000mg Granu-Stix
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-ES Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 - EUCTR2006-005377-22-LV Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-LT Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-DE Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
- Phase 3 EUCTR2006-005377-22-PL Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Salofalk 1000mg Granu-Stix®
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-SK Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Salofalk 1000mg Granu-stix®
Dr. Falk Pharma GmbH
2007 - EUCTR2006-005377-22-CZ Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
Salofalk 3g gastro-resistant prolonged-release granules
Dr. Falk Pharma GmbH
2021 Phase 3 EUCTR2019-003334-16-BG Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
2020 Phase 3 EUCTR2019-003334-16-DE Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
Salofalk 4g/60ml Klysma
Charité Universitätsmedizin, Campus Charité Mitte
2007 - EUCTR2006-004162-13-DE Germany;
Salofalk Granu-Stix
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Salofalk®
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
Salofalk® 1000mg Granu-Stix®
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001216-31-SK Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001216-31-SI Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001216-31-LV Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-LT Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-HU Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-EE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-DE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-CZ Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
Salofalk® 500 mg gastro-resistant tablet
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Salofalk® 500 mg tablets
Dr. Falk Pharma GmbH
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Salofalk® 500mg Granu-Stix®
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001218-15-SK Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001218-15-SI Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001218-15-LV Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-LT Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-HU Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-EE Estonia;Germany;Hungary;Latvia;Lithuania;
Sandimmum
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Sandimmun
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
Sandimmun 50 mg/ml, infuusiokonsentraatti
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Sandimmun Neoral
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Semi-vegetarian diet
Mayo Clinic
2017 Early Phase 1 NCT03309865 United States;
Serum bovine immunoglobulin
Monisha Hitesh Shah
2020 Early Phase 1 NCT04223518 United States;
Sham Hyperbaric Air
Dartmouth-Hitchcock Medical Center
2013 Phase 2/Phase 3 NCT02144350 United States;
Shingrix
University of Wisconsin, Madison
2019 Phase 4 NCT03798691 United States;
Sigmoidoscopy
Virginia O. Shaffer
2014 Phase 2 NCT02049502 United States;
Simponi
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
Guy's and St Thomas' NHS Foundation Trust
2017 Phase 4 EUCTR2017-001374-42-GB United Kingdom;
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
Janssen Biologics B.V.
2015 Phase 2 EUCTR2013-002042-36-FR Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-PL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-BG Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-NL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-HU Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-DE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-CZ Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-BE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
MSD
2014 Phase 4 EUCTR2013-004583-56-GB United Kingdom;
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
2014 Phase 4 EUCTR2014-003262-25-PT Portugal;
UCD
2015 Phase 4 EUCTR2015-004724-62-IE Ireland;
University Medical Centre Ljubljana, Department of gastroenterology
2020 Phase 4 EUCTR2019-003987-37-SI Slovenia;
Simponi (Golimumab)
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
Simponi®
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Simponi® (Golimumab)
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
Simulect
Cerimon Pharmaceuticals, Inc.
2007 Phase 2 EUCTR2006-006319-54-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-CZ Belgium;Czech Republic;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 - EUCTR2006-006319-54-BE Belgium;United Kingdom;
2007 - EUCTR2006-004303-19-CZ Belgium;Czech Republic;United Kingdom;
2007 - EUCTR2006-004303-19-BE Belgium;Czech Republic;United Kingdom;
Single dose-group A
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Smartject Device delivery of Golimumab
Merck Sharp & Dohme Corp.
2014 Phase 4 NCT02155335 Belgium;
Smoking cigarettes
Meir Medical Center
2010 Phase 1/Phase 2 NCT01040910 Israel;
Smoking of cannabis
Meir Medical Center
2010 Phase 1/Phase 2 NCT01040910 Israel;
Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate
Bridge Biotherapeutics, Inc.
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
Sodium Picosulfate/Magnesium Citrate Laxative
American University of Beirut Medical Center
2018 Phase 4 NCT03581149 Lebanon;
Sotrastaurin (INN) acetate
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Spesolimab
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim
2018 Phase 2/Phase 3 NCT03482635 Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 NCT03123120 Denmark;Germany;Ireland;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 NCT03100864 Belgium;Germany;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Spesolimab IV infusion
Boehringer Ingelheim
2018 Phase 2 NCT03648541 Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States;
Spesolimab SC solution for injection
Boehringer Ingelheim
2018 Phase 2 NCT03648541 Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States;
Standard 2 hours-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Standard Therapy
Merck Sharp & Dohme Corp.
2007 - NCT00705484 Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Standardized FMT
The Second Hospital of Nanjing Medical University
2012 Phase 2/Phase 3 NCT01790061 China;
Standardized FODMAP
Vendsyssel Hospital
2018 - NCT02469220 Denmark;
Standardized anthocyanin-rich extract
University of Zurich
2019 Phase 2 NCT04000139 Switzerland;
Stasis
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
2020 Phase 0 ChiCTR2000037261 China;
Stelara
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Sterile saline for injection
Bristol-Myers Squibb
2008 Phase 2 NCT00656890 Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States;
Steroids
Medical University of Graz
2018 - NCT03460847 Austria;
Stool samples
University Hospital, Bordeaux
2020 - NCT04272307 France;
Sucrosomial Iron
American University of Beirut Medical Center
2019 Phase 3 NCT05225545 Lebanon;
Sugar Extract
Oslo University Hospital
2011 Phase 2/Phase 3 NCT01496053 Norway;
Sulphsalazine, Pentasa, Asacol, Colazide, Depentum
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Suspension de microbiote fécal
CHU Nantes
2018 Phase 3 EUCTR2017-004967-11-FR France;
Synergy-1
University of Alberta
2016 - NCT02865707 Canada;
Synergy1
University of Alberta
2007 - NCT02093767 Canada;
Sübetaholzwurzel 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Süßholzwurzel 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
TA-650
Mitsubishi Tanabe Pharma Corporation
2012 Phase 3 NCT01585155 Japan;
TA-650 (Infliximab)
Mitsubishi Tanabe Pharma Corporation
- Phase 3 JPRN-JapicCTI-060298 -
TD-1473
Theravance Biopharma
2016 Phase 1 NCT02818686 Georgia;Moldova, Republic of;Romania;United States;
Theravance Biopharma Ireland Limited
2021 Phase 3 EUCTR2018-002135-19-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-002135-19-IT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-002136-24-IT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
TD-1473 Dose A
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-1473 Dose B
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-1473 Dose C
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-3504
Theravance Biopharma
2017 Phase 1 NCT03103412 United States;
THRX-139060
Theravance Biopharma Ireland Limited
2021 Phase 3 EUCTR2018-002135-19-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
TJ301
I-Mab Biopharma HongKong Limited
2018 Phase 2 NCT03235752 Australia;China;Korea, Republic of;Taiwan;
TLL018
Hangzhou Highlightll Pharmaceutical Co., Ltd
2021 Phase 2 NCT05121402 -
TOFACINITIB
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2021 Phase 4 EUCTR2020-003006-31-IT Italy;
TOP1288
Topivert Pharma Ltd
2017 Phase 1 NCT03071081 United Kingdom;
2016 Phase 2 NCT02888379 Bulgaria;Czech Republic;Czechia;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom;
2015 Phase 1 NCT02463045 United Kingdom;
TP05
Tillotts Pharma AG
2015 Phase 3 EUCTR2013-000366-11-RO Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-SK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;
2014 Phase 3 EUCTR2013-000366-11-LV Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-LT Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-HU Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-BG Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 NCT01903252 Netherlands;Switzerland;
2013 Phase 3 EUCTR2013-000366-11-SE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-PL Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine;
2013 Phase 3 EUCTR2013-000366-11-IE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-GB Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-FI Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-DK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-CZ Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-BE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 1 NCT02306798 -
2013 - EUCTR2013-000366-11-ES Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine;
TP05 Coating A
Tillotts Pharma AG
2011 Phase 1 NCT02306772 -
TP05 Coating B
Tillotts Pharma AG
2011 Phase 1 NCT02306772 -
TP05 Coating D
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TP05 Coating E
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TP05 Coating H
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TPMT genotyping
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
TREMFYA®
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
TSO
ParaTech A/S
2018 Phase 2 EUCTR2017-004772-65-DK Denmark;
TYK2 Inhibitor
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
Tacrolimus
Astellas Pharma Inc
2006 Phase 3 NCT00643071 Japan;
2006 Phase 3 NCT00347048 Japan;
Chiba University Hospital
2013 - JPRN-UMIN000010776 Japan;
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
2013 Phase 4 JPRN-UMIN000010612 Japan;
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
2010 Phase 3 JPRN-UMIN000003785 Japan;
Department of lower gastroenterology, Hyogo College of Medicine
2010 Phase 4 JPRN-UMIN000003952 Japan;
Juntendo University
2011 - JPRN-UMIN000005824 Japan;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Kitasato University Kitasato Institute Hospital
2014 - JPRN-UMIN000013694 Japan;
Medical College of Wisconsin
2017 Phase 3 NCT02954159 United States;
Osaka City University, Graduate School of Medicine,Department of Gastroenterology
2013 - JPRN-UMIN000004201 Japan;
Osaka Medical College
2014 - JPRN-UMIN000015912 Japan;
Saitama Medical Center, Saitama Medical University
2011 - JPRN-UMIN000005033 Japan;
Yokohama City University Medical Center
2014 Phase 2 JPRN-UMIN000013716 Japan;
Tauroursoursodeoxycholic acid, brand name Tudcabil
Washington University School of Medicine
2019 Phase 1 NCT04114292 United States;
Telotristat Etiprate
Lexicon Pharmaceuticals
2012 Phase 2 NCT01456052 Lithuania;Poland;Slovakia;United States;
Telotristat etiprate
Lexicon Pharmaceuticals, Inc.
2012 - EUCTR2011-003532-32-LT Belgium;Lithuania;Poland;Slovakia;United States;
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
Terbinafine
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
Tetracycline
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
Thalidomide
IRCCS Burlo Garofolo
2008 Phase 3 NCT00720538 Italy;
Thalidomide Pharmion
ISTITUTO PER L INFANZIA BURLO GAROFOLO
2006 - EUCTR2005-005414-20-IT Italy;
The Colonic Transendoscopic enteral Tubing.
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Threonine
Nestlé
2015 - NCT02423460 Canada;
Tilpisertib
Gilead Sciences
2019 Phase 2 NCT04130919 Australia;Austria;Canada;France;Germany;Italy;Poland;Switzerland;United States;
To be confirmed
Gilead Sciences, Inc.
2020 Phase 2 EUCTR2019-001430-33-GB Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
To be requested
Landos Biopharma Inc.
2020 Phase 2 EUCTR2018-005086-39-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HU Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Tofacitinib
Kawai Norisuke
2021 Phase 3 JPRN-jRCT2071210075 Australia;Canada;Japan;United States;
PFIZER INC.
2013 - EUCTR2011-004578-27-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
PFIZER LIMITED
2013 Phase 3 EUCTR2011-004580-79-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-IT Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer
2021 Phase 3 NCT04624230 Australia;Canada;Israel;Japan;Poland;Spain;United States;
2020 - NCT04424303 France;
2020 - NCT04338204 Sweden;
2012 Phase 3 NCT01465763 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01458951 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc
2012 Phase 3 EUCTR2011-004580-79-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2013 Phase 3 EUCTR2011-004580-79-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004579-35-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004581-14-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004580-79-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Postgraduate Institute of Medical Education and Research
2021 - NCT05112263 -
University of Miami
2020 Phase 3 NCT04505410 United States;
Tofacitinib 10 MG [Xeljanz]
McMaster University
2021 Phase 2 NCT04925973 Canada;
Tofacitinib citrate
PFIZER INC
2018 Phase 3;Phase 4 EUCTR2017-002274-39-IT Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 3;Phase 4 EUCTR2017-002274-39-NL Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-CZ Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-BE Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002274-39-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-002274-39-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Pfizer Inc.
2017 Phase 3;Phase 4 EUCTR2017-002274-39-SK Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Phase III Formulation)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercial formulation - debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercial formulation – debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-AT Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercialFormulation - debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (clinical trial image)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Traditional treatments
The Second Hospital of Nanjing Medical University
2012 Phase 2/Phase 3 NCT01790061 China;
Tralokinumab
ASTRAZENECA
2011 - EUCTR2011-004812-40-IT Czech Republic;Germany;Italy;Netherlands;United Kingdom;
AstraZeneca
2012 Phase 2 NCT01482884 Czech Republic;France;Germany;Italy;Netherlands;Poland;United Kingdom;
AstraZeneca AB
2012 Phase 2 EUCTR2011-004812-40-GB Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-NL Czech Republic;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-DE Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-CZ Czech Republic;Italy;Netherlands;United Kingdom;
Treatment Algorithm A
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Treatment Algorithm B
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Treatment Algorithm C
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Trexan inj 25 mg/ml
GETAID, Jean Minjoz Hospital
2009 - EUCTR2006-003607-40-FI Austria;Belgium;Finland;Netherlands;
Trichuris suis eggs
University of Aarhus
2012 - NCT03079700 -
Trichuris suis ova
New York University School of Medicine
2012 - NCT01433471 United States;
ParaTech A/S
2018 Phase 2 NCT03565939 Denmark;
Trichuris suis ova (TSO)
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 2 NCT01953354 United States;
UCB4940
UCB Biopharma SPRL
2017 Phase 2 EUCTR2016-000420-26-PL Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-000420-26-BG Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-ES Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-CZ Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
UCMSC group
Affiliated Hospital to Academy of Military Medical Sciences
2015 Phase 1/Phase 2 NCT02442037 China;
UR-12746-S
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
UTTR1147A
Genentech, Inc.
2019 Phase 2 NCT03650413 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03558152 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 1 NCT02749630 Canada;Germany;United Kingdom;
UTTR1147A, IL22-Fc, IL-22Fc
Genentech, Inc.
2019 Phase 2 EUCTR2017-004997-32-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-DE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004997-32-IE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
UTTR1147A/RO7021610 (Active)
GENENTECH, INC.
2019 Phase 2 EUCTR2017-004997-32-IT Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2019 Phase 2 EUCTR2017-004997-32-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-DE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Umbilical Cord Mesenchymal Stem Cells
Qingdao University
2010 Phase 1/Phase 2 NCT01221428 China;
Umbilical cord blood mononuclear cells
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Unknown
F. Hoffmann-La Roche Ltd
2015 Phase 3 EUCTR2013-004435-72-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Upadacitinib
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2016-000642-62-IT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-IT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 3 EUCTR2016-000642-62-SE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2016-000642-62-FR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-SK Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-NL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-LT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-IE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-HR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GB Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-ES Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-DE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-CZ Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-AT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-NO Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-LV Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-HU Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-FI Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-000641-31-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-HU Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
Upadacitinib (ABT-494)
AbbVie
2018 Phase 3 NCT03653026 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 NCT03006068 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib - Direct compression-yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib - Wet Granulation-Yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib -Direct compression-yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Updacitinib (ABT-494)
AbbVie
2016 Phase 3 NCT02819635 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Urbason
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
2017 Phase 4 EUCTR2016-001170-15-ES Spain;
Ursodeoxycholic acid
The 900th Hospital of PLA
2018 Phase 4 ChiCTR2000038316 China;
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
Ursodiol (ursodeoxycholic acid, UDCA)
Stanford University
2019 Phase 2/Phase 3 NCT03724175 United States;
Ursofalk
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
Ustekinumab
Janssen Cilag S.A.S.
2018 - NCT03606499 France;
Janssen Pharmaceutical K.K.
2021 - NCT04963725 Japan;
2015 Phase 3 JPRN-JapicCTI-163122 Japan, Asia except Japan, North America, Europe, Oceania;
Janssen Scientific Affairs, LLC
2021 - NCT04372108 United States;
Janssen-Cilag International NV
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Nishikawa Kazuko
2021 Phase 3 JPRN-jRCT2041200098 Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom Of Great Britain And Northern Irela;United States Of America;
Ustekinumab Dose Based on BSA and Body Weight
Janssen Research & Development, LLC
2021 Phase 3 NCT04630028 Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
Ustekinumab IV
Janssen Research & Development, LLC
2015 Phase 3 NCT02407236 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
Ustekinumab IV Infusion
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Ustekinumab SC
Janssen Research & Development, LLC
2015 Phase 3 NCT02407236 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
Ustekinumab SC Injection
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Usual current care
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
V565
VHsquared Ltd.
2017 Phase 1 NCT03705117 United Kingdom;
VB-201
Vascular Biogenics Ltd.
2013 - EUCTR2012-003974-18-BG Bulgaria;Hungary;
2012 - EUCTR2012-003974-18-HU Bulgaria;Hungary;
Vascular Biogenics Ltd. operating as VBL Therapeutics
2013 Phase 2 NCT01839214 Bulgaria;Hungary;Poland;
VE202
Vedanta Biosciences, Inc.
2021 Phase 2 EUCTR2021-001280-24-LT Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-001280-24-HU Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
VEDULIZUMAB
ALIMENTIV INC.
2021 Phase 4 EUCTR2019-002485-12-IT Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
VSL#3
VSL Pharmaceuticals
2006 - NCT00951548 Italy;
VSL#3 (Original De Simone formulation)
Charles University, Czech Republic
2014 - NCT01765439 Czech Republic;Czechia;
VSL#3®
VSL Pharmaceuticals
2017 - NCT03415711 Italy;
VTX002
Oppilan Pharma Ltd
2021 Phase 2 NCT05156125 Czechia;Georgia;Hungary;Poland;Ukraine;United States;
Oppilan Pharma Ltd.
2022 Phase 2 EUCTR2021-003050-23-PL Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
VTX002 is not biologic
Oppilan Pharma Ltd.
2022 Phase 2 EUCTR2021-003050-23-LT Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-003050-23-HU Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-003050-23-CZ Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
Vaccine Vivotif + Vaccine Dukoral + oats
Haukeland University Hospital
2008 Phase 2 NCT00751933 Norway;
Valganciclovir
CHU de Saint Etienne
2019 Phase 4 EUCTR2019-001032-54-FR France;
Centre Hospitalier Universitaire de Saint Etienne
2021 Phase 3 NCT04064697 France;
Vaminolac
Aarhus University Hospital
2015 - NCT02084550 Denmark;
Vaminolac, komb.
Department of Medicine and Endocrinology
2015 Phase 3 EUCTR2014-000784-41-DK Denmark;
Vamorolone suspension for oral dosing
ReveraGen BioPharma, Inc.
2020 Phase 1/Phase 2 NCT04348890 -
Vancomycin
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
University of Dundee
2006 - NCT00355602 United Kingdom;
Vancomycin Pre-Treat
Seres Therapeutics, Inc.
2016 Phase 1 NCT02618187 United States;
Vancomycin Pre-Treatment
KoBioLabs
2021 Phase 2 NCT04898348 -
Seres Therapeutics, Inc.
2018 Phase 2 NCT03759041 Canada;United States;
Vatelizumab
Sanofi aventis Recherche&Développement
2013 Phase 2 EUCTR2012-002013-19-BE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-PL Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-IT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-DE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-AT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi-aventis recherche & développement
2014 - EUCTR2013-001012-30-DE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 Phase 2 EUCTR2013-001012-30-BE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-PL Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-IT Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-AT Austria;Canada;Germany;Italy;Poland;United States;
Vedolizumab
AstraZeneca
2018 Phase 2 NCT04718818 Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States;
CHU de Saint Etienne
2019 Phase 4 EUCTR2019-001032-54-FR France;
Fujiya Mikihiro
2021 Phase 4 JPRN-jRCTs011200009 Japan;
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Geert D'Haens
2015 Phase 4 NCT02646657 Belgium;Hungary;Netherlands;
Genentech, Inc.
2018 Phase 2 NCT03558152 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Guy's & St Thomas NHS Foundation Trust
2018 Phase 4 EUCTR2018-002794-21-GB United Kingdom;
Guy's and St Thomas' NHS Foundation Trust
2019 Phase 4 NCT04006080 United Kingdom;
MILLENNIUM PHARMACEUTICALS, INC.
2009 Phase 3 EUCTR2008-002784-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002782-32-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
Medical College of Wisconsin
2017 Phase 3 NCT02954159 United States;
Millennium Pharmaceuticals, Inc.
2009 Phase 3 NCT00783718 Canada;Puerto Rico;United States;
2007 Phase 2 NCT01177228 -
2007 Phase 2 NCT00619489 Canada;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Shaare Zedek Medical Center
2017 - NCT02862132 Denmark;Finland;Ireland;Israel;Slovenia;United Kingdom;United States;
Shikamura Mitsuhiro
2021 Phase 3 JPRN-jRCT2071210030 Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 JPRN-jRCT2031200371 Japan;
Stanford University
2020 - NCT03802214 Canada;United States;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda
2021 Phase 3 NCT04779307 United States;
2021 Phase 3 NCT04738942 Japan;
2019 - NCT03824561 Japan;
2018 Phase 2 NCT03196427 Belgium;Canada;France;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 4 NCT02559713 United States;
2017 Phase 2 NCT03138655 Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 4 NCT02760615 United States;
2016 Phase 4 NCT02743806 Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2015 Phase 3 NCT02497469 Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 - NCT02674308 Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 3 NCT02039505 Japan;
2009 Phase 3 NCT00790933 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;Korea, Republic of;Malaysia;United States;
Takeda Development Center Americas, Inc.
2021 Phase 3 EUCTR2020-004300-34-SK Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-LT Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HU Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HR Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-GR Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-ES Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-CZ Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-BE Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda Pharmaceutical Company Limited
2019 - JPRN-JapicCTI-194603 Japan;
University of Pennsylvania
2017 Phase 4 NCT03237260 United States;
Yonsei University
2021 Phase 3 NCT04919252 Korea, Republic of;
ooi makoto
2021 Phase 3 JPRN-jRCT1051210145 Japan;
Vedolizumab 108 mg SC
Takeda
2015 Phase 3 NCT02611830 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Vedolizumab 300 mg IV
Takeda
2015 Phase 3 NCT02611830 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Vedolizumab IV
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda
2022 Phase 4 NCT04804540 -
2017 Phase 4 NCT03029143 Canada;United States;
2017 Phase 3 NCT03221036 China;
Takeda Development Centre Europe Limited
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
Vedolizumab IV, Placebo IV, Placebo SC
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab IV, Placebo SC
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab Injection
Mayo Clinic
2017 Early Phase 1 NCT03309865 United States;
Rennes University Hospital
2019 Phase 4 NCT03679546 France;
Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab SC
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000482-31-IT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda
2016 Phase 3 NCT02620046 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000482-31-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BG Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda Pharmaceutical Company Limited
2016 Phase 3 JPRN-JapicCTI-163220 Japan, Refer to Othersection;
Vedolizumab intravenous injection
Takeda
2014 Phase 2 NCT02913508 -
Vedolizumab subcutaneous injection
Takeda
2014 Phase 2 NCT02913508 -
Vedolizumab, Ustekinumab, or Tofacitinib
Asan Medical Center
2022 - NCT05186623 Korea, Republic of;
Vidofludimus calcium
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
Vidofludimus calcium dihydrate
Immunic AG
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Vigantol Oel TM
Imperial College London
2008 Phase 4 EUCTR2007-006692-37-GB United Kingdom;
2008 - EUCTR2008-001467-10-GB United Kingdom;
Visilizumab
Abbott
2006 Phase 2 NCT00307827 Canada;Croatia;Ireland;Italy;Poland;Russian Federation;Serbia;Spain;Switzerland;United States;
Facet Biotech
2007 Phase 3 NCT00502294 -
2006 Phase 2/Phase 3 NCT00279435 Australia;Austria;Belgium;Canada;Croatia;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Ukraine;United States;
2006 Phase 2/Phase 3 NCT00279422 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Norway;Slovakia;Ukraine;United States;
2004 Phase 1/Phase 2 NCT00267306 United States;
2002 Phase 2/Phase 3 NCT00032305 United States;
PDL BioPharma , Inc.
2006 - EUCTR2005-003482-17-IT Greece;Ireland;Italy;Spain;United Kingdom;
PDL BioPharma, Inc
PDL BioPharma, Inc.
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
Visilizumab (Nuvion)
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Vitamin B2
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Vitamin D
Stanford University
2021 Phase 1 NCT04828031 United States;
University Hospital of North Norway
2013 Phase 1/Phase 2 NCT01846026 Norway;
Vitamin D drops
Second Affiliated Hospital of Wenzhou Medical University
2020 Early Phase 1 NCT04309058 China;
Vitamin D3
Boston Children's Hospital
2020 Phase 2 NCT04331639 United States;
2017 Phase 3 NCT03162432 United States;
Massachusetts General Hospital
2020 - NCT04225819 United States;
University Hospital, Basel, Switzerland
2022 Phase 3 NCT04991324 -
University of California, San Francisco
2012 - NCT01877577 United States;
University of Chicago
2012 - NCT01640496 United States;
Vitamin E 800IU
University Health Network, Toronto
2002 Phase 2 NCT00152841 Canada;
Vitamin K
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Warfarin
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Water
411th Hospital of PLA
2013 - ChiCTR-TRC-13003530 China;
The Jikei University School of MedicineDivision of Gastroenterology and Hepatology
2009 - JPRN-UMIN000008967 Japan;
Wharton Jelly Mesenchymal stem cells
Hanan Jafar
2017 Phase 1/Phase 2 NCT03299413 Jordan;
XELJANZ -
PFIZER INC
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Xeljanz
DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
2019 Phase 4 EUCTR2018-004890-28-IT Italy;
Erasmus Medical Center
2019 Phase 4 EUCTR2018-004587-61-NL Netherlands;
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Xeljanz 5 mg film-coated tablets
Academic Medical Center
2017 Phase 3 EUCTR2016-002691-27-NL Netherlands;
Xeljanz 5mg film-coated tablets
Amsterdam UMC, location AMC
2020 Phase 2 EUCTR2020-002695-12-NL Netherlands;
Z-206
Zeria Pharmaceutical Co., Ltd.
2013 Phase 3 JPRN-JapicCTI-132135 -
- Phase 2 JPRN-JapicCTI-121943 -
ZEPOSIA® (ozanimod)
Celgene International II Sàrl
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Zessly
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Zoenasa-1:4
Altheus Therapeutics, Inc.
2012 Phase 2 NCT01586533 United States;
[124I]IB PF 06687234
Pfizer
2020 Phase 1 NCT03414788 United States;
[18F]FSPG
Asan Foundation
2018 Phase 2 NCT03546868 Korea, Republic of;
hydrocortisone acetate suppository with Sephure suppository applicator
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-DE Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States;
idrocortisone acetato in supposta con appli
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-IT Germany;Hong Kong;India;Italy;Philippines;Poland;Russian Federation;Spain;Ukraine;United States;
idrocortisone acetato in supposta con applicatore per supposte Sephure
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-IT Germany;Hong Kong;India;Italy;Philippines;Poland;Russian Federation;Spain;Ukraine;United States;
mesalazine pellets
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001218-15-SK Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 Phase 3 EUCTR2004-001216-31-SK Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001218-15-SI Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001218-15-LV Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-LT Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-HU Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-EE Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-DE Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-SI Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001216-31-LV Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-LT Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-HU Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-EE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-DE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-CZ Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
(-)-3-(4-Aminophenyl)-2-methoxypropionic acid
GIULIANI
2012 - EUCTR2011-003283-78-IT Italy;
(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid
PPM SERVICES SA
2017 Phase 2 EUCTR2016-001684-36-LV Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2017 Phase 2 EUCTR2016-001684-36-ES Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2016 Phase 2 EUCTR2016-001684-36-SK Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-HU Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-BG Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben
Celgene International II Sàrl
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride
CELGENE INTERNATIONAL II SàRL
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
-aminosalicylic acid
National Center for Research Resources (NCRR)
1996 Phase 2 NCT00004810 -
1.Remicade
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
100
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
15N2-tofacitinib
Theravance Biopharma
2017 Phase 1 NCT03103412 United States;
2 x 10 mg Natura-alpha capsules
Natrogen Therapeutics International, Inc
2010 Phase 2 NCT01216280 United States;
2'-Fucosyllactose
Children's Hospital Medical Center, Cincinnati
2019 Phase 1/Phase 2 NCT03847467 United States;
23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)
Cedars-Sinai Medical Center
2005 - NCT00829595 United States;
2L polyethylene glycol/ascorbic acid
American University of Beirut Medical Center
2018 Phase 4 NCT03581149 Lebanon;
3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)
Iron Therapeutics (Switzerland) AG
2012 - EUCTR2010-023588-16-DE Austria;Germany;Hungary;United Kingdom;
2011 Phase 3 EUCTR2010-023588-16-GB Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-HU Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-AT Austria;Germany;Hungary;United Kingdom;
331731-18-1
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2013-001682-16-DK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2017 Phase 3 EUCTR2015-001346-29-CZ Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-HU Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-GB Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-ES Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-BE Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2013-001682-16-BE Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-003032-77-IT Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-HU Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-GB Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001682-16-SK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-PL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-HU Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-ES Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-DE Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-AT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
- Phase 3 EUCTR2015-001346-29-SE Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-AT Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
AbbVie Inc.
- - EUCTR2014-004559-29-Outside-EU/EEA Japan;
Abbvie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2013-003032-77-PL Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-BE Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2013-003032-77-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
42942019
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-002061-54-IT Italy;
5 ASA, enemas, suppositories, corticosteroids
Bausch Health Americas, Inc.
2005 Phase 3 NCT00269438 United States;
5-ASA
Bausch Health Americas, Inc.
2012 Phase 3 NCT01532648 Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
Center for Diagnostic and Therapeutic Endoscopy,Keio University
2015 - JPRN-UMIN000018075 Japan;
Centre Hospitalier Universitaire de Saint Etienne
2016 Phase 3 NCT02665845 France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
2015 - JPRN-UMIN000019310 Japan;
Department of Gastroenterology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
2014 Phase 1 study ChiCTR-TRC-14004153 -
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
2017 - JPRN-UMIN000026175 Japan;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
Friendship Hospital of Capital Medical University
2008 Phase 1 study ChiCTR-TRC-08000145 China;
5-ASA (5-Aminosalicylate)
Ferring Pharmaceuticals
2007 Phase 3 NCT00603733 Canada;
5-ASA MMx
GIULIANI
2004 - EUCTR2004-000916-25-IT Italy;
5-Aminosalicyclic acid
Asian Institute of Gastroenterology, India
2016 Phase 3 NCT02683759 India;
5-Aminosalicylic acid (5-ASA)
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
5-Aminosalicylic acid(5-ASA) and/or Prednisone
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
5-HTP
University Hospital, Ghent
2018 Phase 2 NCT03574948 Belgium;
5-amino salicylic acid
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-amino salicylic acid (5-ASA)
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
5-amino-2-hydroxybenzoic acid
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
5-aminosalicylate (Pentasa, Ferring)
VU University Medical Center
2005 Phase 4 NCT00167882 Netherlands;
5-aminosalicylic acid
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
2010 Phase 3 JPRN-UMIN000003785 Japan;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
2012 Phase 2 EUCTR2012-002023-15-AT Austria;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Sheba Medical Center
2011 Phase 3 NCT01320436 Israel;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-aminosalicylic acid (5-ASA)
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
549-0261/F02-01
F. Hoffmann-La Roche Ltd
2018 Phase 1 EUCTR2017-003649-10-GB Belgium;Germany;Poland;Spain;United Kingdom;
2018 Phase 1 EUCTR2017-003649-10-DE Belgium;Germany;Poland;Spain;United Kingdom;United States;
2018 Phase 1 EUCTR2017-003649-10-BE Belgium;Germany;Poland;Spain;United Kingdom;
- Phase 1 EUCTR2017-003649-10-PL Belgium;Germany;Poland;Spain;United Kingdom;United States;
6 mercaptopurine
Indiana University
2015 - NCT02413047 United States;
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
A multistrain probiotic product (DSF)
Xijing Hospital of Digestive Diseases
2019 - NCT04006977 China;
A07DA03
Department of surgery, Odense University Hospital
2014 Phase 4 EUCTR2014-004740-35-DK Denmark;
A: 1 dosis
AB Biotics, SA
2018 - NCT03444311 Spain;
AB (antibiotics)
Shaare Zedek Medical Center
2014 - NCT02033408 Canada;Finland;Israel;Italy;Poland;Spain;
ABBV-006
ABBVIE DEUTSCHLAND GMBH & CO. KG
2018 Phase 3 EUCTR2016-004676-22-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2021 Phase 3 EUCTR2016-004676-22-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-066
ABBVIE DEUTSCHLAND GMBH & CO. KG
2018 Phase 3 EUCTR2016-004676-22-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2021 Phase 3 EUCTR2016-004676-22-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2016-004677-40-FR Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-004676-22-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-SI Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2016-004677-40-BG Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-DK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004676-22-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-SE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-PT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-NL Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-LV Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-LT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-DK Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-BE Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-004677-40-AT Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-004676-22-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-GB Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-004677-40-CZ Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-323
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 2 EUCTR2018-000930-37-IT Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 2 EUCTR2018-000930-37-HU Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-GB Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-FR Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-ES Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-DE Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000930-37-NL Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose A
AbbVie
2019 Phase 2 NCT03695185 Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose B
AbbVie
2019 Phase 2 NCT03695185 Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABI-M201
Assembly Biosciences
2019 Phase 1 NCT03923478 Canada;United States;
ABT-494
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2016-000642-62-IT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-IT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 3 EUCTR2016-000642-62-SE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2016-000642-62-FR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-SK Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-NL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-LT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-IE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-HR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GB Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-ES Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-DE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-CZ Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-AT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-NO Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-LV Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-HU Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-FI Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-000641-31-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-LV Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-HU Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-ES Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
2016 Phase 3 EUCTR2016-000674-38-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-LV Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-HU Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-ES Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
ABT-Humira
AbbVie Deutschland GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
Abbott GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
ABX464
ABIVAX
2022 Phase 2 EUCTR2021-004398-30-SI Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2021 Phase 2 EUCTR2021-004398-30-SK Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2021 Phase 2 EUCTR2021-004398-30-HU Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2020 Phase 2 EUCTR2019-000733-39-GB Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-FR Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-DE Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2019-000733-39-AT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2020 Phase 2 EUCTR2018-003558-26-GB Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2019-000733-39-SK Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-SI Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-PL Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2019-000733-39-ES Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-SK Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-SI Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-PL Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-HU Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003558-26-FR Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-DE Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-CZ Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-BE Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003284-35-PL Belgium;Hungary;Poland;Spain;
2018 Phase 2 EUCTR2017-003284-35-HU Belgium;Hungary;Poland;Spain;
2018 Phase 2 EUCTR2017-003284-35-ES Hungary;Spain;
2018 Phase 2 EUCTR2017-000937-30-AT Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-003284-35-BE Belgium;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-PL Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-FR Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-ES Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-DE Austria;Belgium;France;Germany;Hungary;Poland;Spain;
2017 Phase 2 EUCTR2017-000937-30-BE Austria;Belgium;Germany;Hungary;Poland;Spain;
Abivax
2021 Phase 2 EUCTR2021-004398-30-IT Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
2020 Phase 2 EUCTR2019-000733-39-IT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 EUCTR2018-003558-26-IT Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
Abivax S.A.
2021 Phase 2 NCT05177835 Belgium;Czechia;Hungary;Poland;
2020 Phase 2 NCT04023396 Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
2019 Phase 2 NCT03760003 Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03368118 Belgium;
2017 Phase 2 NCT03093259 Belgium;
Owada Yasuko
2021 Phase 1 JPRN-jRCT2051210087 Japan;
ACETATO DI AMMONIO
Protagonist Therapeutics, Inc.
2020 Phase 2 EUCTR2019-004469-41-IT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States;
AEB071
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Novartis Pharmaceuticals
2010 Phase 2 NCT00572585 Denmark;Germany;Poland;United States;
AEB071A
Novartis Pharma Services AG
2007 - EUCTR2007-002542-38-DE Denmark;Germany;
AG011
ActoGeniX N.V.
2008 Phase 1/Phase 2 NCT00729872 Belgium;Canada;Netherlands;Sweden;
AG011 - Capsules
ActoGeniX N.V
2008 - EUCTR2008-000967-40-BE Belgium;Netherlands;Sweden;
ActoGeniX NV.
2008 - EUCTR2008-000967-40-SE Belgium;Netherlands;Sweden;
2008 - EUCTR2008-000967-40-NL Belgium;Netherlands;Sweden;
AG011 - Enema
ActoGeniX N.V
2008 - EUCTR2008-000967-40-BE Belgium;Netherlands;Sweden;
ActoGeniX NV.
2008 - EUCTR2008-000967-40-SE Belgium;Netherlands;Sweden;
2008 - EUCTR2008-000967-40-NL Belgium;Netherlands;Sweden;
AJG501
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2-3 JPRN-JapicCTI-101144 -
AJG511
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2 JPRN-JapicCTI-132294 -
EA Pharma Co.,Ltd.
2014 Phase 3 JPRN-JapicCTI-142704 -
AJM300
EA Pharma Co., Ltd.
2018 Phase 3 NCT03531892 Japan;
ALTH12-1:4
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
ALTH12-2:4
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
AMG 181
Amgen
2011 Phase 1 NCT01290042 Australia;United States;
Amgen Inc
2014 Phase 2 EUCTR2011-005251-13-LV Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2014 Phase 2 EUCTR2011-005251-13-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2013 Phase 2 EUCTR2011-005251-13-PL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2013 Phase 2 EUCTR2011-005251-13-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-GR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
2012 Phase 2 EUCTR2011-005251-13-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
AMG 592
AMGEN INC.
2021 Phase 2 EUCTR2021-002537-41-IT Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
Amgen Inc.
2022 Phase 2 EUCTR2021-002537-41-ES Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States;
2022 Phase 2 EUCTR2021-002537-41-BG Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-NL Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-HU Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
2021 Phase 2 EUCTR2021-002537-41-DE Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
AMG181
AMGEN INC.
2012 Phase 2 EUCTR2011-005251-13-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Poland;Switzerland;United Kingdom;United States;
AMGEVITA
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
AMGEVITA (Adalimumab biosimilar )
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
AMGEVITA®
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
AMT-101
Applied Molecular Transport
2019 Phase 1 NCT04224857 Georgia;Germany;Moldova, Republic of;Ukraine;
Applied Molecular Transport Inc.
2021 Phase 2 EUCTR2020-002833-13-PL Georgia;Netherlands;Poland;Ukraine;
2021 Phase 2 EUCTR2020-002833-13-NL Georgia;Netherlands;Poland;Ukraine;
2021 Phase 2 EUCTR2020-000047-31-PL Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-000047-31-DE Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-HU Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-GB Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-FR Belarus;Belgium;Bulgaria;Canada;Czech Republic;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2020-000047-31-BG Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
AMT-101 (oral)
Applied Molecular Transport
2020 Phase 2 NCT04583358 Bulgaria;Canada;France;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Switzerland;Ukraine;United Kingdom;United States;
AND (Andrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA (ethanol extract)
Hutchison MediPharma Enterprises Limited
2008 - EUCTR2007-005166-12-DE Germany;
AODG (Apigenin-7-O-glucuronide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
APD334
ARENA PHARMACEUTICALS, INC.
2021 Phase 2 EUCTR2020-003507-34-IT Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2019 Phase 3 EUCTR2018-003987-29-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003797-40-DE Belgium;Germany;United States;
2017 Phase 2 EUCTR2016-003797-40-BE Belgium;Germany;United States;
2017 Phase 2 EUCTR2015-001942-28-FR Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2015-001942-28-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-LT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-BG Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-BE Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-002109-12-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-PL Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-BE Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-001942-28-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-LT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-ES Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-001942-28-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
APD334 L-arginine
ARENA PHARMACEUTICALS, INC.
2019 Phase 3 EUCTR2018-003986-33-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
APRISO 375 mg extended-release capsules
Bausch Health Americas, Inc.
2017 Phase 1 NCT03327558 United States;
APVO210
Aptevo Therapeutics
2019 Phase 1 NCT03768219 Australia;
AR401959 L-arginine
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
AS INN
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
ASACOL
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
ASC
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
ASP015K
Janssen-Cilag International NV
2014 Phase 2 EUCTR2013-000263-88-RO Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-DE Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-BG Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-PL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-NL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-HU Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-BE Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
ASP3291
Telsar Pharma Inc.
2012 Phase 2 NCT01612039 United States;
2010 Phase 1 NCT01320332 United States;
AST-120
Ocera Therapeutics, Inc.
2007 - EUCTR2005-005363-28-HU Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2007 - EUCTR2005-005363-28-AT Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 Phase 3 EUCTR2005-005363-28-GB Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-DE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-CZ Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-BE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
ATL-2502
ALIZYME
2006 - EUCTR2004-005032-35-IT Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Alizyme Therapeutics Limited
2007 - EUCTR2004-005032-35-BE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-SE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-HU Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-DK Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-CZ Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
AVX 470
Avaxia Biologics, Incorporated
2013 Phase 1 NCT01759056 Belgium;Canada;Hungary;United States;
AZA
Dipartimento di Pediatria Università Federico II di Napoli
2013 - EUCTR2012-001653-13-IT Italy;
AZAFOR
Dipartimento di Pediatria Università Federico II di Napoli
2013 - EUCTR2012-001653-13-IT Italy;
AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL
IRCCS ISTITUTO CLINICO HUMANITAS
2017 Phase 4 EUCTR2016-002707-25-IT Italy;
AZATHIOPRINE BP
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
AbGn-168H
AbGenomics International, Inc.
2018 Phase 2 NCT03298022 Puerto Rico;United States;
Abalimumab
AbbVie GK
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
Abatacept
Bristol-Myers Squibb International Corporation
2008 - EUCTR2006-003604-19-PL Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-FR Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IT Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Abatacept (ABA)
Bristol-Myers Squibb
2006 Phase 3 NCT00410410 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;South Africa;Spain;Switzerland;United Kingdom;United States;
Abrilumab
Amgen
2012 Phase 2 NCT01694485 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
Accelerated 1 hour-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Accelerated 30 minutes-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Acetic acid
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2015 - JPRN-UMIN000021460 Japan;
Acidophilus
Odense University Hospital
2003 - NCT00374725 Denmark;
Adalimumab
AbbVie
2016 - NCT02750800 Hungary;
2015 Phase 3 NCT02632175 Japan;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 NCT02065622 Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT02065557 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2013 - NCT01768858 Austria;
AbbVie (prior sponsor, Abbott)
2012 Phase 3 NCT01550965 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 NCT00853099 Japan;
2007 Phase 3 NCT00573794 Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;United States;
AbbVie Deutschland GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
AbbVie GK
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
2014 Phase 3 JPRN-JapicCTI-142648 Japan, North America, Europe;
2009 Phase 2-3 JPRN-JapicCTI-090718 -
Abbott
2006 Phase 3 NCT00408629 Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United States;
2006 Phase 3 NCT00385736 Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Puerto Rico;Slovakia;Sweden;United States;
Abbott GmbH & Co. KG
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-IT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 - EUCTR2006-002782-40-DE Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002782-40-AT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002781-20-SE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2008 - EUCTR2006-002781-20-AT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 Phase 3 EUCTR2006-002782-40-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 Phase 3 EUCTR2006-002781-20-SK Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
2007 - EUCTR2006-002782-40-PT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-HU Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-DK Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-CZ Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002781-20-HU Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-DE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-CZ Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-BE Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
Clalit Health Services
2012 Phase 3 NCT01494857 Israel;
Fukuyama Medical Center
2016 - JPRN-UMIN000020840 Japan;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2020 Phase 4 NCT04183608 France;
Hoffmann-La Roche
2014 Phase 3 NCT02171429 Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 NCT02163759 Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
Iwate Medical UniversityKochi Medical School HospitalKeio University School of Medicine
2016 - JPRN-UMIN000019958 Japan;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Mayo Clinic
2006 Phase 1 NCT00421642 United States;
McMaster University
2018 Phase 4 NCT03059849 -
Odense University Hospital
2012 Phase 3 NCT01670240 Denmark;
Osaka Medical College
2014 - JPRN-UMIN000015912 Japan;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
Sakura Medical Center, Toho university
2018 - JPRN-UMIN000030988 Japan;
Sakura Medical Center,Toho university
2015 - JPRN-UMIN000019066 Japan;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Takeda
2015 Phase 3 NCT02497469 Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
University of Western Ontario, Canada
2014 Phase 4 NCT01960426 United States;
2013 Phase 4 NCT01716039 -
Adipose derived, autologous mesenchymal stem cells
Mayo Clinic
2020 Phase 1 NCT04312113 United States;
Adipose tissue-derived mesenchymal stem cells
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
Adipose-cord mesenchymal stromal cells (A-MSCs)
Liaocheng People's Hospital
2018 Phase 1/Phase 2 NCT03609905 China;
Algin
Ishikawa Dai
2020 - JPRN-jRCTs031200103 Japan;
Alicaforsen
Isis Pharmaceuticals
2003 Phase 2 NCT00063830 United States;
2003 Phase 2 NCT00063414 United States;
Allogeneic adipose tissue-derived mesenchymal stem cells
Instituto de Investigación Hospital Universitario La Paz
2013 Phase 1/Phase 2 NCT01914887 Spain;
Allopurinol
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
AloASC
Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
2012 - EUCTR2010-023798-20-ES Spain;
Aloe Barbadensis Miller
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
2012 Phase 0 NCT01783119 Mexico;
Aloe vera gel
Ospedale Sandro Pertini, Roma
2010 - NCT04753775 -
Also referred to as 'MEDI2070'
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
AstraZeneca AB
2022 Phase 2 EUCTR2021-001644-10-HU Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-001644-10-ES Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Also referred to as MEDI2070
AstraZeneca AB
2021 Phase 2 EUCTR2018-001605-93-HU Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-DE Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-CZ Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Amg 181
Amgen
2010 Phase 1 NCT01164904 Australia;New Zealand;United States;
Amgevita
IRCCS ISTITUTO CLINICO HUMANITAS
2021 Phase 4 EUCTR2020-003420-16-IT Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
Instituto Clinico Humanitas
2021 Phase 4 EUCTR2020-003420-16-ES Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
2021 Phase 4 EUCTR2020-003420-16-BE Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Amgevita 40 mg Injektionslösung im Fertigpen
Universitätsklinikum Erlangen
2019 Phase 4 EUCTR2019-003662-40-DE Germany;
Amgevita 40 mg Injektionslösung in einer Fertigspritze
Universitätsklinikum Erlangen
2019 Phase 4 EUCTR2019-003662-40-DE Germany;
Amgevita 40Mg Solution for Injection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
2019 Phase 4 NCT04131322 Spain;
Amiselimod
Salix Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-005232-30-SK Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-HU Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-EE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-DE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-BG Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
Amitriptyline hydrochloride
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Amoxicillin
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Juntendo university school of medicine Department of gastroenterology
2015 - JPRN-UMIN000018642 Japan;
2014 - JPRN-UMIN000014152 Japan;
Juntendo university school of medicineDepartment of gastroenterology
2017 - JPRN-UMIN000025846 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
Amoxicillin and doxycyclin
Wolfson Medical Center
2019 Phase 2 NCT03986996 Israel;
Amoxicillin, metronidazole and doxycycline
Wolfson Medical Center
2019 Phase 2 NCT03986996 Israel;
Anakinra
Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
2017 Phase 2 EUCTR2017-001389-10-GB United Kingdom;
Andecaliximab
Gilead Sciences
2015 Phase 2/Phase 3 NCT02520284 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;Iceland;Ireland;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AndoSan
Oslo University Hospital
2011 Phase 2/Phase 3 NCT01496053 Norway;
Anrukinzumab
Pfizer
2011 Phase 2 NCT01284062 Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Anti Beta7
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
Anti CD3 monoclonal antibody
PDL BioPharma, Inc
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
Anti TNF therapy including infliximab
Janssen Biotech, Inc.
2007 - NCT00606346 Canada;United States;
Anti-CD3 monoclonal antibody
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Anti-IP-10 Antibody
Bristol-Myers Squibb
2011 Phase 2 NCT01294410 Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2022 Phase 2 EUCTR2021-001644-10-HU Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-001644-10-ES Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2018-001605-93-HU Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-DE Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2018-001605-93-AT Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-CZ Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-MAdCAM antibody
Baxalta Innovations GmbH
- Phase 3 EUCTR2017-000573-37-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
2014 - EUCTR2012-002030-37-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Pfizer Inc.
2013 - EUCTR2012-002030-37-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom;
Shire Human Genetic Therapie, Inc.
2013 Phase 2 EUCTR2012-002031-28-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2019 Phase 3 EUCTR2017-000574-11-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-FR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-ES Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000573-37-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-GR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2013 Phase 2 EUCTR2012-002031-28-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Anti-TL1A
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-SK Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-PL Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-HU Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-GB Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-FR Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-ES Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-DE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BG Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Anti-TNF Drug
HaEmek Medical Center, Israel
2009 - NCT03747068 -
Anti-TNF Therapy
Takeda
2017 - NCT03090139 Argentina;China;Colombia;Korea, Republic of;Mexico;Russian Federation;Saudi Arabia;Singapore;Taiwan;Turkey;
Anti-TNF discontinuation: Physiological saline solution
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Anti-TNF: Infliximab (Infusion)
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Anti-TNF:Adalimumab (Subcutaneus)
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2017 Phase 4 NCT02994836 Spain;
Antibiotic cocktail
Prof. Arie Levine
2015 Phase 4 NCT02345733 Canada;Israel;United States;
2014 - NCT02217722 Israel;
Apixaban 2.5 milligram
McMaster University
2021 Early Phase 1 NCT03935451 Canada;
Apremilast
Amgen
2015 Phase 2 NCT02289417 Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Ukraine;United States;
Apriso 0.375G ER CAP
Bausch Health Americas, Inc.
2017 Phase 1 NCT03327558 United States;
Aquamin
James Varani
2021 Phase 2 NCT04855799 United States;
Aquamin®
James Varani
2019 Phase 2 NCT03869905 United States;
Asacol
Annette Langseder
2006 - NCT00349388 United States;
Procter & Gamble Pharmaceuticals
- Phase 3 EUCTR2007-005702-49-PL Poland;
Shire
2005 Phase 3 NCT00151892 Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States;
Tillotts Pharma AG
2015 Phase 3 EUCTR2013-000366-11-RO Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-SK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;
2014 Phase 3 EUCTR2013-000366-11-LV Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-LT Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-HU Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-BG Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 NCT01903252 Netherlands;Switzerland;
2013 Phase 3 EUCTR2013-000366-11-SE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-PL Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine;
2013 Phase 3 EUCTR2013-000366-11-IE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-GB Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-FI Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-DK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-CZ Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-BE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2013-000366-11-ES Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine;
Warner Chilcott
2009 Phase 3 NCT01004185 Canada;Croatia;Poland;Romania;Russian Federation;United States;
2008 Phase 3 NCT00713310 Canada;Croatia;Poland;Romania;United States;
Asacol (mesalamine)
University of Chicago
2006 Phase 3 NCT00343850 United States;
University of Washington
2003 Phase 4 NCT00194818 United States;
Asacol (mesalamine) Delayed-release Tablets
Otsuka Maryland Research Institute, Inc.
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
Asacol 400 mg (mesalamine)
Warner Chilcott
2000 Phase 3 NCT00073021 Canada;Puerto Rico;United States;
Asacol 400 mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 400mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800 mg (mesalamine)
Warner Chilcott
2000 Phase 3 NCT00073021 Canada;Puerto Rico;United States;
Asacol 800 mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800mg tablet
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol Delayed Release Tablets
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Asacol Delayed-Release Tablets
EMET Pharmaceuticals LLC
2008 - EUCTR2007-004732-23-LV Estonia;Latvia;Poland;
2007 - EUCTR2007-004732-23-EE Estonia;Latvia;Poland;
EMET Pharmaceuticals, LLC
2008 - EUCTR2007-004732-23-PL Estonia;Latvia;Poland;
Asacol tablet
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
Asacol®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
Copenhagen University Hospital Hvidovre
2019 Phase 4 EUCTR2019-002070-31-DK Denmark;
Otsuka Pharmaceutical Development & Commercialization, Inc.
2004 Phase 3 NCT00092508 United States;
Tillotts Pharma AG
2010 Phase 3 NCT01257399 China;
2010 Phase 3 NCT01257386 China;
Aspergillus oryzae
Graduate School of Medical Science, KyotoPrefectural University of Medicine
2012 Phase 2 JPRN-UMIN000009364 Japan;
Atorvastatin Calcium
National Cancer Institute (NCI)
2021 Phase 2 NCT04767984 United States;
Avonex
Biogen Idec Ltd
2009 Phase 2 EUCTR2007-004867-22-SK Czech Republic;Hungary;Slovakia;
2008 - EUCTR2007-004867-22-HU Czech Republic;Hungary;
2008 - EUCTR2007-004867-22-CZ Czech Republic;Hungary;
Azathioprine
Affiliated Hospital of Nanjing University of Chinese Medicine
2015 Phase 1 study ChiCTR-IPR-15005760 China;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Indiana University
2015 - NCT02413047 United States;
Istituto Clinico Humanitas
2017 Phase 4 NCT03151525 Italy;
Kyungpook National University Hospital
2016 Phase 4 NCT02579733 Korea, Republic of;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
Sakura Medical Center, Toho university
2018 - JPRN-UMIN000030988 Japan;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
Azathioprine (AZA)
Merck Sharp & Dohme Corp.
2007 Phase 3 NCT00537316 Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Azathioprine (AZA) or 6-mercaptopurine (6-MP)
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
Azathioprine (Imuran) 50 mg Overencapsulated Tablet
Schering-Plough Research Institute, a division of Schering Corporation
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
Azathioprine and Allopurinol
Hvidovre University Hospital
2016 Phase 3 NCT03101800 Denmark;
Azathioprine or 6-mercaptopurine
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
B2-ASmedic
Novartis Pharma Services AG
2007 - EUCTR2007-002542-38-DE Denmark;Germany;
B: 2 dosis
AB Biotics, SA
2018 - NCT03444311 Spain;
BBT-401-1S
Bridge Biotherapeutics, Inc.
2021 Phase 2 NCT04596293 Korea, Republic of;New Zealand;Poland;Ukraine;United States;
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
2021 Phase 1 NCT04478825 New Zealand;
2019 Phase 2 NCT03800420 United States;
BBT-401-1S, Multiple doses
Bridge Biotherapeutics, Inc.
2018 Phase 1 NCT03482648 United States;
BBT-401-1S, Single dose
Bridge Biotherapeutics, Inc.
2018 Phase 1 NCT03482648 United States;
BG9418 (Interferon beta-1a)
Biogen
2008 Phase 2 NCT00616434 Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia;United States;
BG9924
Biogen Idec Ltd.
2011 Phase 2 EUCTR2010-019558-42-SK Belgium;Czech Republic;Hungary;Slovakia;
2011 - EUCTR2010-019558-42-HU Belgium;Czech Republic;Hungary;
2011 - EUCTR2010-019558-42-CZ Belgium;Czech Republic;Hungary;
2010 - EUCTR2010-019558-42-BE Belgium;Czech Republic;Hungary;
BGP-014
BioGaia Pharma AB
2022 Phase 1/Phase 2 NCT05118919 Sweden;
BGP-014 Capsules
BioGaia Pharma AB
2021 Phase 1;Phase 2 EUCTR2019-004578-25-SE Sweden;
BI 655130
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim BV Netherlands
2017 Phase 2 EUCTR2016-004572-21-NL Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim España, S.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-ES Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-ES Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-ES Denmark;Germany;Netherlands;Norway;Spain;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-GR Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-CZ Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-GB Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-GB Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-NO Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-DE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-DE Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DK Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DE Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000334-35-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim bv
2018 Phase 2;Phase 3 EUCTR2017-004230-28-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim bv Netherlands
2019 Phase 2 EUCTR2018-000334-35-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2;Phase 3 EUCTR2017-004230-28-BE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-BE Belgium;Germany;United Kingdom;
BITTER CANDYTUFT FRESH PLANT EXTRACT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
BL-7040
BioLineRx, Ltd.
2012 Phase 2 NCT01506362 Israel;
BMS-188667
Bristol-Myers Squibb International Corporation
2008 - EUCTR2006-003604-19-PL Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 Phase 3 EUCTR2006-003604-19-FR Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
BMS-936557
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-IT Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
BMS-986165
BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
2021 Phase 2 EUCTR2020-004461-40-IT Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-IT Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
Bristol-Myers Squibb
2021 Phase 2 NCT04877990 Australia;Brazil;China;Germany;Hungary;Italy;Japan;Poland;Romania;Russian Federation;United Kingdom;United States;
2019 Phase 2 NCT03934216 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2020 Phase 2 EUCTR2018-004694-27-FR Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-PL Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-HU Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-GB Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-DE Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-CZ Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BMS-986165 Dose 1
Bristol-Myers Squibb
2021 Phase 2 NCT04613518 Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986165 Dose 2
Bristol-Myers Squibb
2021 Phase 2 NCT04613518 Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986166
Bristol-Myers Squibb
2017 Phase 1 NCT03038711 United States;
BMS-986184
Bristol-Myers Squibb
2016 Phase 1 NCT02864264 Australia;Georgia;Moldova, Republic of;Romania;
BMS986165
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2020 Phase 2 EUCTR2018-004694-27-FR Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-PL Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-HU Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-GB Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-DE Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004694-27-CZ Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BT-11
Landos Biopharma Inc.
2020 Phase 2 EUCTR2018-005086-39-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HU Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (1000 mg)
Landos Biopharma Inc.
2019 Phase 2 NCT03861143 Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (500 mg)
Landos Biopharma Inc.
2019 Phase 2 NCT03861143 Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 Active
Landos Biopharma Inc.
2018 Phase 1 NCT03860571 United States;
BT051 up to
Bacainn Therapeutics, Inc.
2021 Phase 1 NCT05084261 Georgia;Moldova, Republic of;Poland;Ukraine;United States;
Bacteriotherapy
David Suskind
2012 Phase 1 NCT01757964 United States;
Balsalazide
Roxane Laboratories
2005 - NCT00618202 United States;
2004 - NCT00618228 United States;
Balsalazide Disodium
Bausch Health Americas, Inc.
2006 Phase 3 NCT00486031 United States;
Balsalazide disodium
Bausch Health Americas, Inc.
2006 Phase 3 NCT00408174 United States;
Baminercept
Biogen Idec Ltd.
2011 Phase 2 EUCTR2010-019558-42-SK Belgium;Czech Republic;Hungary;Slovakia;
2011 - EUCTR2010-019558-42-HU Belgium;Czech Republic;Hungary;
2011 - EUCTR2010-019558-42-CZ Belgium;Czech Republic;Hungary;
2010 - EUCTR2010-019558-42-BE Belgium;Czech Republic;Hungary;
Bascial prescription plus or minus herbs depend on symptoms
Shanghai University of Traditional Chinese Medicine
2009 - NCT00963287 China;
Basiliximab
Cerimon Pharmaceuticals
2007 Phase 2 NCT01061996 United Kingdom;
2007 Phase 2 NCT00430898 Belgium;Czech Republic;India;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
Cerimon Pharmaceuticals, Inc.
2007 Phase 2 EUCTR2006-006319-54-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-CZ Belgium;Czech Republic;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 - EUCTR2006-006319-54-BE Belgium;United Kingdom;
2007 - EUCTR2006-004303-19-CZ Belgium;Czech Republic;United Kingdom;
2007 - EUCTR2006-004303-19-BE Belgium;Czech Republic;United Kingdom;
Beclometasone
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
Beclomethasone diproprionate
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
Berberine
Xijing Hospital of Digestive Diseases
2016 Phase 4 NCT02962245 -
Berberine Chloride
National Cancer Institute (NCI)
2016 Phase 1 NCT02365480 China;United States;
Bertilimumab
Immune Pharmaceuticals
2015 Phase 2 NCT01671956 Israel;
Beta-1,3/1,6-D-Glucan
Fakultas Kedokteran Universitas Indonesia
2019 Phase 2/Phase 3 NCT04029649 Indonesia;
Bezlotoxumab
David Binion, MD
2021 Phase 4 NCT04626947 United States;
Bifidobacterium breve
Public Health Research foundation
2012 - JPRN-UMIN000007593 Japan;
Bifidobacterium infantis 35624
University College Cork
2002 Phase 2/Phase 3 NCT00510978 Ireland;
Bimekizumab
UCB Biopharma SPRL
2017 Phase 2 EUCTR2016-000420-26-PL Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-000420-26-BG Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-ES Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-CZ Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
Bio-enhanced Curcumin Soft Gelatin Capsule
Asian Institute of Gastroenterology, India
2016 Phase 3 NCT02683759 India;
2016 Phase 3 NCT02683733 India;
Biological Drug
Assiut University
2021 - NCT04818788 -
Biologically active human fecal microbiota
Virginia O. Shaffer
2014 Phase 2 NCT02049502 United States;
Biopsies
Centre Hospitalier Universitaire de Saint Etienne
2019 - NCT04030676 France;
2017 - NCT03172195 France;
Biosimilar
McGill University Health Centre/Research Institute of the McGill University Health Centre
2018 - NCT03729674 Canada;
Biosimilar infliximab
Diakonhjemmet Hospital
2014 Phase 4 NCT02148640 Norway;
Biospecimen Collection
National Cancer Institute (NCI)
2021 Phase 2 NCT04767984 United States;
Bitterschleifenblume-ganzpflanze 1,5ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Blood sample
Centre Hospitalier Universitaire de Saint Etienne
2017 - NCT03172195 France;
Blood samples
Centre Hospitalier Universitaire de Saint Etienne
2019 - NCT04030676 France;
2017 Phase 2 NCT03182166 France;
University Hospital, Bordeaux
2020 - NCT04272307 France;
Blood sampling, endoscopy
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Boulardii
University Clinic Dr Dragisa Misovic-Dedinje
2019 - NCT03941418 -
Bovine intestinal alkaline phosphatase (BIAP)
AM-Pharma
2006 Phase 2 NCT00727324 Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase (BIAP)
AM-Pharma B.V.
2006 - EUCTR2006-000197-69-CZ Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase BIAP
AM PHARMA B.V.
2006 - EUCTR2006-000197-69-IT Italy;
Brazikumab
ASTRAZENECA AB
2021 Phase 2 EUCTR2021-001644-10-IT Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
AstraZeneca
2018 Phase 2 NCT04718818 Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States;
2018 Phase 2 NCT03616821 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Hibi Kazushige
2021 Phase 2 JPRN-jRCT2011210047 Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
2021 Phase 2 JPRN-jRCT2011210030 Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Induction Dose
AstraZeneca
2020 Phase 2 NCT04277546 Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Maintenance Dose
AstraZeneca
2020 Phase 2 NCT04277546 Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brepocitinib
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Broccoli
University of Tsukuba
2020 - JPRN-UMIN000041972 Japan;
Budenofalk
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-SK Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 Phase 3 EUCTR2006-005377-22-ES Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 - EUCTR2006-005377-22-LV Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-LT Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-DE Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-CZ Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
- Phase 3 EUCTR2006-005377-22-PL Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Budenofalk 2mg rectal foam
University Hospital Birmingham NHS Foundation Trust
2009 Phase 4 EUCTR2009-015077-12-GB United Kingdom;
Budenofalk rectal foam
University Hospital Birmingham NHS Foundation Trust
2009 Phase 4 EUCTR2009-015077-12-GB United Kingdom;
Budenofalk® suppositories (BUS)
Dr. Falk Pharma GmbH
2021 Phase 3 EUCTR2019-003334-16-BG Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
2020 Phase 3 EUCTR2019-003334-16-DE Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
Budesonide
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2 JPRN-JapicCTI-132294 -
Bausch Health Americas, Inc.
2010 Phase 3 NCT01100112 India;
Dr. Falk Pharma GmbH
2015 Phase 2 NCT02550418 Germany;
2007 Phase 3 NCT00747110 Germany;
EA Pharma Co.,Ltd.
2018 - JPRN-JapicCTI-183858 Japan;
2014 Phase 3 JPRN-JapicCTI-142704 -
Hyogo College of Medicine
2018 - JPRN-UMIN000034016 Japan;
Matsuoka Katsuyoshi
2021 - JPRN-jRCTs031210326 Japan;
Budesonide (6 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Budesonide (9 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg capsules, hard (BUX-PV)
Dr. Falk Pharma GmbH
2015 Phase 2 EUCTR2014-005635-14-LV Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-LT Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-HU Hungary;Latvia;Lithuania;
2015 Phase 2 EUCTR2014-005635-14-DE Germany;Hungary;Latvia;Lithuania;
Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide MMX
COSMO TECHNOLOGIES LTD
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide MMX 6 mg Tablet
Bausch Health Americas, Inc.
2008 Phase 3 NCT00801723 Canada;United States;
Budesonide MMX®
Bausch Health Americas, Inc.
2012 Phase 3 NCT01532648 Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Ferring Pharmaceuticals
2015 - NCT02586259 Canada;Germany;Ireland;Israel;Italy;Netherlands;Poland;Sweden;Switzerland;United Kingdom;
Budesonide-MMX
COSMO TECHNOLOGIES LTD
2009 - EUCTR2008-003913-28-IT Italy;
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide-MMX®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679432 Canada;India;Mexico;United States;
Santarus, Inc.
2012 - EUCTR2011-005115-82-PL Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-LV Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-LT Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-HU Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-EE Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-CZ Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2012 - EUCTR2011-005115-82-BG Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
Budesonide-MMX™
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Butyrate
Children's Hospital Los Angeles
2022 Phase 1 NCT05218850 United States;
By demand
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
CARVI EXTRACTUM FLUIDUM
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
CAT-354
ASTRAZENECA
2011 - EUCTR2011-004812-40-IT Czech Republic;Germany;Italy;Netherlands;United Kingdom;
AstraZeneca AB
2012 Phase 2 EUCTR2011-004812-40-GB Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-NL Czech Republic;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-DE Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-CZ Czech Republic;Italy;Netherlands;United Kingdom;
CB-01-02
COSMO TECHNOLOGIES LTD
2009 - EUCTR2008-003913-28-IT Italy;
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
CB-01-05-MMX
COSMO TECHNOLOGIES LTD
2006 - EUCTR2006-001782-42-IT Hungary;Italy;United Kingdom;
Cosmo Technologies Ltd
2006 Phase 2 EUCTR2006-001782-42-GB Hungary;Italy;United Kingdom;
2006 - EUCTR2006-001782-42-HU Hungary;Italy;United Kingdom;
CBP-307
Suzhou Connect Biopharmaceuticals, Ltd.
2019 Phase 2 NCT04700449 China;Pakistan;Ukraine;United States;
CC-10004
CELGENE CORPORATION
2015 Phase 2 EUCTR2014-002981-64-IT Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Celgene Corporation
2016 Phase 2 EUCTR2014-002981-64-BG Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 Phase 2 EUCTR2014-002981-64-NL Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;United Kingdom;United States;
2015 Phase 2 EUCTR2014-002981-64-DE Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 Phase 2 EUCTR2014-002981-64-CZ Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
2015 - EUCTR2014-002981-64-HU Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Turkey;Ukraine;United Kingdom;United States;
CD7 CAR T-cells
Zhejiang University
2022 Early Phase 1 NCT05239702 China;
CGMP protein
University of Aarhus
2012 - NCT01534312 Denmark;
CLA (Chlorogenic acid)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
CLIPPER*30CPR 5MG R.M.
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
CNTO 148
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
CNTO-148
University Medical Centre Ljubljana, Department of gastroenterology
2020 Phase 4 EUCTR2019-003987-37-SI Slovenia;
CNTO1275
JANSSEN CILAG INTERNATIONAL NV
2015 Phase 3 EUCTR2014-005606-38-IT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 3 EUCTR2020-004457-76-PL Argentina;France;Japan;Poland;Russian Federation;Turkey;United States;
2021 Phase 3 EUCTR2019-004224-38-DE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004224-38-HU Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2020-004457-76-FR Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-PL Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-Outside-EU/EEA Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-GB Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-BE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
CNTO148
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2015 Phase 2 EUCTR2013-002042-36-FR Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-PL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-BG Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-NL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-HU Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-DE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-CZ Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-BE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO1959
JANSSEN CILAG INTERNATIONAL NV
2019 Phase 3 EUCTR2018-004002-25-IT Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 2;Phase 3 EUCTR2018-004002-25-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2018-004002-25-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-PT Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-ES Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-SE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-HU Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-GB Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-FR Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO312
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
COFFEE COAL
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
COLAL PRED
ALIZYME
2006 - EUCTR2004-005032-35-IT Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
COLAL-PRED®
Alizyme
2006 Phase 3 NCT00299013 Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom;
CP- 690 550
Pfizer
2008 Phase 2 NCT00787202 Belgium;Brazil;Chile;Czech Republic;Denmark;France;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Slovakia;South Africa;Spain;Sweden;Turkey;United Kingdom;
CP-690, 550-10
PFIZER INC
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
CP-690,500
Pfizer
2017 Phase 4 NCT03281304 Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
CP-690,550
PFIZER
2009 - EUCTR2008-004564-40-IT Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
Pfizer
2017 Phase 4 NCT03281304 Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01470612 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01458574 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer S.A
2008 Phase 2 EUCTR2008-004564-40-ES Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
Pfizer limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2009 Phase 2 EUCTR2008-004564-40-FR Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-SE Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-NL Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-GB Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-CZ Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-004564-40-BE Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2008-004564-40-SK Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-004564-40-HU Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
CP-690,550-10
PFIZER INC
2018 Phase 3;Phase 4 EUCTR2017-002274-39-IT Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
PFIZER INC.
2013 - EUCTR2011-004578-27-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
PFIZER LIMITED
2013 Phase 3 EUCTR2011-004580-79-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-IT Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc
2012 Phase 3 EUCTR2011-004580-79-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 3;Phase 4 EUCTR2017-002274-39-NL Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-CZ Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-BE Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002274-39-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-002274-39-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-004580-79-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004579-35-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-AT Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004581-14-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2022 Phase 3 EUCTR2018-002378-30-HU Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-SK Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-SK Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-PL Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-DE Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-BE Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CP690,550
Pfizer
2012 Phase 3 NCT01458574 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CS (corticosteroids) Only
Shaare Zedek Medical Center
2014 - NCT02033408 Canada;Finland;Israel;Italy;Poland;Spain;
CT-P13
Celltrion
2016 Phase 1 NCT02883452 Korea, Republic of;
Pfizer
2015 - NCT02539368 Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom;
CT-P13 SC (Infliximab)
Celltrion
2020 Phase 3 NCT04205643 Poland;
CYCLOSPORINE VS INFLIXIMAB
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2007 Phase 4 NCT00542152 Belgium;Finland;France;Italy;Spain;
Caffeine
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Calcitonin nasal spray (salmon)
Children's Hospital Boston
2004 - NCT00114803 United States;
Caltrate
Second Affiliated Hospital of Wenzhou Medical University
2015 - NCT04276649 China;
Cannabidiol
Meir Medical Center
2010 Phase 1/Phase 2 NCT01037322 Israel;
Cannabis, Medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Carbon
Hyogo College of Medicine, Department of Internal medicine, Division of Lower GI disease
2007 Phase 2,3 JPRN-UMIN000004401 Japan;
Carbon dioxide
Osaka University, Graduate School of Medicine,Department of Gastroenterology and Hepatology
2015 - JPRN-UMIN000018801 Japan;
Carrageenan
University of Illinois at Chicago
2010 - NCT01065571 United States;
Casein glycomacropeptide (CGMP)
University of Aarhus
2016 - NCT02825914 Denmark;
Catridecacog
Novo Nordisk A/S
2013 - EUCTR2011-001568-22-HU Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 Phase 2 NCT01706159 Bulgaria;Croatia;Denmark;Hungary;Poland;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-DK Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-BG Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
Ceftriaxone
Postgraduate Institute of Medical Education and Research
2019 Phase 2 NCT03794765 India;
Cefuroxime
University of Dundee
2006 - NCT00355602 United Kingdom;
Cholecalciferol
Boston Children’s Hospital
2008 - NCT00621257 United States;
Medical clinic, University Hospital of North Norway
2009 - EUCTR2009-015649-21-NO Norway;
Ciclosporin
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
Ciclosporina
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Cimzia
University of Washington
2010 Phase 2 NCT01090154 United States;
Ciprofloxacin
Hvidovre University Hospital
2011 Phase 4 NCT01772615 Denmark;
University of Dundee
2006 - NCT00355602 United Kingdom;
Clarithromycin
University of Dundee
2006 - NCT00355602 United Kingdom;
Clipper
CHIESI ESPAÑA S.A.U.
2017 Phase 3 EUCTR2017-000330-61-ES Spain;
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
2007 - EUCTR2006-004230-32-ES Belgium;Italy;Poland;Spain;
Clipper 30 cpr 5mg R.M.
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Clotrimazole
Paul Rufo
2002 Phase 1/Phase 2 NCT00061282 United States;
Coamoxiclav
University of Dundee
2006 - NCT00355602 United Kingdom;
Cobitolimod
INDEX PHARMACEUTICALS AB
2021 Phase 3 EUCTR2021-002549-13-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2016-004217-26-IT Czech Republic;France;Germany;Hungary;Italy;Montenegro;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
InDex Pharmaceuticals
2021 Phase 3 NCT04985968 Hungary;
2017 Phase 2 NCT03178669 Czechia;France;Germany;Hungary;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;
InDex Pharmaceuticals AB
2021 Phase 1;Phase 2 EUCTR2021-003023-14-SE Sweden;
2017 Phase 2 EUCTR2016-004217-26-SE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-HU Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-FR Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-ES Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-DE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-CZ Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
Colectomy
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Colonoscopy
London North West Healthcare NHS Trust
2006 - NCT00292175 United Kingdom;
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Colorectal biopsies
University Hospital, Bordeaux
2020 - NCT04272307 France;
Coltect
Tel-Aviv Sourasky Medical Center
2008 - NCT00793130 Israel;
Combination Oral Budesonide and Rectal Hydrocortisone
University of Maryland, Baltimore
2008 Phase 2 NCT00805285 United States;
Combination Product: Beclomethasone dipropionate in addition to MC-EVOO
Casa Sollievo della Sofferenza IRCCS
2017 - NCT03408847 Italy;
Combination Product: Beclomethasone dipropionate in addition to refined oil
Casa Sollievo della Sofferenza IRCCS
2017 - NCT03408847 Italy;
Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator
Cristcot LLC
2020 Phase 3 NCT04469686 Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States;
Companion Diagnostic (CDx) Testing
Prometheus Biosciences, Inc.
2021 Phase 2 NCT04996797 United States;
Corticosteroid
Sixth Affiliated Hospital, Sun Yat-sen University
2021 - NCT04879966 China;
Tampere University Hospital
2015 - NCT04564638 -
Corticosteroids
Centre Hospitalier Universitaire de Saint Etienne
2016 Phase 3 NCT02665845 France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Children's Hospital of Fudan University
2021 Phase 4 NCT04999228 -
Jinling Hospital, China
2013 Phase 1/Phase 2 NCT02922374 China;
Corticosteroids only
Sheba Medical Center
2013 Phase 4 NCT01941589 China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
CortimentMMX
Dr. Falk Pharma GmbH
2019 Phase 3 EUCTR2017-004576-57-SK Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-PL Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LV Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-LT Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-HU Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-DE Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2019 Phase 3 EUCTR2017-004576-57-CZ Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
CosmoFer 50mg/ml solution for infusion or injection
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Cotrimoxazole
University of Dundee
2006 - NCT00355602 United Kingdom;
Curcumin
Chinese University of Hong Kong
2017 - NCT03122613 Hong Kong;
Schneider Children's Medical Center, Israel
2020 Phase 3 NCT02277223 Israel;
Seattle Children's Hospital
2009 Phase 1 NCT00889161 United States;
Sheba Medical Center
2011 Phase 3 NCT01320436 Israel;
Tianjin Medical University General Hospital
2019 Phase 0 ChiCTR1900022243 China;
CyCol
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
CyCol™
Sigmoid Pharma
2010 Phase 2 NCT01033305 Ireland;United Kingdom;
Cyclosporine
Chiba University Hospital
2013 - JPRN-UMIN000010776 Japan;
Postgraduate Institute of Medical Education and Research
2021 - NCT05112263 -
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Cyclosporine (USAN)
Sigmoid Pharma Ltd
2010 Phase 2 EUCTR2008-003169-19-GB Ireland;United Kingdom;
2009 - EUCTR2008-003169-19-IE Ireland;United Kingdom;
Cytochrome P450 (CYP) Substrates
AbbVie
2020 Phase 1 NCT04254783 Germany;Israel;United States;
D.3.6.2.1 - valore: 45 / 0.45 mg/ml
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
D.3.6.2.1 - valore: 5 o
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
DACORTIN
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2007 - EUCTR2007-003815-30-ES Portugal;Spain;
DAND (14-Deoxyandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DDAND (14-deoxy-11,12-didehydroandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DELTACORTENE FORTE*10CPR
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
DELTACORTENE*20CPR
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
DEXTRAN 1 FOR INJECTION
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
DIMS0150
INDEX PHARMACEUTICALS
2012 - EUCTR2011-003130-14-IT Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals AB
2021 Phase 1;Phase 2 EUCTR2021-003023-14-SE Sweden;
2017 Phase 2 EUCTR2016-004217-26-SE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-HU Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-FR Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-ES Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-DE Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2017 Phase 2 EUCTR2016-004217-26-CZ Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
2012 - EUCTR2011-003130-14-CZ Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 Phase 3 EUCTR2011-003130-14-GB Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-PL Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-HU Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-DE Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2006 - EUCTR2006-001846-15-SE Sweden;
Daclizumab
Facet Biotech
2003 Phase 2 NCT00073047 Belgium;Canada;United States;
Dacortin
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2009 - EUCTR2007-003815-30-PT Portugal;Spain;
Decortin H
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Dekavil
PFIZER INC
2018 Phase 2 EUCTR2017-002108-28-IT Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
Dekristol
Medical clinic, University Hospital of North Norway
2009 - EUCTR2009-015649-21-NO Norway;
Delayed and extended release mesalazine
Shire
2003 Phase 3 NCT00503243 United States;
Deligoparin
Incara Pharmaceuticals
2001 Phase 2/Phase 3 NCT00033943 United States;
Delmitide acetate
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
Deltacortene
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
2007 - EUCTR2006-004230-32-ES Belgium;Italy;Poland;Spain;
Deltacortene 10 cpr
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Deltacortene 20 cpr
CHIESI Farmaceutici S.p.A.
2007 - EUCTR2006-004230-32-BE Belgium;Italy;Poland;Spain;
Dersalazina sodica
Palau Pharma S.A.
2008 - EUCTR2008-004610-27-ES Belgium;Hungary;Spain;
Dersalazine sodium
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 Phase 2 NCT00808977 Belgium;Hungary;Slovakia;Spain;
2008 - EUCTR2008-004610-27-ES Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Deucravacitinib
BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
2021 Phase 2 EUCTR2020-004461-40-IT Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2020-004461-40-DE Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
Dexamethasone 21-phosphate
Casa Sollievo della Sofferenza IRCCS
2003 Phase 2 NCT01171807 Italy;
Dextromethorphan
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Diet
Assiut University
2020 - NCT04332328 -
Doxycycline
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
University of Dundee
2006 - NCT00355602 United Kingdom;
E. coli Nissle
Hvidovre University Hospital
2011 Phase 4 NCT01772615 Denmark;
E. coli Nissle 1917 (Mutaflor®)
Kangbuk Samsung Hospital
2018 Phase 4 NCT04969679 Korea, Republic of;
E6007
EA Pharma Co., Ltd.
2016 Phase 2 NCT03018054 Japan;
EGF enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
EMEA/H/C/000240
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
EMEA/H/C/000481
Odense University Hospital
2011 Phase 3 EUCTR2011-004268-31-DK Denmark;
EN
Friendship Hospital of Capital Medical University
2008 Phase 1 study ChiCTR-TRC-08000145 China;
ENTOCORT CR
COSMO TECHNOLOGIES LTD
2008 - EUCTR2006-004776-12-IT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
2016 Phase 4 EUCTR2015-003270-32-IT Italy;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Ecologic 825
Wageningen University
2014 - NCT02361957 Netherlands;
Efavaleukin alfa
Amgen
2022 Phase 2 NCT04987307 Austria;Bulgaria;Japan;Korea, Republic of;Poland;United States;
Efmarodocokin alfa
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-IE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Eicosapentaenoic acid
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
2014 - NCT02179372 Italy;
Empagliflozin
Sadat City University
2021 Phase 2 NCT05058417 Egypt;
Encapsulated Mesalamine Granules (eMG)
Bausch Health Americas, Inc.
2005 Phase 3 NCT00326209 United States;
Encapsulated faecal microbiota filtrate
Jena University Hospital
2021 Phase 2/Phase 3 NCT03843385 -
Enema
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Entecavir
Saitama Medical University
2016 - JPRN-UMIN000020029 Japan;
Entocort EC®
Bausch Health Americas, Inc.
2008 Phase 3 NCT00679380 Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Entocort® CR
COSMO Technologies Ltd
2008 Phase 3 EUCTR2006-004776-12-SK Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-004776-12-GB Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-SE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LV Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-LT Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-FR Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-EE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
2008 - EUCTR2006-004776-12-BE Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Entyvio
ALIMENTIV INC.
2021 Phase 4 EUCTR2019-002485-12-IT Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Academic Medical Center, Gastroenterology
2017 Phase 4 EUCTR2014-005443-40-HU Belgium;Hungary;Netherlands;
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-NL Belgium;Hungary;Netherlands;
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
Alimentiv Inc.
2021 Phase 4 EUCTR2019-002485-12-PL Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 4 EUCTR2019-002485-12-NL Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Alimentiv Inc. (formerly Robarts Clinical Trials)
2020 Phase 4 EUCTR2019-002485-12-GB Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Eli Lilly and Company
2021 Phase 3 EUCTR2019-001653-99-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001653-99-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe Limited
2017 Phase 4 EUCTR2016-000678-40-BG Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-LV Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-HU Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-EE Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
Epaxal Berna (virosomal hepatitis A vaccine)
Asan Medical Center
2011 Phase 4 NCT01341808 Korea, Republic of;
Epidermal growth factor enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Ergocalciferol
Boston Children’s Hospital
2008 - NCT00621257 United States;
Etrasimod
Arena Pharmaceuticals
2022 Phase 2 NCT05287126 -
2021 Phase 2 NCT05061446 Japan;
2021 Phase 2 NCT04607837 Australia;Belarus;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States;
2020 Phase 3 NCT04706793 Japan;
2020 Phase 3 NCT03996369 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 NCT03950232 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 NCT03945188 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 NCT02536404 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 Phase 2 NCT02447302 Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Everstar Therapeutics Limited
2019 Phase 3 NCT04176588 China;
IQVIA Services Japan K.K. ICCC:
2021 Phase 3 JPRN-jRCT2071200081 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea;Lebanon;Mexico;Moldova;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;
2020 Phase 3 JPRN-jRCT2071200080 Japan;
Tanabe Masakazu
2021 Phase 2 JPRN-jRCT2071210052 Japan;
Etrasimod L-arginine
ARENA PHARMACEUTICALS, INC.
2021 Phase 2 EUCTR2020-003507-34-IT Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2019 Phase 3 EUCTR2018-003987-29-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals Inc.
2020 Phase 3 EUCTR2018-003987-29-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003987-29-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003985-15-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-SK Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HU Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-HR Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003987-29-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003985-15-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003987-29-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003985-15-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
Arena Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-003507-34-PT Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-HU Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-FR Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
2021 Phase 2 EUCTR2020-003507-34-BG Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
2020 Phase 3 EUCTR2018-003986-33-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-LV Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-GB Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-003986-33-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-003986-33-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-PL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-EE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-003986-33-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
Etrolizumab
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Genentech, Inc.
2011 Phase 2 NCT01461317 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
Hoffmann-La Roche
2018 Phase 1 NCT03478956 Belgium;Germany;Poland;Spain;United Kingdom;United States;
2014 Phase 3 NCT02171429 Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 NCT02165215 Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Hungary;India;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 NCT02163759 Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 NCT02136069 Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 NCT02118584 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Etrozulimab
Hoffmann-La Roche
2014 Phase 3 NCT02100696 Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
ExoFlo
Direct Biologics, LLC
2022 Phase 1 NCT05176366 -
Exposure to golimumab
University of Zurich
2018 - NCT03394586 Switzerland;
F8IL10
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
FE 999301
University Hospital Schleswig-Holstein (UKSH)
2016 Phase 2 EUCTR2016-000205-36-DE Germany;
FMT
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Yanling Wei
2015 Phase 2 NCT02335281 China;
FMT enema
University of British Columbia
2020 Phase 2 NCT04202211 Canada;
FMT infusions
The University of New South Wales
2013 Phase 2 NCT01896635 Australia;
FMT oral
University of British Columbia
2020 Phase 2 NCT04202211 Canada;
FP-110
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
FP-CYA-050
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
FP-CYA-053
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Faecal Microbiota Transplant
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Faecal Microbiota Transplantation
St Vincent's Hospital Melbourne
2018 - NCT03477032 Australia;
Faecal matter
University of Birmingham
2017 Phase 3 EUCTR2015-005753-12-GB United Kingdom;
Faecal microbiota transplantation
Torkell Ellingsen
2022 Phase 2 NCT04924270 -
Fecal Microbial Transplant
Children's Hospital Los Angeles
2016 Phase 1 NCT02291523 United States;
Fecal Microbial Transplantation
Stony Brook University
2013 Early Phase 1 NCT03268213 United States;
Fecal Microbiota
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Fecal Microbiota Enema
McMaster Children's Hospital
2015 Phase 1 NCT02487238 Canada;
Fecal Microbiota Transplant
Baylor College of Medicine
2014 Phase 1 NCT01947101 United States;
Children's Hospital of Philadelphia
2015 - NCT02636517 United States;
University of Alberta
2014 Phase 1/Phase 2 NCT02227342 Canada;
University of Vermont
2015 Early Phase 1 NCT02390726 United States;
Fecal Microbiota Transplant (FMT)
Stacy A. Kahn
2015 Phase 1/Phase 2 NCT02330653 United States;
Fecal Microbiota Transplantation
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
Dayanand Medical College and Hospital
2018 Phase 3 NCT03716388 India;
Jun Liu
2015 Phase 2/Phase 3 NCT02435160 -
Weill Medical College of Cornell University
2020 Phase 2 NCT03998488 United States;
2016 Phase 1 NCT02516384 United States;
Fecal Microbiota Transplantation (FMT)
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03483246 France;
Children's Mercy Hospital Kansas City
2014 Phase 1 NCT02108821 United States;
Fecal Microbiota Transplantation (FMT), OpenBiome
Najwa Elnachef
2017 Phase 1 NCT03006809 United States;
Fecal microbiota
University of Minnesota
2019 Phase 1 NCT03948919 United States;
Fecal microbiota capsule
Zhongshan Hospital Xiamen University
2020 Phase 1 NCT04521205 China;
Fecal microbiota transplantation
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
Gulhane Military Medical Academy
2015 Phase 3 NCT02575040 Turkey;
Helsinki University Central Hospital
2018 Phase 2 NCT03378921 Finland;
McMaster University
2021 Phase 4 NCT04231110 Canada;
The Second Hospital of Nanjing Medical University
2016 Phase 4 NCT02998112 China;
University of Chicago
2013 Phase 1 NCT02058524 United States;
Ferric carboxymaltose
Vifor Inc.
2008 Phase 3 NCT00810030 Austria;Russian Federation;
Ferrous sulphate
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Queen Mary University of London
2011 Phase 4 NCT01991314 United Kingdom;
Filgotinib
GILEAD SCIENCES INCORPORATED
2018 Phase 3 EUCTR2016-002765-58-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001392-78-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences
2018 Phase 1 NCT03417778 Germany;New Zealand;United States;
2017 Phase 3 NCT02914535 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 NCT02914522 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Film-coated tablet
LG Chem
2020 Phase 1 NCT04360343 Korea, Republic of;
Flagyl
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
Flaxseed lignan-enriched complex (FLC)
University of Saskatchewan
2018 Phase 2 NCT02201758 Canada;
Flixabi
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
UMC Amsterdam location AMC
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
University Southampton Hospital NHS Foundation Trust
2018 Phase 4 EUCTR2018-001546-33-GB United Kingdom;
Fluorescein
Fujita Health University School of Medicine, Department of Gastroenterology
2017 - JPRN-UMIN000032250 Japan;
Ohmiya Naoki
2017 - JPRN-jRCTs041180035 Japan;
Flupentixol
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Fosfomycin
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Freeze-dried black raspberry powder
UConn Health
2013 Phase 1 NCT02267694 United States;
G1567970
Galapagos NV
2020 Phase 2 EUCTR2020-000659-11-PL Georgia;Moldova, Republic of;Poland;Ukraine;
G321605
Galapagos NV
2015 Phase 2 EUCTR2014-001893-32-CZ Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2015 - EUCTR2014-001893-32-PL Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-HU Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-DE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-BE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GB004
GB004, Inc.
2020 Phase 2 NCT04556383 Australia;Georgia;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
2019 Phase 1 NCT03860896 Georgia;Moldova, Republic of;United States;
GB004-HCl
GB004, Inc.
2021 Phase 2 EUCTR2020-002306-12-PL Australia;Belarus;Georgia;Italy;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
GED-0301
Celgene
2015 Phase 2 NCT02601300 Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
Celgene Corporation
2016 Phase 2 EUCTR2015-003364-36-SK Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-HU Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-BG Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
GED-0507-34-Levo
GIULIANI
2012 - EUCTR2011-003283-78-IT Italy;
PPM Services S.A.
2016 Phase 2 NCT02808390 Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine;United States;
GED0507
PPM SERVICES SA
2017 Phase 2 EUCTR2016-001684-36-LV Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2017 Phase 2 EUCTR2016-001684-36-ES Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
2016 Phase 2 EUCTR2016-001684-36-SK Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-HU Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001684-36-BG Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
GI-270384
GlaxoSmithKline
2004 Phase 1 NCT00457171 Netherlands;
GLPG0974
Galapagos NV
2013 Phase 2 NCT01829321 Belgium;Czech Republic;Latvia;Slovakia;
2013 Phase 2 EUCTR2012-005521-73-BE Belgium;Czech Republic;Latvia;
2013 - EUCTR2012-005521-73-LV Czech Republic;Latvia;
2013 - EUCTR2012-005521-73-CZ Belgium;Czech Republic;Latvia;
GLPG1205
Galapagos NV
2015 Phase 2 EUCTR2014-001893-32-CZ Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2015 - EUCTR2014-001893-32-PL Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 Phase 2 NCT02337608 Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-HU Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-DE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
2014 - EUCTR2014-001893-32-BE Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GLPG3970
Galapagos NV
2020 Phase 2 NCT04577794 Georgia;Moldova, Republic of;Poland;Ukraine;
2020 Phase 2 EUCTR2020-000659-11-PL Georgia;Moldova, Republic of;Poland;Ukraine;
GLYCYRRHIZA GLABRA ROOT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
GM-CSF, fosfomycin and metronidazole
Zealand University Hospital
2021 Phase 1/Phase 2 NCT04979832 Denmark;
GS-4875
GILEAD SCIENCES INCORPORATED
2020 Phase 2 EUCTR2019-001430-33-IT Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
Gilead Sciences, Inc.
2020 Phase 2 EUCTR2019-001430-33-PL Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-GB Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-DE Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
2020 Phase 2 EUCTR2019-001430-33-AT Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
GS-5745
Gilead Sciences
2013 Phase 1 NCT01831427 Belgium;Canada;Hungary;Moldova, Republic of;Netherlands;Romania;United States;
Gilead Sciences, Inc
2016 Phase 2;Phase 3 EUCTR2014-005217-24-SE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-IS Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-HR Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-BG Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2016 Phase 2;Phase 3 EUCTR2014-005217-24-BE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-SK Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-NL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-LV Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-IE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-GB Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-CZ Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 2;Phase 3 EUCTR2014-005217-24-AT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
GS-5745 IV
Gilead Sciences
2014 Phase 1 NCT02209987 New Zealand;
GS-5745 SC
Gilead Sciences
2014 Phase 1 NCT02209987 New Zealand;
GS-6034
GILEAD SCIENCES INCORPORATED
2018 Phase 3 EUCTR2016-002765-58-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001392-78-IT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Galapagos NV
2017 Phase 3 EUCTR2016-002765-58-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences, Inc
2017 Phase 3 EUCTR2016-002765-58-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Gilead Sciences, Inc.
2018 Phase 2 EUCTR2017-000402-38-SE Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-PT Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-NL Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-GB Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-DE Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-BE Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-000402-38-AT Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-IS Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-FR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-CZ Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-BG Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002765-58-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-SK Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-PT Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-NO Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-NL Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-IS Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-HU Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-HR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-GR Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-ES Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-DE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-BE Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-001392-78-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-002765-58-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-001392-78-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
GSK1399686
GlaxoSmithKline
2009 Phase 2 NCT01036022 Belgium;Canada;Germany;Norway;Sweden;
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
GSK1605786
GlaxoSmithKline
2013 Phase 2 NCT01658605 Belgium;Netherlands;United Kingdom;
GSK1605786A
GlaxoSmithKline Research & Development Ltd
2012 Phase 2 EUCTR2011-002818-37-BE Belgium;Netherlands;United Kingdom;
2012 - EUCTR2011-002818-37-NL Netherlands;United Kingdom;
2012 - EUCTR2011-002818-37-GB Netherlands;United Kingdom;
GSK2586184
GlaxoSmithKline
2013 Phase 1 NCT02000453 Netherlands;
GSK2831781
GlaxoSmithKline Research & Development Limited
2020 Phase 2 EUCTR2018-003278-28-BG Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-PL Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-NL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-HU Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-GB Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-FR Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003278-28-CZ Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Double Blind Phase
GlaxoSmithKline
2019 Phase 2 NCT03893565 Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Open Label phase
GlaxoSmithKline
2019 Phase 2 NCT03893565 Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2982772
GlaxoSmithKline
2016 Phase 2 NCT02903966 Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
GlaxoSmithKline Research & Development Ltd
2017 Phase 2 EUCTR2016-001833-29-PL Germany;Netherlands;Poland;Sweden;United Kingdom;
2017 Phase 2 EUCTR2016-001833-29-NL Germany;Netherlands;Poland;Sweden;United Kingdom;
2016 Phase 2 EUCTR2016-001833-29-SE Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001833-29-GB Germany;Netherlands;Poland;Sweden;United Kingdom;
GSK2982772A, where A denotes the free base
GlaxoSmithKline Research & Development Ltd
2017 Phase 2 EUCTR2016-001833-29-PL Germany;Netherlands;Poland;Sweden;United Kingdom;
2017 Phase 2 EUCTR2016-001833-29-NL Germany;Netherlands;Poland;Sweden;United Kingdom;
2016 Phase 2 EUCTR2016-001833-29-SE Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001833-29-GB Germany;Netherlands;Poland;Sweden;United Kingdom;
GWP42003
GW Pharma Ltd.
2013 Phase 2 EUCTR2011-003208-19-CZ Czech Republic;United Kingdom;
2011 Phase 2 EUCTR2011-003208-19-GB Czech Republic;United Kingdom;
GW Research Ltd
2012 Phase 2 NCT01562314 Czech Republic;United Kingdom;
Ganciclovir
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2016 - JPRN-UMIN000022588 Japan;
Graduate School of Medicine, Kyoto University, Gastroenterology and Hepatology
2007 - JPRN-UMIN000013925 Japan;
Gastro-resistant phosphatidylcholine granules
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Gastroscopy
Tel-Aviv Sourasky Medical Center
2015 Phase 2 NCT04434872 Israel;
Glutamine
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Gold
Peking University First Hospital
2018 - ChiCTR1800019676 China;
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
2012 - ChiCTR1900023689 China;
Golimumab
Guy's and St Thomas' NHS Foundation Trust
2017 Phase 4 NCT03124121 United Kingdom;
2017 Phase 4 EUCTR2017-001374-42-GB United Kingdom;
Hospital San Carlos, Madrid
2019 - NCT03773445 Spain;
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
2016 - NCT03018925 Spain;
Istituto Clinico Humanitas
2015 Phase 4 NCT02412085 Italy;
JANSSEN PHARMACEUTICAL K.K
2008 Phase 3 JPRN-JapicCTI-090740 -
2008 Phase 2-3 JPRN-JapicCTI-090739 -
Janssen Biologics B.V.
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Janssen Pharmaceutical K.K.
2013 Phase 3 NCT01863771 Japan;
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
2018 Phase 3 NCT03596645 Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2013 Phase 2 NCT01988961 Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Russian Federation;Ukraine;United States;
2013 Phase 1 NCT01900574 Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2007 Phase 3 NCT00488631 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 2/Phase 3 NCT00487539 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
Janssen Scientific Affairs, LLC
2013 Phase 4 NCT01804166 United States;
Kliniken im Naturpark Altmuehltal
2014 Phase 4 NCT02186886 Germany;
MSD
2014 Phase 4 EUCTR2013-004583-56-GB United Kingdom;
Merck Sharp & Dohme Corp.
2015 Phase 4 NCT02318667 Portugal;
2014 Phase 4 NCT02092285 United Kingdom;
Golimumab (GLM)
University College Dublin
2016 Phase 4 NCT02687724 Ireland;
Golimumab (Optimization)
Centre Hospitalier Universitaire de Saint Etienne
2017 Phase 2 NCT03182166 France;
Golimumab 1 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 2 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 4 mg per kg
Janssen Research & Development, LLC
2007 Phase 2/Phase 3 NCT00488774 Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg
Hospital de Manises
2018 Phase 4 NCT03669029 Spain;
Golimumab Dose 1
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Dose 2
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Liquid in Vial
Centocor BV
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Golimumab Liquid in prefilled syringe
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Golimumab Prefilled Syringe
David Drobne
2020 Phase 4 NCT04156984 Slovenia;
Golimumab treatment optimization.
Hospital de Manises
2018 Phase 4 NCT03669029 Spain;
Gralise
Shirley Ryan AbilityLab
2012 Phase 4 NCT01678911 United States;
Granulated mesalamine
Bausch Health Americas, Inc.
2004 Phase 3 NCT00767728 United States;
2004 Phase 3 NCT00744016 United States;
Grapefruit
Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
2014 - JPRN-UMIN000013546 Japan;
Group 1- Control Diet
Prof. Arie Levine
2020 - NCT03980405 Israel;
Group 2- UCD Diet
Prof. Arie Levine
2020 - NCT03980405 Israel;
Guaiazulene
Mie University Graduate School of Medicine, Gastrointestinal and Pediatric Surgery
2013 - JPRN-UMIN000013266 Japan;
Guselkum
Janssen-Cilag International NV
2020 Phase 2;Phase 3 EUCTR2018-004002-25-ES Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-FR Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Guselkumab
Janssen Pharmaceutical K.K.
2020 Phase 2-3 JPRN-JapicCTI-194980 Japan, Asia except Japan, North America, Europe;
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
2019 Phase 2/Phase 3 NCT04033445 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Janssen-Cilag International NV
2021 Phase 2;Phase 3 EUCTR2018-004002-25-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 2;Phase 3 EUCTR2018-004002-25-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-004002-25-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-GB Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-004002-25-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 1
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 2
Janssen Research & Development, LLC
2018 Phase 2 NCT03662542 Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
H02AB
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
2009 - EUCTR2007-003815-30-PT Portugal;Spain;
HE3286
Harbor Therapeutics
2008 Phase 1/Phase 2 NCT00628433 United States;
HF2
Sheba Medical Center
2019 Phase 1/Phase 2 NCT03720002 Israel;
HGS1025
Human Genome Sciences Inc.
2011 Phase 1 NCT01434576 -
HM201
Syneos Health
2021 Early Phase 1 NCT05088369 -
HMPL-004
Hutchison MediPharma Enterprises Limited
2008 - EUCTR2007-005166-12-DE Germany;
Hutchison Medipharma Limited
2013 Phase 3 NCT01882764 United States;
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
HMPL-004 1800 mg/day
Hutchison Medipharma Limited
2013 Phase 3 NCT01805791 United States;
HMPL-004 2400 mg/day
Hutchison Medipharma Limited
2013 Phase 3 NCT01805791 United States;
HMPL-004 high dose
Hutchison Medipharma Limited
2008 Phase 2 NCT00659802 United States;
HMPL-004 low dose
Hutchison Medipharma Limited
2008 Phase 2 NCT00659802 United States;
HMPL004-6599
Nutrition Science Partners Limited
2018 Phase 1 NCT03597971 Australia;
HUMIRA
Abbott GmbH Co. KG
2007 - EUCTR2006-002781-20-IT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
GETAID
2019 Phase 4 EUCTR2018-003490-10-FR France;
HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
HUMIRA 40Mg Solution for Injection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
2019 Phase 4 NCT04131322 Spain;
HUMIRA ®
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
Hemay007
Tianjin Hemay Pharmaceutical Co.,Ltd
2019 Phase 2 NCT03977480 China;
Herbal treatment (SA100)
Stanford University
2014 Phase 1 NCT02442960 United States;
Hextend
Spectrum Health Hospitals
2007 Phase 3 NCT00467922 United States;
Hgd40
sterna biologicals GmbH & Co. KG
2014 Phase 2 EUCTR2013-004599-36-DE Germany;
High Dose Budesonide
Bausch Health Americas, Inc.
2022 Phase 4 NCT04314375 -
High Dose MT-1303
Bausch Health Americas, Inc.
2021 Phase 2 NCT04857112 United States;
High Protein and Low Fiber Diet
Mayo Clinic
2021 - NCT04933162 United States;
High dose
Holy Stone Healthcare Co., Ltd
2016 Phase 2 NCT02493712 Italy;Taiwan;
HuM291
Facet Biotech
2007 Phase 3 NCT00502294 -
PDL BioPharma , Inc.
2006 - EUCTR2005-003482-17-IT Greece;Ireland;Italy;Spain;United Kingdom;
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Hulio
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Human Anti-TNF IgG1 Monoclonal Antibody
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human Anti-TNFalfa
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human anti-IP10 monoclonal antibody
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-IT Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Human anti-TNF-alpha monoclonal antibody
Janssen Biologics B.V.
2014 - EUCTR2012-004366-18-BE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DK Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-DE Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 Phase 1 EUCTR2012-004366-18-AT Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
2013 - EUCTR2012-004366-18-NL Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
- Phase 1 EUCTR2012-004366-18-FR Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Humanized recombinant IgG4 monoclonal antibody against CD-127
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-LV Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Humira
Abbott GmbH & Co. KG
2008 - EUCTR2006-002782-40-DE Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002782-40-AT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2008 - EUCTR2006-002781-20-SE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2008 - EUCTR2006-002781-20-AT Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 Phase 3 EUCTR2006-002782-40-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 Phase 3 EUCTR2006-002781-20-SK Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
2007 - EUCTR2006-002782-40-PT Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-HU Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002782-40-DK Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-CZ Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
2007 - EUCTR2006-002782-40-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
2007 - EUCTR2006-002781-20-HU Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-DE Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-CZ Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
2007 - EUCTR2006-002781-20-BE Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
F. Hoffmann-La Roche Ltd
2019 Phase 3 EUCTR2013-004279-11-FR Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-HU Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-CZ Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2013-004279-11-BG Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2015 Phase 3 EUCTR2013-004277-27-BG Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-SK Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-EE Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LV Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LT Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-HR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-GR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Humira (adalimumab original)
Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
2019 Phase 4 EUCTR2019-000717-37-ES Spain;
Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringe
ABBOTT GMBH & Co. KG
2012 - EUCTR2011-002411-29-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
AbbVie Deutschland GmbH & Co. KG
2013 - EUCTR2011-002411-29-SK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2013 - EUCTR2011-002411-29-PL Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2013 - EUCTR2011-002411-29-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-SE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-IE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-DE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-BE Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 EUCTR2007-004157-28-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
2008 Phase 3 EUCTR2007-004157-28-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
Abbott GmbH & Co. KG
2012 - EUCTR2011-002411-29-GR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2012 - EUCTR2011-002411-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2009 Phase 3 EUCTR2007-004157-28-PT Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-SK Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
2008 Phase 3 EUCTR2007-004157-28-FR Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
Abbvie Deutschland GmbH & Co. KG
2012 - EUCTR2011-002411-29-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringes
Odense University Hospital
2011 Phase 3 EUCTR2011-004268-31-DK Denmark;
Humira 40 mg/0.8 ml solution for injection
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2013-001682-16-DK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2015 Phase 3 EUCTR2013-001682-16-BE Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-SK Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-PL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-HU Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-ES Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-DE Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
2014 Phase 3 EUCTR2013-001682-16-AT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
AbbVie Inc.
- - EUCTR2014-004559-29-Outside-EU/EEA Japan;
Humira 40 mg/0.8 ml solution for injection for paediatric use
AbbVie Deutschland GmbH & Co. KG
2017 Phase 3 EUCTR2015-001346-29-CZ Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-HU Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-GB Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-ES Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001346-29-BE Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-IT Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-HU Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-GB Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-SE Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-AT Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
Abbvie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2013-003032-77-PL Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-ES Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-BE Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003032-77-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2013-003032-77-FR Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)
AbbVie Deutschland GmbH & Co. KG
2015 Phase 3 EUCTR2015-001346-29-SK Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
- Phase 3 EUCTR2015-001346-29-PL Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira®
Samsung Bioepis Co., Ltd.
2014 Phase 3 EUCTR2013-005013-13-BG Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-PL Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-LT Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-CZ Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
Hydrocortisone
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Hydrogen
411th Hospital of PLA
2013 - ChiCTR-TRC-13003530 China;
Juntendo University Hospital
2020 - JPRN-UMIN000042017 Japan;
Hydroxocobalamin with Butyrate
Joshua Korzenik
2020 Phase 2 NCT04259060 United States;
Hydroxychloroquine
Icahn School of Medicine at Mount Sinai
2022 Phase 1/Phase 2 NCT05119140 United States;
Hyperbaric oxygen
Dartmouth-Hitchcock Medical Center
2013 Phase 2/Phase 3 NCT02144350 United States;
IBD98-M Delayed-release Capsules
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
IDOFORM®Travel
Oslo University Hospital
2020 Phase 1 NCT04241029 Norway;
IM90838
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
IMU-838
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03341962 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
INCB039110
Incyte Corporation
2020 Phase 2 EUCTR2018-004491-35-RO Czechia;Germany;Poland;Romania;United States;
2019 Phase 2 EUCTR2018-004491-35-PL Czech Republic;Germany;Poland;Romania;United States;
ITACITINIB ADIPATE
Incyte Corporation
2020 Phase 2 EUCTR2018-004491-35-RO Czechia;Germany;Poland;Romania;United States;
2019 Phase 2 EUCTR2018-004491-35-PL Czech Republic;Germany;Poland;Romania;United States;
IV Corticosteroid
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Iberogast N
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Imolope
Department of surgery, Odense University Hospital
2014 Phase 4 EUCTR2014-004740-35-DK Denmark;
Impact
Hospices Civils de Lyon
2018 - NCT03504930 France;
Lawson Health Research Institute
2016 - NCT02742597 Canada;
Imuran
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Imurek 25mg Filmtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Imurek 50mg Filmtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Imurel
Hvidovre Hospital
2016 Phase 3 EUCTR2016-002433-30-DK Denmark;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
2018 Phase 4 EUCTR2016-004112-35-SE Sweden;
Infectofos
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Inflectra
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Celltrion, Inc.
2020 Phase 3 EUCTR2019-003849-15-HR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-GR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-FR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-ES Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-CZ Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-BG Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-AT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Erasmus Medical Center
2019 Phase 4 EUCTR2018-004587-61-NL Netherlands;
Pfizer
2018 - NCT03801928 Canada;United States;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Inflectra 100 mg powder for concentrate for solution for infusion
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
Infliximab
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2019 Phase 4 NCT03937609 Netherlands;
Alimentiv Inc.
2018 - NCT03765450 Canada;United States;
Austin Health
2016 Phase 4 NCT02770040 Australia;
CENTOCOR
2007 - EUCTR2006-000410-20-IT Belgium;Denmark;Italy;Netherlands;
Centocor BV
2007 - EUCTR2006-000410-20-DK Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-BE Belgium;Denmark;Italy;Netherlands;
Centocor, Inc.
2006 Phase 3 NCT00336492 Belgium;Canada;Denmark;Netherlands;United States;
2002 Phase 3 NCT00096655 -
2002 Phase 3 NCT00036439 Belgium;United States;
Chiba University Hospital
2012 Phase 2 JPRN-UMIN000015297 Japan;
2012 Phase 2 JPRN-UMIN000007806 Japan;
Children's Hospital of Fudan University
2021 Phase 4 NCT04999228 -
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2011 - JPRN-UMIN000006141 Japan;
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
2013 Phase 4 JPRN-UMIN000010612 Japan;
Department of Internal Medicine,Juntendo University
2014 - JPRN-UMIN000013033 Japan;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Fukuoka University Chikushi Hospital
2021 - JPRN-UMIN000043165 Japan;
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Grupo de Estudo da Doença Inflamatória Intestinal
2011 Phase 4 NCT01408810 Portugal;
Hikma Pharmaceuticals LLC
2018 - NCT03452501 Saudi Arabia;
Hiroshima University Hospital, Department of Endoscopy
2014 - JPRN-UMIN000015068 Japan;
Hoffmann-La Roche
2014 Phase 3 NCT02136069 Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Hyogo College of Medicine
2014 Phase 1 JPRN-UMIN000014275 Japan;
Hyogo college of medicine
2013 - JPRN-UMIN000013371 Japan;
Inflammatory bowel disease center, Hyogo college of medicine
2013 Phase 1 JPRN-UMIN000013370 Japan;
Istituto Clinico Humanitas
2017 Phase 4 NCT03151525 Italy;
Janssen Research & Development, LLC
2018 Phase 3 NCT03596645 Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2004 - NCT00207688 Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Israel;Netherlands;New Zealand;Switzerland;United Kingdom;United States;
Janssen Scientific Affairs, LLC
2013 Phase 4 NCT01804166 United States;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
2007 - NCT00705484 Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Nagoya University Graduate School of Medicine, Department of Gastroentrology and hepatology
2015 - JPRN-UMIN000018745 Japan;
Rennes University Hospital
2019 Phase 4 NCT03679546 France;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schneider Children's Medical Center, Israel
2018 - NCT03209232 Israel;
Sixth Affiliated Hospital, Sun Yat-sen University
2021 - NCT04879966 China;
Tohoku University Graduate School of Medicine (Tohoku University Hospital)
2012 - JPRN-UMIN000007341 Japan;
University Hospitals Cleveland Medical Center
2008 - NCT00791557 United States;
University Southampton Hospital NHS Foundation Trust
2018 Phase 4 EUCTR2018-001546-33-GB United Kingdom;
University of California, San Francisco
2013 Phase 1 NCT01971814 United States;
University of Toyama
2017 - JPRN-UMIN000027465 Japan;
University of Western Ontario, Canada
2014 Phase 4 NCT01960426 United States;
Xian-Janssen Pharmaceutical Ltd.
2012 Phase 3 NCT01551290 China;
Yokohama City University Medical Center
2014 Phase 2 JPRN-UMIN000013716 Japan;
Infliximab (IFX)
Merck Sharp & Dohme Corp.
2007 Phase 3 NCT00537316 Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Infliximab [infliximab biosimilar 3]
Pfizer
2019 - NCT03884439 Japan;
Infliximab and adalimumab
Regionshospitalet Viborg, Skive
2009 - NCT02322008 -
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2019 Phase 4 NCT03885713 Spain;
Infliximab therapeutic drug monitoring
Imelda GI Clinical Research Center
2018 Phase 4 NCT04775732 Belgium;
Infliximab, adalimumab, certolizumab pegol
Oslo University Hospital
2013 - NCT02073526 Norway;
Infusion of Saline
Guangzhou First People's Hospital
2019 Phase 2/Phase 3 NCT03804931 China;
Innovator infliximab
Diakonhjemmet Hospital
2014 Phase 4 NCT02148640 Norway;
Inositol
National Cancer Institute (NCI)
2010 Phase 1/Phase 2 NCT01111292 United States;
Interferon-beta-1a, 44 microgram
EMD Serono
2001 Phase 2 NCT00303381 Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interferon-beta-1a, 66 microgram
EMD Serono
2001 Phase 2 NCT00303381 Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interleukin-2 (aldesleukin).
Scott Snapper
2015 Phase 1 NCT02200445 United States;
Intestinal flora capsule
Third Military Medical University
2021 - NCT05030064 China;
Iron sulphate 200mg coated tablets
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Iron supplement 300-600 mg/day
University Health Network, Toronto
2002 Phase 2 NCT00152841 Canada;
Iron(III)- hydroxide dextran complex
Barts Health NHS Trust
2011 Phase 4 EUCTR2010-023797-39-GB United Kingdom;
Itacitinib
Incyte Corporation
2018 Phase 2 NCT03627052 United States;
JNJ-54781532 150 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 25 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg once daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg twice daily
Janssen Research & Development, LLC
2013 Phase 2 NCT01959282 Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532-AAD-
Janssen-Cilag International NV
2014 Phase 2 EUCTR2013-000263-88-RO Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-DE Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-000263-88-BG Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-PL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-NL Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-HU Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-000263-88-BE Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-66525433
Janssen Research & Development, LLC
2020 Phase 1 NCT04457960 Georgia;Germany;Moldova, Republic of;
JNJ-72537634
Vedanta Biosciences, Inc.
2021 Phase 2 EUCTR2021-001280-24-LT Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-001280-24-HU Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
JNJ-78934804
Janssen Research & Development, LLC
2022 Phase 2 NCT05242484 United States;
Janus Kinase Inhibitor
Alimentiv Inc.
2020 - NCT04576000 Belgium;Canada;Italy;Netherlands;Spain;United States;
Janus kinase Inhibitor
Alimentiv Inc.
2020 Phase 4 EUCTR2019-003780-21-NL Belgium;Canada;Italy;Netherlands;Spain;United States;
K(D)PT
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
Dr. August Wolff GmbH & Co. KG Arzneimittel
2011 Phase 2 EUCTR2010-023494-19-SE Sweden;
KBL697
KoBioLabs
2021 Phase 2 NCT04898348 -
KHK4083
Kyowa Kirin Co., Ltd.
2016 Phase 1 NCT02985593 Japan;
Kyowa Kirin Pharmaceutical Development, Inc.
2016 Phase 2 NCT02647866 Czech Republic;Czechia;Hungary;Poland;Puerto Rico;Romania;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-PL Czech Republic;Hungary;Poland;Romania;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-HU Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
2016 Phase 2 EUCTR2015-001555-69-CZ Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
KRP203
Novartis Pharmaceuticals
2010 Phase 2 NCT01375179 Belgium;Germany;Hungary;Sweden;Switzerland;United Kingdom;
Novartis Services AG
2010 - EUCTR2010-019970-33-SE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-DE Belgium;Germany;Hungary;Sweden;United Kingdom;
KRP203A
Novartis Services AG
2011 - EUCTR2010-019970-33-GB Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019970-33-BE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-SE Belgium;Germany;Hungary;Sweden;United Kingdom;
2010 - EUCTR2010-019970-33-HU Belgium;Germany;Hungary;Sweden;United Kingdom;
Kamillenblüten 3ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Kappaproct
INDEX PHARMACEUTICALS
2012 - EUCTR2011-003130-14-IT Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals
2011 Phase 3 NCT01493960 Czech Republic;France;Germany;Hungary;Italy;Poland;United Kingdom;
InDex Pharmaceuticals AB
2012 - EUCTR2011-003130-14-CZ Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 Phase 3 EUCTR2011-003130-14-GB Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-PL Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-HU Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2011 - EUCTR2011-003130-14-DE Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
2006 - EUCTR2006-001846-15-SE Sweden;
KdPT
Dr August Wolff GmbH & Co KG Arzneimittel
2012 - EUCTR2011-002462-20-SK Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
2011 - EUCTR2011-002462-20-PL Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-HU Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-DE Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-CZ Czech Republic;Germany;Hungary;Italy;Poland;
Kremezin®, Spherical Adsorptive Carbon
Ocera Therapeutics, Inc.
2007 - EUCTR2005-005363-28-HU Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2007 - EUCTR2005-005363-28-AT Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 Phase 3 EUCTR2005-005363-28-GB Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-DE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-CZ Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
2006 - EUCTR2005-005363-28-BE Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
Kyo-Dophilus
University of California, Irvine
2007 Phase 1 NCT00578799 United States;
Kümmel 2ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
L-Lysyl-D-Prolyl-L-Threonine Acetate
Dr August Wolff GmbH & Co KG Arzneimittel
2012 - EUCTR2011-002462-20-SK Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
2011 - EUCTR2011-002462-20-PL Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-HU Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-DE Czech Republic;Germany;Hungary;Italy;Poland;
2011 - EUCTR2011-002462-20-CZ Czech Republic;Germany;Hungary;Italy;Poland;
L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
LC51-0255
LG Chem
2020 Phase 2 NCT04096573 -
LDP-02
Millennium Pharmaceuticals, Inc.
2009 - EUCTR2008-002782-32-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
LT-02
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 NCT02280629 Germany;
2014 Phase 3 NCT02142725 Germany;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Lipid Therapeutics GmbH
2009 Phase 2 NCT01011322 Germany;Lithuania;Romania;
Prometheus Laboratories
2016 Phase 3 NCT02849951 United States;
LT-02 (modified-release PC pellets)
Lipid Therapeutics GmbH
2009 - EUCTR2008-007952-90-LT Germany;Lithuania;
2009 - EUCTR2008-007952-90-DE Germany;Lithuania;
LX1606
Lexicon Pharmaceuticals, Inc.
2012 - EUCTR2011-003532-32-LT Belgium;Lithuania;Poland;Slovakia;United States;
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
LY3074828
ELI LILLY & COMPANY, LILLY CORPORATE CENTER
2019 Phase 3 EUCTR2017-004092-31-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
Eli Lilly Cork Limited
2018 Phase 3 EUCTR2017-003229-14-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-DK Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Eli Lilly Japan K.K.
2018 Phase 3 JPRN-JapicCTI-184062 Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Eli Lilly and Company
2021 Phase 3 EUCTR2019-001653-99-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001653-99-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001653-99-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-004092-31-RO Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-004092-31-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004092-31-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-003238-96-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-003229-14-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004092-31-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-LT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-HU Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-DE Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-CZ Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003238-96-AT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-SK Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-LT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-DE Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-CZ Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003229-14-AT Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-PL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-NL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-HU Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-GB Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-DK Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-CZ Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-BE Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-003123-57-LT Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Lilly S.A.
2019 Phase 3 EUCTR2017-004092-31-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
LY3471851
Eli Lilly and Company
2021 Phase 2 NCT04677179 Argentina;Australia;Belgium;Brazil;Canada;China;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-SK Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-HU Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-CZ Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2020-003017-35-BE Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
LYC-30937
Lycera Corp.
2016 Phase 1 NCT02818543 Hungary;
LYC-30937-EC
Lycera Corp.
2017 Phase 2 EUCTR2016-003633-26-PL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2017 Phase 2 EUCTR2016-003633-26-NL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2017 Phase 2 EUCTR2016-003633-26-CZ Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 NCT02764229 Czechia;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 NCT02762500 Canada;Czech Republic;Czechia;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-003633-26-HU Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-PL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-NL Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-HU Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
2016 Phase 2 EUCTR2016-000518-31-CZ Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
LYS006
Novartis Pharma AG
2021 Phase 2 EUCTR2019-003113-34-SK Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-NO Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-HU Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
2020 Phase 2 EUCTR2019-003113-34-DE Czech Republic;Germany;Hungary;Norway;United States;
Novartis Pharmaceuticals
2020 Phase 2 NCT04074590 Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United Kingdom;United States;
Lactated Ringers
Spectrum Health Hospitals
2007 Phase 3 NCT00467922 United States;
Lactobacillus GG
Children's Hospital Medical Center, Cincinnati
2011 Phase 2 NCT00895336 United States;
Lactobacillus casei
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
Lactobacillus casei DG
University of Padova
2016 - NCT03136419 Italy;
Lactobacillus plantarum
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
Lactobacillus reuteri
Uppsala University
2017 Phase 2 NCT03798210 Sweden;
Lactobacillus rhamnosus GG ATCC 53103
San Giovanni Addolorata Hospital
2019 Phase 1/Phase 2 NCT04102852 Italy;
Lactobacillus salivarius UCC118
University College Cork
2002 Phase 2/Phase 3 NCT00510978 Ireland;
Lactobacilus acidophilus & bifidobacterium animalis/lactis
Hvidovre University Hospital
2004 Phase 2 NCT00268164 Denmark;
Lactose in water
University Hospitals, Leicester
2007 - NCT00403923 United Kingdom;
Leucine
Showa Inan General Hospital
2020 - NCT04535882 Japan;
Levocarnitine
SIGMA-TAU
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
Levocarnitine propyl hydrochloride
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
Linaclotide
University of Virginia
2015 Phase 4 NCT02465385 United States;
Lixacol
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Loperamide
Odense University Hospital
2014 Phase 3 NCT02266849 Denmark;
Loperamide hydrochloride
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Losartan
Takeda
2016 Phase 4 NCT02760615 United States;
Low Dose Budesonide
Bausch Health Americas, Inc.
2022 Phase 4 NCT04314375 -
Low Dose MT-1303
Bausch Health Americas, Inc.
2021 Phase 2 NCT04857112 United States;
Low FODMAP
Vendsyssel Hospital
2018 - NCT02469220 Denmark;
Low Protein and High Fiber Diet
Mayo Clinic
2021 - NCT04933162 United States;
Low dose
Holy Stone Healthcare Co., Ltd
2016 Phase 2 NCT02493712 Italy;Taiwan;
Low dose naltrexone
Santa Barbara Cottage Hospital
2013 Phase 2 NCT01810185 United States;
Lumbar puncture
Shire
2012 Phase 1 NCT01387594 Austria;Belgium;France;Germany;Netherlands;
Lusvertikimab
OSE Immunotherapeutics
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Lysine-D-Proline-Threonine
Dr. August Wolff GmbH & Co. KG Arzneimittel
2011 Phase 2 EUCTR2010-023494-19-SE Sweden;
Lysine-D-proline-threonine
DR. AUGUST WOLFF GMBH & CO. KG
2012 - EUCTR2011-002462-20-IT Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
MATRICARIA RECUTITA L. FLOS
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MD-0901
MOCHIDA PHARMACEUTICAL CO., LTD
2018 Phase 2-3 JPRN-JapicCTI-173803 Japan;
2018 Phase 2-3 JPRN-JapicCTI-173802 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
2010 Phase 3 JPRN-JapicCTI-101381 -
2010 Phase 3 JPRN-JapicCTI-101380 -
MDX-1100
Bristol-Myers Squibb
2008 Phase 2 NCT00656890 Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States;
Bristol-Myers Squibb Company
2008 - EUCTR2007-002544-25-LV Czech Republic;Hungary;Latvia;
Bristol-Myers Squibb International Corporation
2011 Phase 2 EUCTR2010-022506-41-BE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-PL Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-HU Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-DE Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2011 - EUCTR2010-022506-41-AT Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
2008 - EUCTR2007-002544-25-HU Czech Republic;Hungary;Latvia;
2008 - EUCTR2007-002544-25-CZ Czech Republic;Hungary;Latvia;
MDX-1100 (anti-CXCL10 human monoclonal antibody)
Bristol-Myers Squibb
2006 Phase 1 NCT00295282 United States;
MEDI7183 high dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MEDI7183 low dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MEDI7183 medium dose
AstraZeneca
2013 Phase 2 NCT01959165 Japan;
MELISSAE FOLII DRY AQUEOUS EXTRACT
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MENTHA × PIPERITA L. FOLIUM
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
MESENCHYMAL CELLS
Leiden University Medical Center
2018 Phase 2 EUCTR2017-003524-75-NL Netherlands;
MET-2
NuBiyota
2019 Phase 1 NCT03832400 Canada;
METHOTREXATE DISODIUM
UMC Amsterdam location AMC
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
METHYLPREDNISOLONE SODIUM HEMISUCCINATE
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
2017 Phase 4 EUCTR2016-001170-15-ES Spain;
MEZAVANT
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
MH002
MRM Health NV
2021 Phase 1;Phase 2 EUCTR2020-004355-33-CZ Belgium;Czech Republic;
2021 Phase 1;Phase 2 EUCTR2020-004355-33-BE Belgium;
MK-6194
Merck Sharp & Dohme Corp.
2021 Phase 1 NCT04924114 Georgia;Germany;Moldova, Republic of;Ukraine;United Kingdom;United States;
MK-8259
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
MLN0002
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
MILLENNIUM PHARMACEUTICALS, INC.
2009 Phase 3 EUCTR2008-002784-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002782-32-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
Millennium Pharmaceuticals, Inc.
2009 Phase 3 EUCTR2008-002784-14-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-IE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-EE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002782-32-IS Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-GB Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-002782-32-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002784-14-MT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002783-33-MT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002783-33-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
2009 - EUCTR2008-002782-32-PT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-MT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-IE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-GR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-EE Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-DE Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;
2009 - EUCTR2008-002782-32-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2009 - EUCTR2008-002782-32-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
2008 - EUCTR2008-002782-32-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Center Americas, Inc.
2021 Phase 3 EUCTR2020-004300-34-SK Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-LT Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HU Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HR Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-GR Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-ES Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-CZ Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-BE Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe Ltd
2009 Phase 3 EUCTR2008-002784-14-IS Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Takeda Development Centre Europe Ltd.
2010 Phase 3 EUCTR2008-002784-14-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2008-002784-14-GB Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-CZ Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
2009 Phase 3 EUCTR2008-002784-14-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-002784-14-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2008-002784-14-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe ltd.
2009 Phase 3 EUCTR2008-002784-14-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002182-21-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002182-21-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
MLN0002 (Vedolizumab)
TAKEDA PHARMACEUTICAL COMPANY LTD.
2014 Phase 3 JPRN-JapicCTI-142403 Japan;
MLN0002 SC
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000482-31-IT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000482-31-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BG Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
MLN002
Takeda Development Centre Europe Limited
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
MMX Mesalamine
Shire
2010 Phase 1 NCT01130844 Australia;Poland;Slovakia;United Kingdom;United States;
2007 Phase 4 NCT00446849 United States;
MMX Mesalamine/Mesalazine
Shire Development Inc
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
MMX Mesalamine/Mesalazine (High Dose)
Shire
2014 Phase 3 NCT02093663 Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX Mesalamine/Mesalazine (Low Dose)
Shire
2014 Phase 3 NCT02093663 Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX mesalamine/ mesalazine
Shire
2010 Phase 4 NCT01124149 Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Ireland;Poland;Romania;South Africa;Spain;United Kingdom;United States;
MONOCLONAL ANTIBODY ANTI-IGG1
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-IT Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim BV Netherlands
2017 Phase 2 EUCTR2016-004572-21-NL Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim España, S.A.
2018 Phase 2;Phase 3 EUCTR2017-004230-28-ES Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-ES Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-ES Denmark;Germany;Netherlands;Norway;Spain;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-GR Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2017-004230-28-CZ Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-GB Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-GB Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2016-004572-21-NO Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-DE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-DE Belgium;Germany;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DK Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-004572-21-DE Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000334-35-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim bv
2018 Phase 2;Phase 3 EUCTR2017-004230-28-NL Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim bv Netherlands
2019 Phase 2 EUCTR2018-000334-35-NL Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2;Phase 3 EUCTR2017-004230-28-BE Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 EUCTR2017-000100-20-BE Belgium;Germany;United Kingdom;
MS-20 oral solution
National Taiwan University Hospital
2021 - NCT04908644 -
MSB11022
Fresenius Kabi SwissBioSim GmbH
2019 Phase 1 NCT04018599 United States;
MSC
Leiden University Medical Center
2018 Phase 2 EUCTR2017-003524-75-NL Netherlands;
MT-1303
Salix Pharmaceuticals, Inc.
2021 Phase 2 EUCTR2020-005232-30-SK Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-HU Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-EE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-DE Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
2021 Phase 2 EUCTR2020-005232-30-BG Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
MTX 12.5
University of Western Ontario, Canada
2013 Phase 4 NCT01716039 -
MTX 25
University of Western Ontario, Canada
2013 Phase 4 NCT01716039 -
Maltodextrin
Capital Medical University
2020 Phase 0 ChiCTR2000032498 China;
Jiangnan University
2020 Phase 0 ChiCTR2000033953 China;
University of Alberta
2016 - NCT02865707 Canada;
Maltose
Honda Takashi
2018 - JPRN-jRCTs041190010 Japan;
Mango polyphenolics
Texas A&M University
2014 - NCT02227602 United States;
Mare´s milk
University of Jena
2000 - NCT00940576 Germany;
Maximal oral 5ASA
University of Aarhus
2012 - NCT01534312 Denmark;
Melatonin
Emory University
2009 Phase 2 NCT00790478 United States;
Melissenblätter 15ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Melitracen
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Mercaptopurine (Puri-Nethol)
Academic Medical Centre
2016 Phase 3 EUCTR2015-005260-41-NL Netherlands;
Mercaptopurine (Purinethol)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
Mesalamin
Tillotts Pharma AG
2009 Phase 3 NCT01059344 Belarus;India;Turkey;Ukraine;
Mesalamine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
Altheus Therapeutics, Inc.
2009 Phase 1 NCT01020708 United States;
Beijing Friendship Hospital, Capital Medical University
2019 - ChiCTR1900021229 China;
Department of Gastroenterology, Jinan Central Hospital
2018 - ChiCTR2100043797 China;
Dr. Falk Pharma GmbH
2014 Phase 3 NCT02280629 Germany;
EMET Pharmaceuticals, LLC
2008 Phase 3 NCT01045018 -
2008 - EUCTR2007-004732-23-PL Estonia;Latvia;Poland;
Ferring Pharmaceuticals
2021 - NCT04499495 Korea, Republic of;
2016 Phase 3 NCT02522780 Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 NCT02522767 Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
Icahn School of Medicine at Mount Sinai
2022 Phase 1/Phase 2 NCT05119140 United States;
James Lewis
2008 Phase 4 NCT00652145 United States;
VSL Pharmaceuticals
2017 - NCT03415711 Italy;
Warner Chilcott
2006 Phase 3 NCT00350415 Belarus;Canada;Croatia;Czech Republic;Estonia;Former Serbia and Montenegro;Hungary;Latvia;Lithuania;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Ukraine;United States;
2005 Phase 1 NCT00254618 United States;
2001 Phase 3 NCT00577473 United States;
Wolfson Medical Center
2010 Phase 4 NCT01201122 Israel;
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
2020 Phase 0 ChiCTR2000037261 China;
Mesalamine Delayed Release Tablets
EMET Pharmaceuticals LLC
2008 - EUCTR2007-004732-23-LV Estonia;Latvia;Poland;
2007 - EUCTR2007-004732-23-EE Estonia;Latvia;Poland;
Mesalamine Enema
Altheus Therapeutics, Inc.
2012 Phase 2 NCT01586533 United States;
Mesalamine Granules
Dayanand Medical College and Hospital
2018 Phase 3 NCT03716388 India;
Mesalamine Once-Daily
Warner Chilcott
2007 Phase 3 NCT00505778 Canada;Puerto Rico;United States;
Mesalamine Twice-Daily
Warner Chilcott
2007 Phase 3 NCT00505778 Canada;Puerto Rico;United States;
Mesalamine granules
Dr. Falk Pharma GmbH
2005 Phase 3 NCT00746447 Germany;
Mesalamine, 5-ASA
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
Mesalamine, 5-aminosalicylic acid [5-ASA]
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002558-11-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2015-002557-35-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002558-11-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002557-35-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Mesalazine
Affiliated Hospital of Inner Mongolia Medical University
2017 - ChiCTR-IPR-17010306 China;
Affiliated Hospital of Jiangnan University
2021 - ChiCTR2100046446 China;
Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Province Traditional Chinese Medicine Hospital)
2014 - ChiCTR1800016668 China;
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University
2020 Phase 2 ChiCTR2000028869 China;
Cardiff and Vale NHS Trust
2006 Phase 3 EUCTR2005-002784-91-GB United Kingdom;
Chengdu University of Traditional Chinese Medicine
2020 Phase 0 ChiCTR2000039161 China;
2020 Phase 0 ChiCTR2000038888 China;
Chiba University Hospital
2013 Phase 2 JPRN-UMIN000010906 Japan;
Chinese University of Hong Kong
2015 - NCT02537210 China;Hong Kong;
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Department of Gastroenterology and Hepatology, Kyoto University Hospital
2013 - JPRN-UMIN000010127 Japan;
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
2017 - JPRN-UMIN000026175 Japan;
Department of anorectal surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine
2014 - ChiCTR-IOR-15006812 China;
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine
2011 - JPRN-UMIN000011236 Japan;
Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
2014 - ChiCTR-OCH-14004615 China;
Dongfang Hospital of Beijing University of Chinese Medicine
2019 Phase 0 ChiCTR1900023159 China;
Dongfang hospital, Beijing univetsity of Chinese Medicine
2015 - ChiCTR-IOR-15007194 China;
Dr. Falk Pharma GmbH
2007 Phase 3 NCT00747110 Germany;
2005 Phase 3 NCT00449722 Germany;
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-FI Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-DK Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
- - EUCTR2004-004565-15-DE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Ferring Pharmaceuticals
2015 - NCT02368743 France;
2015 - NCT02261636 Netherlands;
2012 - NCT01517607 Germany;
Flemming Bendtsen
2019 Phase 4 NCT04133194 Denmark;
GIULIANI
2009 - EUCTR2008-007292-25-IT Italy;
2004 - EUCTR2004-000916-25-IT Italy;
Guiyang 1st People's Hospital
2018 - ChiCTR1800016438 China;
Hyogo College of Medicine
2018 - JPRN-UMIN000034016 Japan;
Jiangsu Province Hospital of Chinese Medicine
2020 Phase 0 ChiCTR2000035099 China;
2019 Phase 4 ChiCTR1900023158 China;
Kitasato University Kitasato Institute Hospital
2016 - JPRN-UMIN000022954 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD
2018 Phase 2-3 JPRN-JapicCTI-173803 Japan;
2018 Phase 2-3 JPRN-JapicCTI-173802 Japan;
MOCHIDA PHARMACEUTICAL CO., LTD.
2013 Phase 3 JPRN-JapicCTI-142475 -
Nanjing Hospital of Chinese Medicine
2019 Phase 3 ChiCTR1900025900 China;
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 Phase 2 NCT00808977 Belgium;Hungary;Slovakia;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
Peking University First Hospital
2019 Phase 0 ChiCTR1900024591 China;
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Limited
2006 - EUCTR2006-001310-32-LV Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-LT Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-HU Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-EE Czech Republic;Estonia;Hungary;Latvia;Lithuania;
2006 - EUCTR2006-001310-32-CZ Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
Saitama Medical Center, Saitama Medical University
2013 - JPRN-UMIN000010340 Japan;
2012 - JPRN-UMIN000008352 Japan;
Shire Development Inc
2012 - EUCTR2011-000164-10-SK Slovakia;United Kingdom;United States;
Shire Development LLC
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100048176 China;
Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
2020 Phase 0 ChiCTR2000037220 China;
2020 Phase 0 ChiCTR2000035497 China;
Southern Medical University, Nanfang Hospital, Department of Gastroenterology
2015 - ChiCTR-ICR-15007188 China;
The 900th Hospital of PLA
2018 Phase 4 ChiCTR2000038316 China;
The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
2006 Phase 1 study ChiCTR-TRC-08000048 China;
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
2021 - ChiCTR2100048502 China;
2019 - ChiCTR1900024086 China;
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Tillotts Pharma AG
2010 Phase 3 NCT01257399 China;
2010 Phase 3 NCT01257386 China;
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
University Medical Center Groningen
2010 - EUCTR2010-018557-35-NL Netherlands;
Xiangya Hospital of Central South University
2020 - ChiCTR2000028767 China;
Yanling Wei
2015 Phase 2 NCT02335281 China;
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of TCM
2020 Phase 0 ChiCTR2000036950 China;
Zeria Pharmaceutical Co., Ltd.
2013 Phase 3 JPRN-JapicCTI-132135 -
- Phase 2 JPRN-JapicCTI-121943 -
Zeria Pharmaceutical Co.,LTD.
2005 Phase 3 JPRN-C000000289 Japan;
2005 Phase 3 JPRN-C000000288 Japan;
Mesalazine (3,600 mg)
Ferring Pharmaceuticals
2018 Phase 3 NCT03412682 Japan;
Mesalazine (Asacol®)
Cardiff and Vale University Health Board
2006 Phase 3 NCT00708656 United Kingdom;
Mesalazine - TID 2x
Dr. Falk Pharma GmbH
2013 Phase 3 NCT01745770 Germany;
Mesalazine 1000 mg gastro-resistant tablets
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
2015 Phase 1/Phase 2 NCT03441893 -
Mesalazine 4G Enema
Institute for Clinical and Experimental Medicine
2017 Phase 2 NCT03104036 Czech Republic;Czechia;
Mesalazine 500 mg gastro-resistant tablets (Salofa
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine Enema
Ferring Pharmaceuticals
2015 Phase 3 NCT02368717 China;
Mesalazine enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Mesalazine liquid enema
Ferring Pharmaceuticals
2008 Phase 3 NCT00737789 Belgium;France;Netherlands;United Kingdom;
Mesalazine slow-release granules
Ferring Pharmaceuticals
2008 Phase 3 NCT00737789 Belgium;France;Netherlands;United Kingdom;
Mesalazine tablet
Ajinomoto Pharmaceuticals Co., Ltd.
- Phase 2-3 JPRN-JapicCTI-101144 -
MOCHIDA PHARMACEUTICAL CO., LTD.
2010 Phase 3 JPRN-JapicCTI-101381 -
2010 Phase 3 JPRN-JapicCTI-101380 -
Mesalazine with hydrocortisone sodium succinate
Xijing Hospital of Digestive Diseases
2017 Phase 4 NCT03110198 China;
Mesalazinum
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Metformin 500 mg TID Oral Tablet
National Hepatology & Tropical Medicine Research Institute
2021 Phase 2 NCT04750135 Egypt;
Methotrexate
Centre Hospitalier Universitaire de Besancon
2007 Phase 2 NCT00498589 Austria;Belgium;France;Israel;Italy;Netherlands;
GETAID, Jean Minjoz Hospital
2009 - EUCTR2006-003607-40-FI Austria;Belgium;Finland;Netherlands;
Indiana University
2015 - NCT02413047 United States;
University of North Carolina, Chapel Hill
2012 Phase 2 NCT01393405 United States;
Methotrexate bellon 25mg/ml
Besancon University Hospital
2008 - EUCTR2006-003607-40-NL Austria;Finland;Netherlands;
2008 - EUCTR2006-003607-40-BE Austria;Belgium;Finland;Netherlands;
Besancon University Hospitaö
2008 - EUCTR2006-003607-40-AT Austria;Finland;Netherlands;
Methotrexate injection
Amsterdam UMC location AMC
2019 Phase 4 EUCTR2018-003594-95-NL Netherlands;
Methylene blue 25mg tablets
COSMO TECHNOLOGIES LTD
2012 - EUCTR2011-005693-36-IT Italy;
Methylprednisolone
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
2018 Phase 4 NCT02921555 Spain;
Metoject
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
Metronidazole
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Ishikawa Dai
2017 - JPRN-jRCTs031180415 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Juntendo university school of medicine Department of gastroenterology
2015 - JPRN-UMIN000018642 Japan;
2014 - JPRN-UMIN000014152 Japan;
Juntendo university school of medicineDepartment of gastroenterology
2017 - JPRN-UMIN000025846 Japan;
National Center for Child Health and Development
2016 - JPRN-UMIN000026485 Japan;
Postgraduate Institute of Medical Education and Research
2019 Phase 2 NCT03794765 India;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
University of Dundee
2006 - NCT00355602 United Kingdom;
Metronidazole capsule
FORMAC Pharmaceuticals NV
2009 - EUCTR2009-015136-14-BE Belgium;
Mezavant 1200 mg magensaftresistente Retardtabletten
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
2012 Phase 2 EUCTR2012-002023-15-AT Austria;
Mezavant Gastro-resistant, prolonged release tablets
Shire Development LLC
2018 Phase 3 EUCTR2013-001744-65-DE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2018 Phase 3 EUCTR2013-001744-65-BE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
Shire Devlopment LLC
2014 Phase 3 EUCTR2013-001744-65-SK Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-PL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
Mezavant XL 1200 mg gastro-resistant prolonged release tablets
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.
Shire Pharmaceutical Development Ltd
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200mg gastro-resistant, prolonged release tablets
Shire Development LLC
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
Mezavant XL Gastro-resistant, prolonged release tablets
Shire Development Inc
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2014 Phase 3 EUCTR2013-001744-65-GB Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Devlopment LLC
2015 Phase 3 EUCTR2013-001744-65-NL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-HU Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
Microbiote fécal
AP-HP/DRCD
2022 Phase 2 EUCTR2020-000311-71-FR France;
Midazolam
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Mirikizumab
ELI LILLY & COMPANY, LILLY CORPORATE CENTER
2019 Phase 3 EUCTR2017-004092-31-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Eli Lilly Japan K.K.
2018 Phase 3 JPRN-JapicCTI-184062 Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Eli Lilly and Company
2021 Phase 3 NCT04844606 Israel;Japan;Korea, Republic of;United States;
2020 Phase 2 NCT04004611 Canada;Israel;Japan;Korea, Republic of;United States;
2018 Phase 3 NCT03524092 Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03519945 Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03518086 Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-PL Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-DK Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-CZ Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-003123-57-BE Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 NCT02589665 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Ukraine;United Kingdom;United States;
2015 Phase 2 EUCTR2015-003123-57-LT Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Yoshimoto Yusuke
2021 Phase 3 JPRN-jRCT2031210210 Japan;United States;
Mirikizumab IV
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
Mirikizumab SC
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
MitoQ
University of Edinburgh
2021 Phase 2 NCT04276740 -
Modified Gegen Qinlian Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Early Phase 1 NCT04057547 China;
Modified-release phosphatidylcholine
Lipid Therapeutics GmbH
2009 - EUCTR2008-007952-90-LT Germany;Lithuania;
2009 - EUCTR2008-007952-90-DE Germany;Lithuania;
Molgramostim
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Mongersen
Celgene Corporation
2016 Phase 2 EUCTR2015-003364-36-SK Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-HU Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
2016 Phase 2 EUCTR2015-003364-36-BG Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
MultiStem high dose
Pfizer
2011 Phase 2 NCT01240915 Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
MultiStem low dose
Pfizer
2011 Phase 2 NCT01240915 Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
Multiple dose- Group B
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Multiple dose-Group B
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Mycodigest supplement
Tel-Aviv Sourasky Medical Center
2018 - NCT04329481 Israel;
Myrrhinil-Intest®
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
N.d.
IRCCS ISTITUTO CLINICO HUMANITAS
2021 Phase 4 EUCTR2020-003420-16-IT Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
NAND (Neoandrographolide)
Nutrition Science Partners Limited
2014 - EUCTR2013-003060-31-PL Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LV Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-LT Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-HU Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-CZ Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2014 - EUCTR2013-003060-31-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
2013 Phase 3 EUCTR2013-002116-27-CZ Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LV Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-LT Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-HU Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
2013 - EUCTR2013-002116-27-BG Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
NEORAL
GETAID
2008 - EUCTR2006-005299-42-BE Belgium;Finland;France;Spain;
2007 - EUCTR2006-005299-42-FR Belgium;Finland;France;Spain;
NO
Peking Union Medical College Hospital
2019 - ChiCTR2000029648 China;
University of Texas at Austin
2021 - NCT04898530 United States;
2021 - NCT04617184 United States;
NX-13
Landos Biopharma Inc.
2020 Phase 1 NCT04458805 Australia;
NX-13 250mg IR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
NX-13 500mg IR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
NX-13 500mg MR
Landos Biopharma Inc.
2021 Phase 1 NCT04862741 Ukraine;United States;
Nanocort
Enceladus Pharmaceuticals
2011 - EUCTR2010-020448-37-NL Belgium;Netherlands;
2010 Phase 2 EUCTR2010-020448-37-BE Belgium;Netherlands;
Narrow Band Imaging
London North West Healthcare NHS Trust
2006 - NCT00292175 United Kingdom;
Natura-alpha capsule
Natrogen Therapeutics International, Inc
2010 Phase 2 NCT01216280 United States;
Neomycin
University of Dundee
2006 - NCT00355602 United Kingdom;
Neoral Soft Gelatin Capsules
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
Niclosamide
First Wave Bio, Inc.
2018 Phase 1/Phase 2 NCT03521232 Italy;
Nicolon
S.L.A. PHARMA (UK) LTD
2007 - EUCTR2006-006052-35-IT Italy;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States;
Nolpitantium Besylate
SANOFI-SYNTHELABO
2005 - EUCTR2004-001677-26-IT Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Nolpitantium besylate
Sanofi
2005 Phase 2 NCT00232258 Argentina;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;France;Hungary;Italy;Russian Federation;Singapore;South Africa;Spain;Sweden;United States;
Sanofi-Synthelabo Recherche
2005 Phase 2 EUCTR2004-001677-26-HU Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-SE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-ES Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-EE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
sanofi-aventis recherche & developpement
2004 - EUCTR2004-001677-26-CZ Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Non as of yet
Lexicon Pharmaceuticals, Inc.
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
None
Bridge Biotherapeutics, Inc.
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
None given
Shire Pharmaceutical Development Ltd
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Normal Saline Enema
McMaster Children's Hospital
2015 Phase 1 NCT02487238 Canada;
Nutrition supplement
Baptist Memorial Health Care Corporation
2018 - NCT03594708 United States;
Nutritional dietary intervention
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
Nuvion®
Facet Biotech
2007 Phase 3 NCT00502294 -
PDL BioPharma, Inc.
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
OPC-6535
Otsuka Maryland Research Institute, Inc.
2005 Phase 3 EUCTR2005-003724-19-HU Czech Republic;Hungary;
2005 - EUCTR2005-003724-19-CZ Czech Republic;Hungary;
2004 - EUCTR2004-000611-25-IE Hungary;Ireland;
2004 - EUCTR2004-000611-25-HU Hungary;Ireland;
Otsuka Pharmaceutical Development & Commercialization, Inc.
2004 Phase 3 NCT00092508 United States;
OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.
2003 Phase 3 NCT00064454 United States;
2003 Phase 3 NCT00064441 United States;
OPC-6535(Tetomilast)
Otsuka Pharmaceutical Co., Ltd.
2006 Phase 2 NCT00317356 Japan;
OPRX-106
Protalix
2016 Phase 2 NCT02768974 Israel;
OPRX-106 (plant cells expressing TNFR-Fc)
Protalix Biotherapeutics Ltd.
2016 Phase 2 EUCTR2016-000509-35-BG Bulgaria;Israel;Serbia;
ORE1001
Ore Pharmaceuticals, Inc.
2009 Phase 1/Phase 2 NCT01039597 Canada;India;
OSE-127
OSE Immunotherapeutics
2020 Phase 2 NCT04882007 Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;South Africa;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-LV Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-HR Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BG Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
2020 Phase 2 EUCTR2020-001398-59-BE Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
OST-122
ONCOSTELLAE S.L.
2020 Phase 1;Phase 2 EUCTR2019-004090-50-ES Spain;
Oncostellae S.L
2020 Phase 1/Phase 2 NCT04353791 Spain;
Omeprazole
Brigham and Women's Hospital
2011 Phase 1/Phase 2 NCT01287195 United States;
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Takeda
2016 Phase 4 NCT02760615 United States;
Ondansetron hydrochloride dihydrate
University of Leeds
2020 Phase 2;Phase 3 EUCTR2019-003220-21-GB United Kingdom;
Ontamalimab
SHIRE HUMAN GENETIC THERAPIES, INC
2018 Phase 3 EUCTR2017-000599-27-IT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Shire
2018 Phase 3 NCT03290781 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03283085 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 NCT03259334 Australia;Austria;Brazil;Croatia;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States;
2017 Phase 3 NCT03259308 Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;New Zealand;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000572-28-BG Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000599-27-NL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-LT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-HR Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-GB Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-DE Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-CZ Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-PT Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-HU Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-BE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000599-27-AT Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-SK Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
- Phase 3 EUCTR2017-000599-27-PL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000573-37-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000572-28-IE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
Sheba Medical Center
2013 Phase 4 NCT01941589 China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Oral Corticosteroids
Connecticut Children's Medical Center
2012 Phase 4 NCT01536535 Canada;United States;
Oral Iron
American University of Beirut Medical Center
2019 Phase 3 NCT05225545 Lebanon;
Oral OKT3
Brigham and Women's Hospital
2011 Phase 1/Phase 2 NCT01287195 United States;
Orencia
Bristol-Myers Squibb International Corporation
2007 Phase 3 EUCTR2006-003604-19-GB Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-IT Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-DE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-CZ Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
2007 - EUCTR2006-003604-19-BE Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Originator (legacy) drug
McGill University Health Centre/Research Institute of the McGill University Health Centre
2018 - NCT03729674 Canada;
Oseltamivir
Xiangya Hospital of Central South University
2020 - ChiCTR2000028767 China;
Other Biologic Therapies
Janssen Scientific Affairs, LLC
2021 - NCT04372108 United States;
Overencapsulated Azathioprine (Imuran) 50 mg Tablet
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Overencapsulated mesalazine tablets
GlaxoSmithKline Research and Development Ltd
2009 Phase 2 EUCTR2009-011608-51-BE Belgium;Germany;Sweden;
2009 - EUCTR2009-011608-51-SE Germany;Sweden;
GlaxoSmithKline Research and Development Ltd.
2009 - EUCTR2009-011608-51-DE Germany;Sweden;
Oxygen
Dartmouth-Hitchcock Medical Center
2017 Phase 2 NCT03494764 United States;
Ozanimod
Bristol-Myers Squibb
2021 Phase 2/Phase 3 NCT05076175 France;Japan;United States;
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene
2019 Phase 3 NCT03915769 Japan;
2012 Phase 2 NCT01647516 Australia;Belgium;Bulgaria;Canada;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
PARNAPARIN SODIUM
Cosmo Technologies Ltd
2006 Phase 2 EUCTR2006-001782-42-GB Hungary;Italy;United Kingdom;
2006 - EUCTR2006-001782-42-HU Hungary;Italy;United Kingdom;
PBF-677
PaloBiofarma S.L.
2018 Phase 2 EUCTR2017-003228-54-ES Spain;
Palobiofarma SL
2018 Phase 2 NCT03773952 Spain;
PCT (PureCell Technologies Complex)
PurGenesis Techonologies Inc.
2010 - EUCTR2009-017839-18-DE Germany;
PEG
Gunma University Graduate School of Medicine
2013 Phase 4 JPRN-UMIN000013892 Japan;
PEG-liposomal prednisolone sodium phosphate
Enceladus Pharmaceuticals
2011 - EUCTR2010-020448-37-NL Belgium;Netherlands;
2010 Phase 2 EUCTR2010-020448-37-BE Belgium;Netherlands;
PF-00547659
Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
2014 - EUCTR2012-002030-37-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002030-37-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-SE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-IT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-002030-37-ES Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Pfizer Inc.
2013 - EUCTR2012-002030-37-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom;
Shire Human Genetic Therapie, Inc.
2013 Phase 2 EUCTR2012-002031-28-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2013 Phase 2 EUCTR2012-002031-28-SK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
2013 Phase 2 EUCTR2012-002031-28-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
PF-00547659 SC Injection
Shire
2012 Phase 2 NCT01620255 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
PF-05230917
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2012 Phase 2 EUCTR2010-023762-49-BE Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2012 - EUCTR2010-023762-49-PL Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-HU Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-BG Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
2011 - EUCTR2010-023762-49-AT Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
2011 - EUCTR2010-023762-49-DE Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Pfizer, S.L.U.
2011 - EUCTR2010-023762-49-ES Belgium;Bulgaria;Germany;Hungary;Poland;Spain;
PF-05285401
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
PF-06480605
PFIZER INC
2020 Phase 2 EUCTR2019-002698-74-IT Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2016-001158-16-IT Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
Pfizer
2016 Phase 2 NCT02840721 Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-PL Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-HU Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-GB Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-FR Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-ES Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2020 Phase 2 EUCTR2019-002698-74-DE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BG Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2019-002698-74-BE Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Pfizer Inc. 235 East 42nd Street, New York, NY 10017
2017 Phase 2 EUCTR2016-001158-16-NL Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
2016 Phase 2 EUCTR2016-001158-16-PL Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
2016 Phase 2 EUCTR2016-001158-16-BE Belgium;France;Italy;Korea, Republic of;Netherlands;Poland;United States;
PF-06480605 100 mg/ml
Pfizer Inc
2020 Phase 2 EUCTR2019-002698-74-SK Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
PF-06651600
Pfizer
2017 Phase 2 NCT02958865 Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06651600-15
PFIZER INC
2017 Phase 2 EUCTR2016-003708-29-IT Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-NL Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-LT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-HU Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-AT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06687234
PFIZER INC
2018 Phase 2 EUCTR2017-002108-28-IT Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States;
Pfizer
2017 Phase 2 NCT03269695 Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;Turkey;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 2 EUCTR2017-002108-28-ES Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-DE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
2018 Phase 2 EUCTR2017-002108-28-BE Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
PF-06700841
Pfizer
2017 Phase 2 NCT02958865 Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06700841-15
PFIZER INC
2017 Phase 2 EUCTR2016-003708-29-IT Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-NL Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-LT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-HU Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-ES Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Philippines;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-AT Austria;Bulgaria;Canada;Czech Republic;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
PF-06826647
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2020 Phase 2 EUCTR2019-003999-39-NO Armenia;Australia;Belgium;Bosnia and Herzegovina;Brazil;China;Croatia;Czech Republic;France;Georgia;Germany;Hong Kong;India;Ireland;Italy;Jordan;Lebanon;Macedonia, the former Yugoslav Republic of;Malaysia;Mexico;Morocco;Norway;Oman;Poland;Puerto Rico;Qatar;Romania;Russian Federation;Saudi Arabia;Slovakia;Spain;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
PF-06826647 100 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-06826647 300 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-06826647 600 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PF-6826647 400 mg QD
Pfizer
2020 Phase 2 NCT04209556 United States;
PN-10884A
Protagonist Therapeutics, Inc
2017 Phase 2 EUCTR2016-003452-75-PL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-NL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-LV Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HU Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HR Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-CZ Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-BE Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
PN-943
Protagonist Therapeutics, Inc
2020 Phase 2 EUCTR2019-004469-41-DE Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-BG Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-AT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Protagonist Therapeutics, Inc.
2020 Phase 2 NCT04504383 Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2020 Phase 2 EUCTR2019-004469-41-IT Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States;
PRA023
Prometheus Biosciences Inc.
2021 Phase 2 EUCTR2021-000091-11-IT Australia;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
Prometheus Biosciences, Inc.
2021 Phase 2 EUCTR2021-000091-11-PL Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-000091-11-HU Australia;Belarus;Belgium;Canada;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
2021 Phase 2 EUCTR2021-000091-11-CZ Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Hungary;Israel;Italy;Poland;Russian Federation;Ukraine;United Kingdom;United States;
PRA023 IV
Prometheus Biosciences, Inc.
2021 Phase 2 NCT04996797 United States;
PRD5973697
CHU Nantes
2018 Phase 3 EUCTR2017-004967-11-FR France;
PRIM-DJ2727
The University of Texas Health Science Center, Houston
2020 Phase 2 NCT04373473 United States;
PRO145223
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
PRO145223 (RO5490261)
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-ES Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-000897-80-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-HU Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-GB Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-ES Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-DE Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-CZ Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
PROPIONYL L-CARNITINE
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
PROPIONYL L-CARNITINE HYDROCHLORIDE
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
PRV-300
Provention Bio, Inc.
2018 Phase 1 NCT03849599 Georgia;Moldova, Republic of;Ukraine;
PS-QD
Kyorin Pharmaceutical Co.,LTD
- Phase 3 JPRN-JapicCTI-090967 -
PS-SP
Kyorin Pharmaceutical Co.,LTD
- Phase 3 JPRN-JapicCTI-111421 -
PTG-100
Protagonist Therapeutics, Inc
2017 Phase 2 EUCTR2016-003452-75-PL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-NL Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-LV Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HU Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-HR Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-CZ Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-003452-75-BE Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Germany;Greece;Hungary;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Protagonist Therapeutics, Inc.
2016 Phase 2 NCT02895100 Australia;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czechia;Germany;Hungary;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Ukraine;United States;
PUR 0110
PurGenesis Techonologies Inc.
2010 - EUCTR2009-017839-18-DE Germany;
PUR 0110 Rectal Enema
PurGenesis Technologies Inc.
2010 Phase 2 NCT01149707 Germany;
2009 Phase 1 NCT01149694 Germany;
Pending
Reistone Biopharma Company Limited
2019 Phase 2 EUCTR2018-003364-31-PL China;Poland;Ukraine;United States;
Pentasa
Children´s Hospital, University of Helsinki
2012 Phase 4 EUCTR2012-004851-35-FI Finland;Israel;
Ferring Pharmaceuticals
2005 Phase 3 NCT00209300 Belgium;Czech Republic;Denmark;Finland;Germany;Netherlands;Norway;Sweden;
Pentasa 2g sachet prolonged release granules ()
Ferring Pharmaceuticals Ltd.
2009 - EUCTR2008-000045-59-GB Belgium;France;Netherlands;United Kingdom;
Ferring SAS
2008 Phase 3 EUCTR2008-000045-59-FR Belgium;France;Netherlands;United Kingdom;
2008 Phase 3 EUCTR2008-000045-59-BE Belgium;France;Netherlands;United Kingdom;
2008 - EUCTR2008-000045-59-NL Belgium;France;Netherlands;United Kingdom;
Pentasa 500 mg Retardtabletten
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Pentasa Compact 2g, granulate with prolonged release
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002558-11-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002558-11-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002558-11-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Pentasa Compact 4g, granulate with prolonged release
Ferring International PharmaScience Center U.S., Inc.
2017 Phase 3 EUCTR2015-002557-35-BG Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-LV Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2016 Phase 3 EUCTR2015-002557-35-HU Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
2015 Phase 3 EUCTR2015-002557-35-BE Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Pentasa Sachet
Ferring BV
2005 - EUCTR2004-004565-15-DK Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 1 g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 1g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa Sachet 2 g
Ferring BV
2005 - EUCTR2004-004565-15-SE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa enema
University Hospitals of Leicester NHS Trust
2006 Phase 3 EUCTR2006-002036-25-GB United Kingdom;
Pentasa prolonged release granules 2g
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-FI Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
- - EUCTR2004-004565-15-DE Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pentasa sachet 1g
Ferring BV
2005 Phase 3 EUCTR2004-004565-15-CZ Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
2005 - EUCTR2004-004565-15-NO Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
Pfefferminzblätter 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Phentermine-Topiramate
University of California, San Diego
2020 Phase 2 NCT04721873 United States;
Photodynamic therapy with Gliolan
University of Zurich
2012 Phase 1 NCT01697670 Switzerland;
Placebo
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
2014 Phase 3 JPRN-JapicCTI-142649 Japan, North America, Europe;
2014 Phase 3 JPRN-JapicCTI-142648 Japan, North America, Europe;
2009 Phase 2-3 JPRN-JapicCTI-090718 -
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
EA Pharma Co.,Ltd.
2014 Phase 3 JPRN-JapicCTI-142704 -
Eli Lilly Japan K.K.
2016 Phase 2 JPRN-JapicCTI-163356 Japan, North America, Europe, Oceania;
- Phase 3 JPRN-JapicCTI-184217 -
- Phase 3 JPRN-JapicCTI-184216 -
Janssen Pharmaceutical K.K.
2020 Phase 2-3 JPRN-JapicCTI-194980 Japan, Asia except Japan, North America, Europe;
Otsuka Pharmaceutical Co., Ltd.
2007 Phase 2 JPRN-JapicCTI-070399 Japan;
TAKEDA PHARMACEUTICAL COMPANY LTD.
2014 Phase 3 JPRN-JapicCTI-142403 Japan;
Polaprezinc
The Jikei University School of MedicineDivision of Gastroenterology and Hepatology
2009 - JPRN-UMIN000008967 Japan;
Polyethylene glycol
Kyungpook National University
2013 - NCT01929668 Korea, Republic of;
Polyphenon E®
University of Louisville
2008 Phase 2 NCT00718094 United States;
Pomegranate
IRCCS Azienda Ospedaliero-Universitaria di Bologna
2017 - NCT03000101 Italy;
Prednisolon Jenapharm
4SC AG
2010 - EUCTR2008-005903-25-BG Bulgaria;Germany;
2009 - EUCTR2008-005903-25-DE Bulgaria;Germany;
Prednisolone
Alizyme
2006 Phase 3 NCT00299013 Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom;
Department of Inflammatory Bowel DiseaseHyogo College of Medicine
2018 Phase 1 JPRN-UMIN000030000 Japan;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
2016 Phase 4 NCT02425852 France;
Lower Gastroenterology, Hyogo College of Medicine
2011 Phase 2,3 JPRN-UMIN000005358 Japan;
Merck Sharp & Dohme Corp.
2009 Phase 3 NCT00984568 Germany;
Prednisolone Tablets B.P.
Alizyme Therapeutics Limited
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Prednisolone sodium metasulphobenzoate
Alizyme Therapeutics Limited
2007 - EUCTR2004-005032-35-BE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-005032-35-GB Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-SE Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-HU Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-DK Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-005032-35-CZ Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
Prednisone
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2016 Phase 3 NCT02910245 Netherlands;
CHIESI
2007 - EUCTR2006-004230-32-IT Belgium;Italy;Poland;Spain;
Chiesi Farmaceutici SpA
2007 Phase 3 EUCTR2006-004230-32-PL Belgium;Italy;Poland;Spain;
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
2018 Phase 4 NCT02921555 Spain;
Peking University First Hospital
2019 Phase 0 ChiCTR1900024591 China;
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Southern Medical University, Nanfang Hospital, Department of Gastroenterology
2015 - ChiCTR-ICR-15007188 China;
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
2021 Phase 0 ChiCTR2100046284 China;
Prefilled Syringe delivery of Golimumab
Merck Sharp & Dohme Corp.
2014 Phase 4 NCT02155335 Belgium;
Previously referred to as MEDI2070 and AMG 139
ALLERGAN LIMITED
2019 Phase 2 EUCTR2018-001605-93-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Allergan Ltd.
2019 Phase 2 EUCTR2018-001605-93-RO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
AstraZeneca AB
2019 Phase 2 EUCTR2018-001605-93-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001605-93-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Probiotic
Postgraduate Institute of Medical Education and Research
2011 Phase 4 NCT01479660 India;
Probiotic Formula Capsule
University of Jordan
2020 Phase 2/Phase 3 NCT04223479 Jordan;
Probiotic Mixture
Massachusetts General Hospital
2017 - NCT03266484 United States;
Probiotics
The Baruch Padeh Medical Center, Poriya
2012 Phase 4 NCT01078935 -
Products containing aminosalicylate
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Products containing azathioprine or 6-mercaptopurine
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Promiten
PFIZER LIMITED
2012 - EUCTR2010-022766-27-IT Belgium;Canada;Hungary;Italy;Sweden;United States;
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2012 - EUCTR2010-022766-27-SK Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-SE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-HU Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
2012 - EUCTR2010-022766-27-BE Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
Propionyl-L-carnitine
SIGMA-TAU
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
Propionylcarnitinhydrochlorid
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
Psyllium Husk Powder
Weill Medical College of Cornell University
2020 Phase 2 NCT03998488 United States;
Puri-Nethol
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
Puri-nethol
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
QBECO SSI
Qu Biologics Inc.
2015 Phase 2 NCT02426372 Canada;
RDP58
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
RECTABUL2mg rectal form
EA Pharma Co.,Ltd.
2018 - JPRN-JapicCTI-183858 Japan;
REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO
IRCCS ISTITUTO CLINICO HUMANITAS
2017 Phase 4 EUCTR2016-002707-25-IT Italy;
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-002061-54-IT Italy;
RO5490261 / F02
Genentech, Inc.
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
RO5490261/F02
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
RO5490261/F04-02
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
RO7021610
Chugai Pharmaceutical Co., Ltd.
2019 Phase 1 JPRN-JapicCTI-194721 Japan;
RO7049665
Hoffmann-La Roche
2019 Phase 1 NCT03943550 Georgia;Hungary;Moldova, Republic of;Ukraine;United States;
RO7246311
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
ROSUVASTATIN CALCIUM
UZ Leuven
2020 Phase 3 EUCTR2019-004208-37-BE Belgium;
RPC103
CELGENE INTERNATIONAL II SàRL
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-001600-64-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene
2015 Phase 3 NCT02531126 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 NCT02435992 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl
2018 Phase 3 EUCTR2015-001600-64-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-001600-64-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-001600-64-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2018 Phase 3 EUCTR2015-000319-41-LV Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-ES Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2015-000319-41-AT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-000319-41-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000319-41-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2 EUCTR2012-003123-38-PL Belgium;Bulgaria;Czech Republic;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 Phase 2 EUCTR2012-003123-38-BE Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2015-001600-64-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2015-000319-41-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II).
2013 Phase 2 EUCTR2012-003123-38-SK Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-NL Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-HU Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
2013 Phase 2 EUCTR2012-003123-38-BG Belgium;Bulgaria;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Ukraine;United States;
Celgene International II Sárl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000319-41-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Receptos, Inc.
2013 Phase 2 EUCTR2012-003123-38-GR Australia;Belgium;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;United States;
RTNV148B IgG
Centocor BV
2010 - EUCTR2006-003398-28-CZ Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003399-37-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-SE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-NL Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-LT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003398-28-BG Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-SE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-NL Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-LT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2008 - EUCTR2006-003397-94-BG Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 Phase 3 EUCTR2006-003399-37-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003398-28-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-SK Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-HU Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 Phase 2;Phase 3 EUCTR2006-003397-94-FR Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
2007 - EUCTR2006-003398-28-LV Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-HU Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-DE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-BE Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003398-28-AT Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-LV Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-DE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-BE Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
2007 - EUCTR2006-003397-94-AT Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Janssen Biologics B.V.
2010 - EUCTR2006-003399-37-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-SE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2008 - EUCTR2006-003399-37-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-LV Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-HU Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
2007 - EUCTR2006-003399-37-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 - EUCTR2006-003399-37-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
Janssen Biologics BV
2008 - EUCTR2006-003399-37-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
2007 Phase 3 EUCTR2006-003399-37-SK Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
RYAH-Medtech Inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Ravagalimab
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 2 EUCTR2018-000930-37-IT Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 2 EUCTR2018-000930-37-HU Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-GB Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-000930-37-DE Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000930-37-NL Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
Rebamipide
Otsuka Pharmaceutical Co., Ltd.
2007 Phase 2 NCT00463151 Japan;
2007 Phase 2 JPRN-JapicCTI-070399 Japan;
Recombinant Factor XIII (rFXIII)
Novo Nordisk A/S
2013 - EUCTR2011-001568-22-HU Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-DK Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
2012 - EUCTR2011-001568-22-BG Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
Rectal dialysis
NorthShore University HealthSystem
2012 Phase 2 NCT04032652 -
Rectal tacrolimus
The University of Western Australia
2012 Phase 4 NCT01418131 Australia;
Rectosigmoidoscopy
Centre Hospitalier Universitaire de Saint Etienne
2017 - NCT03172195 France;
Regular treatment
Xijing Hospital of Digestive Diseases
2016 Phase 4 NCT02962245 -
Regulatory T cells
University of Erlangen-Nürnberg Medical School
2021 Phase 1 NCT04691232 Germany;
Remestemcel-L
The Cleveland Clinic
2020 Phase 1/Phase 2 NCT04543994 United States;
Remicade
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Centocor BV
2007 - EUCTR2006-000410-20-NL Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-DK Belgium;Denmark;Italy;Netherlands;
2007 - EUCTR2006-000410-20-BE Belgium;Denmark;Italy;Netherlands;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Essex Pharma GmbH
2009 - EUCTR2009-010065-23-DE Germany;
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-004282-14-PT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-NL Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-NO Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-FR Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-DE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-CZ Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-BE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-004282-14-IT Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
GEDII - Grupo de Estudo da Doença inflamatória Intestinal
2010 - EUCTR2009-013890-16-PT Portugal;
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Janssen Biologics B.V.
2019 Phase 3 EUCTR2017-004496-31-IT Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2009 - EUCTR2008-005237-30-NL Canada;Netherlands;Sweden;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
Katholieke Universiteit Leuven
2011 Phase 4 EUCTR2011-002061-38-BE Belgium;
Pfizer
2015 - NCT02539368 Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom;
Region Örebro län
2021 Phase 4 EUCTR2019-002942-19-DK Denmark;
Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004282-14-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Royal Liverpool University Hospital
2012 - EUCTR2011-006084-22-GB United Kingdom;
SCHERING-PLOUGH
2007 - EUCTR2006-002670-22-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
2019 Phase 4 EUCTR2018-003524-36-NL Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
University of Leuven Hospitals, Division of Gastroenterology
2009 - EUCTR2008-007519-34-SE Sweden;
Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
2013 - EUCTR2011-001332-29-AT Austria;
Remicade (infliximab)
Zon MW
2014 Phase 4 EUCTR2013-002651-15-NL Netherlands;
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Remicade 100 mg powder for concentrate for solution for infusion.
Santeon
2015 Phase 4 EUCTR2015-001954-14-NL Netherlands;
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning
Diakonhjemmet Hospital AS
2014 - EUCTR2014-002056-40-NO Norway;
Remsima
CUB- Hopital Erasme
2016 Phase 4 EUCTR2015-004618-10-BE Belgium;
Centre Hospitalier Universitaire de Rennes
2018 Phase 4 EUCTR2018-002673-21-FR France;
Taina Sipponen
2016 Phase 4 EUCTR2016-001278-13-FI Finland;
UMC Amsterdam location AMC
2021 Phase 4 EUCTR2018-003524-36-NO France;Ireland;Netherlands;Norway;United Kingdom;
2020 Phase 4 EUCTR2018-003524-36-IE Ireland;Netherlands;
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Remsima (CT-P13)
CELLTRION INC.
2020 Phase 3 EUCTR2019-003849-15-IT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Celltrion, Inc.
2020 Phase 3 EUCTR2019-003849-15-HR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-GR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-FR Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-ES Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-003849-15-CZ Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-BG Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
2020 Phase 3 EUCTR2019-003849-15-AT Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Remsima (infliximab)
Mundipharma Pharmaceuticals B.V.
2016 Phase 4 EUCTR2014-004904-31-BE Belgium;Netherlands;
2015 Phase 4 EUCTR2014-004904-31-NL Netherlands;
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning
Diakonhjemmet Hospital AS
2014 - EUCTR2014-002056-40-NO Norway;
Remsima and Inflectra
Janssen Biologics B.V.
2009 - EUCTR2008-005237-30-NL Canada;Netherlands;Sweden;United States;
Repomol
Center for Surgical Science
2021 Phase 1;Phase 2 EUCTR2020-000609-10-DK Denmark;
Retarded Release Phosphatidylcholine (rPC)
Heidelberg University
2003 Phase 2 NCT00259545 Germany;
Retarded release phosphatidylcholine
Heidelberg University
2003 Phase 2/Phase 3 NCT00259571 Germany;
2003 Phase 2 NCT00259558 Germany;
2000 - NCT00463619 Germany;
RhIL-11
Wyeth is now a wholly owned subsidiary of Pfizer
1994 Phase 1 NCT00038922 United States;
RhuMAb Beta7
Genentech, Inc.
2012 Phase 2 EUCTR2011-003409-36-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2012 Phase 2 EUCTR2011-003409-36-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 NCT01336465 Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-GB Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-ES Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-003409-36-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-000897-80-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-HU Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-GB Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-ES Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-DE Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2011 - EUCTR2011-000897-80-CZ Australia;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
2008 Phase 1 NCT00694980 Belgium;Canada;Germany;Netherlands;United Kingdom;United States;
RhuMAb Beta7, Anti Beta 7, PRO145223
F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004278-88-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
RhuMAb Beta7, Anti Beta7, PRO145223
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2013-004278-88-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004435-72-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004278-88-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
RhuMab Beta7, Anti Beta7, PRO145223
F. Hoffmann-La Roche Ltd
2015 Phase 3 EUCTR2013-004435-72-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Riboflavin
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Rifaximin
University of Dundee
2006 - NCT00355602 United Kingdom;
Risankizumab
AbbVie
2020 Phase 1 NCT04254783 Germany;Israel;United States;
2019 - NCT03914261 Belgium;Israel;Spain;Switzerland;United States;
2018 Phase 3 NCT03398135 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Risankizumab (Genetical Recombination)
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184008 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa;
2018 Phase 2-3 JPRN-JapicCTI-183997 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa;
Risankizumab IV
AbbVie
2018 Phase 2/Phase 3 NCT03398148 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Risankizumab SC
AbbVie
2018 Phase 2/Phase 3 NCT03398148 American Samoa;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Ritlecitinib
Pfizer Inc.
2017 Phase 2 EUCTR2016-003708-29-SK Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Pfizer Inc., 235 East 42nd Street, New York, NY 10017
2018 Phase 2 EUCTR2016-003708-29-BG Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-PL Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DK Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
2017 Phase 2 EUCTR2016-003708-29-DE Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Rituximab
Royal Liverpool University Hospital
2004 Phase 2/Phase 3 NCT00261118 United Kingdom;
Rivenprost (drug)
Kyoto University, Graduate School of Medicine
2006 Phase 2 NCT00296556 Japan;
Ro 549-0261/F04
F. Hoffmann-La Roche Ltd
2019 Phase 3 EUCTR2013-004279-11-FR Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-HU Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2019 Phase 3 EUCTR2013-004277-27-CZ Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2013-004278-88-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2016 Phase 3 EUCTR2013-004280-31-SK Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2016 Phase 3 EUCTR2013-004280-31-PL Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2015 Phase 3 EUCTR2013-004435-72-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004435-72-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-PT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004282-14-NL Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2015 Phase 3 EUCTR2013-004279-11-BG Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2015 Phase 3 EUCTR2013-004277-27-BG Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2015 - EUCTR2013-004435-72-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004435-72-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-NO Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-FR Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 Phase 3 EUCTR2013-004282-14-DE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-CZ Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-BE Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004282-14-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2013-004280-31-HU Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004280-31-DK Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Poland;Slovakia;South Africa;United States;
2014 Phase 3 EUCTR2013-004280-31-DE Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004280-31-CZ Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-SK Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004279-11-EE Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
2014 Phase 3 EUCTR2013-004278-88-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-GR Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004278-88-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-004277-27-LV Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-LT Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-HR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-004277-27-GR Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
2014 - EUCTR2013-004435-72-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2014 - EUCTR2013-004282-14-IT Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004278-88-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
2014 Phase 3 EUCTR2013-004282-14-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
2014 - EUCTR2013-004435-72-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Rosiglitazone
Herlev Hospital
2005 Phase 1/Phase 2 NCT00309660 Denmark;
James Lewis
2002 Phase 2 NCT00065065 United States;
Rosuvastatin
Universitaire Ziekenhuizen Leuven
2020 Phase 2/Phase 3 NCT04883840 Belgium;
Rosuvastatine EG
UZ Leuven
2020 Phase 3 EUCTR2019-004208-37-BE Belgium;
SANDINUM
GETAID
2008 - EUCTR2006-005299-42-BE Belgium;Finland;France;Spain;
2007 - EUCTR2006-005299-42-FR Belgium;Finland;France;Spain;
SAR339658
Sanofi
2013 Phase 2 NCT01861249 Canada;United States;
2012 Phase 2 NCT01659138 Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi aventis Recherche&Développement
2013 Phase 2 EUCTR2012-002013-19-BE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-PL Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-IT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-DE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-AT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi-aventis recherche & développement
2014 - EUCTR2013-001012-30-DE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 Phase 2 EUCTR2013-001012-30-BE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-PL Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-IT Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-AT Austria;Canada;Germany;Italy;Poland;United States;
SB-656933
GlaxoSmithKline
2009 Phase 2 NCT00748410 Netherlands;
SB-656933 Tablets
GlaxoSmithKline R&D Ltd
2008 - EUCTR2007-005520-32-NL Netherlands;
SB012
Sterna Biologicals GmbH & Co. KG
2014 Phase 1/Phase 2 NCT02129439 Germany;
sterna biologicals GmbH & Co. KG
2014 Phase 2 EUCTR2013-004599-36-DE Germany;
SB5
Samsung Bioepis Co., Ltd
2015 - EUCTR2014-004887-39-PL Poland;
Samsung Bioepis Co., Ltd.
2014 Phase 3 EUCTR2013-005013-13-BG Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-PL Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-LT Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
2014 - EUCTR2013-005013-13-CZ Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
SC12267
4SC AG
2010 - EUCTR2008-005903-25-BG Bulgaria;Germany;
2009 - EUCTR2008-005903-25-DE Bulgaria;Germany;
SC12267 (4SC-101)
4SC AG
2009 Phase 2 NCT00820365 Bulgaria;Germany;Romania;
SCH 900050
Schering-Plough Research Institute, a division of Schering Corporation
2008 Phase 3 EUCTR2006-002670-22-SK Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2008 Phase 3 EUCTR2006-002670-22-GB Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-FR Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 Phase 3 EUCTR2006-002670-22-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-PT Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-HU Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-002670-22-CZ Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
SER-287
Seres Therapeutics, Inc.
2018 Phase 2 NCT03759041 Canada;United States;
2016 Phase 1 NCT02618187 United States;
SF257 C59
Procter & Gamble Pharmaceuticals
2005 Phase 2 EUCTR2004-004077-29-SK Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
2005 - EUCTR2004-004077-29-LT Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-DE Czech Republic;Germany;Lithuania;United Kingdom;
2005 - EUCTR2004-004077-29-CZ Czech Republic;Germany;Lithuania;United Kingdom;
Procter & Gamble Technical Centres Ltd
2005 - EUCTR2004-004077-29-GB Czech Republic;Germany;Lithuania;United Kingdom;
SHP647
Baxalta Innovations GmbH
- Phase 3 EUCTR2017-000573-37-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
SHIRE HUMAN GENETIC THERAPIES, INC
2018 Phase 3 EUCTR2017-000599-27-IT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Shire Human Genetic Therapies, Inc.
2018 Phase 3 EUCTR2017-000572-28-BG Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Shire Human Genetic Therapies, Inc.
2019 Phase 3 EUCTR2017-000574-11-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-NL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-LT Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-HR Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-GB Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-DE Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000599-27-CZ Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000574-11-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-NL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-IE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-HR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000573-37-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-000572-28-PT Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-HU Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-FR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-ES Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2018 Phase 3 EUCTR2017-000572-28-BE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
2017 Phase 3 EUCTR2017-000599-27-AT Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000574-11-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-SK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000573-37-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000572-28-SK Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2017-000572-28-GR Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
- Phase 3 EUCTR2017-000599-27-PL Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000574-11-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000573-37-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2017-000572-28-IE Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
SHP647 (PF-00547659)
Shire
2013 Phase 2 NCT01771809 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;United States;
SHR0302
Reistone Biopharma Company Limited
2021 Phase 3 NCT05181137 China;Georgia;Poland;Ukraine;United States;
2019 Phase 2 NCT03675477 China;Poland;Puerto Rico;Ukraine;United States;
2019 Phase 2 EUCTR2018-003364-31-PL China;Poland;Ukraine;United States;
SHR0302 tablets
Reistone Biopharma Company Limited
2021 Phase 3 EUCTR2021-001940-86-PL China;Georgia;Poland;Ukraine;United States;
SODIUM HYALURONATE
Holy Stone Healthcare Co., Ltd.
2015 Phase 2 EUCTR2015-001022-42-IT Italy;
SOYBEAN PHOSPHATIDYLCHOLINE
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-NL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-LT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-HU Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-CZ Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2014 Phase 3 EUCTR2012-003702-27-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
SPD476
Shire
2005 Phase 3 NCT00151892 Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States;
Shire Development Inc
2012 - EUCTR2011-000164-10-SK Slovakia;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-FR Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
2010 - EUCTR2009-017044-13-DE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Development Inc.
2010 Phase 4 EUCTR2009-017044-13-ES Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
Shire Development LLC
2018 Phase 3 EUCTR2013-001744-65-DE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2018 Phase 3 EUCTR2013-001744-65-BE Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-GB Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2013 Phase 1 EUCTR2011-000164-10-GB Australia;Poland;Slovakia;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-GB Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 Phase 4 EUCTR2009-017044-13-BE Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-IE Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-HU Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
2010 - EUCTR2009-017044-13-CZ Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
Shire Devlopment LLC
2015 Phase 3 EUCTR2013-001744-65-NL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-SK Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-PL Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2013-001744-65-HU Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
Shire Pharmaceutical Development Inc
2004 - EUCTR2004-000733-12-CZ Czech Republic;
Shire Pharmaceutical Development Inc.
2005 - EUCTR2004-000734-36-CZ Czech Republic;
Shire Pharmaceutical Development Ltd
2009 - EUCTR2004-004184-29-DK Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2004-004184-29-NL Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-SE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2004-004184-29-PT Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-HU Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-004184-29-GB Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-ES Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-DE Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-004184-29-CZ Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
SPD476 (mesalazine)
Shire
2003 Phase 3 NCT00151944 -
SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
Shire
2003 Phase 3 NCT00548574 Belgium;
2003 Phase 2 NCT00545389 Belgium;
SPH3127
Shanghai Pharma Biotherapeutics USA Inc.
2021 Phase 2 NCT05019742 United States;
SR140333B
SANOFI-SYNTHELABO
2005 - EUCTR2004-001677-26-IT Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Sanofi-Synthelabo Recherche
2005 Phase 2 EUCTR2004-001677-26-HU Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-SE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-ES Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
2005 - EUCTR2004-001677-26-EE Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
sanofi-aventis recherche & developpement
2004 - EUCTR2004-001677-26-CZ Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
SRT2104
Sirtris, a GSK Company
2012 Phase 1 NCT01453491 United States;
ST 261
SIGMA-TAU
2012 - EUCTR2011-004765-32-IT Belgium;Czech Republic;Italy;Netherlands;
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
2012 Phase 3 EUCTR2011-004770-28-ES Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 Phase 3 EUCTR2011-004765-32-BE Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004770-28-PL Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LV Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-LT Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-HU Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-DE Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004770-28-AT Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
2012 - EUCTR2011-004765-32-SK Belgium;Czech Republic;Italy;Netherlands;Slovakia;
2012 - EUCTR2011-004765-32-NL Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
2012 - EUCTR2011-004765-32-CZ Belgium;Czech Republic;Italy;Netherlands;
ST-0529
Sublimity Therapeutics (Hold Co) Ltd.
2019 Phase 2 EUCTR2018-003349-41-PL Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-HU Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-GB Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-FR Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-DE Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2018-003349-41-BG Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics HoldCo Limited
2019 Phase 2 EUCTR2018-003349-41-IT Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Sublimity Therapeutics Holdco Limited
2019 Phase 2 NCT03844932 Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
ST10-021
Iron Therapeutics (Switzerland) AG
2012 - EUCTR2010-023588-16-DE Austria;Germany;Hungary;United Kingdom;
2011 Phase 3 EUCTR2010-023588-16-GB Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-HU Austria;Germany;Hungary;United Kingdom;
2011 - EUCTR2010-023588-16-AT Austria;Germany;Hungary;United Kingdom;
Shield Therapeutics
2011 Phase 3 NCT01340872 Austria;United Kingdom;
ST261
SIGMA-TAU
2008 - EUCTR2005-003471-20-LT Italy;Lithuania;
2005 - EUCTR2005-003471-20-IT Italy;Lithuania;
STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
JANSSEN CILAG INTERNATIONAL NV
2015 Phase 3 EUCTR2014-005606-38-IT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
STELARA®
Janssen-Cilag International NV
2021 Phase 3 EUCTR2020-004457-76-PL Argentina;France;Japan;Poland;Russian Federation;Turkey;United States;
2021 Phase 3 EUCTR2019-004224-38-DE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004224-38-HU Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
- Phase 3 EUCTR2020-004457-76-FR Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-PL Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-Outside-EU/EEA Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-GB Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
- Phase 3 EUCTR2019-004224-38-BE Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
STNM01
STELIC INSTITUTE & CO.
2013 Phase 2 EUCTR2012-004768-23-DE Germany;
STW5-II
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
STW5-II (Iberogast N, BAY98-7410)
Bayer
2014 Phase 2 NCT02246686 Germany;
SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML
ParaTech A/S
2018 Phase 2 EUCTR2017-004772-65-DK Denmark;
Saffron 100
Shiraz University of Medical Sciences
2022 Phase 2 NCT05117749 -
Saffron 50
Shiraz University of Medical Sciences
2022 Phase 2 NCT05117749 -
Saffron supplement for IBD
Howard University
2020 - NCT04749576 United States;
Saline
The Second Hospital of Nanjing Medical University
2016 Phase 4 NCT02998112 China;
Salmon
Institute of Food Research
2004 - NCT00145015 Netherlands;United Kingdom;
Salofalk
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
University Medical Center Groningen
2010 - EUCTR2010-018557-35-NL Netherlands;
Salofalk 1000mg Granu-Stix
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-ES Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
2007 - EUCTR2006-005377-22-LV Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-LT Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
2007 - EUCTR2006-005377-22-DE Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
- Phase 3 EUCTR2006-005377-22-PL Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Salofalk 1000mg Granu-Stix®
Dr. Falk Pharma GmbH
2007 Phase 3 EUCTR2006-005377-22-SK Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Salofalk 1000mg Granu-stix®
Dr. Falk Pharma GmbH
2007 - EUCTR2006-005377-22-CZ Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
Salofalk 3g gastro-resistant prolonged-release granules
Dr. Falk Pharma GmbH
2021 Phase 3 EUCTR2019-003334-16-BG Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
2020 Phase 3 EUCTR2019-003334-16-DE Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
Salofalk 4g/60ml Klysma
Charité Universitätsmedizin, Campus Charité Mitte
2007 - EUCTR2006-004162-13-DE Germany;
Salofalk Granu-Stix
Dr. Falk Pharma GmbH
2016 Phase 3 EUCTR2013-001205-84-HU Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2016 Phase 3 EUCTR2013-001205-84-BE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-SK Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-PL Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-LV Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-DE Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
2015 Phase 3 EUCTR2013-001205-84-AT Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Salofalk®
REPHA GmbH
2008 - EUCTR2007-007928-18-DE Germany;
Salofalk® 1000mg Granu-Stix®
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001216-31-SK Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001216-31-SI Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001216-31-LV Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-LT Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-HU Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-EE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-DE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-CZ Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
Salofalk® 500 mg gastro-resistant tablet
Dr. Falk Pharma GmbH
2013 Phase 3 EUCTR2012-001830-32-DE Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-PL Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2013 - EUCTR2012-001830-32-LT Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-LV Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Salofalk® 500 mg tablets
Dr. Falk Pharma GmbH
2012 Phase 3 EUCTR2012-001830-32-HU Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Salofalk® 500mg Granu-Stix®
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001218-15-SK Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001218-15-SI Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001218-15-LV Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-LT Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-HU Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-EE Estonia;Germany;Hungary;Latvia;Lithuania;
Sandimmum
GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
2008 - EUCTR2006-005299-42-ES Belgium;Finland;France;Spain;
Sandimmun
Swansea University
2008 Phase 3 EUCTR2008-001968-36-GB United Kingdom;
Sandimmun 50 mg/ml, infuusiokonsentraatti
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Sandimmun Neoral
Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)
2008 - EUCTR2006-005299-42-FI Belgium;Finland;France;Spain;
Semi-vegetarian diet
Mayo Clinic
2017 Early Phase 1 NCT03309865 United States;
Serum bovine immunoglobulin
Monisha Hitesh Shah
2020 Early Phase 1 NCT04223518 United States;
Sham Hyperbaric Air
Dartmouth-Hitchcock Medical Center
2013 Phase 2/Phase 3 NCT02144350 United States;
Shingrix
University of Wisconsin, Madison
2019 Phase 4 NCT03798691 United States;
Sigmoidoscopy
Virginia O. Shaffer
2014 Phase 2 NCT02049502 United States;
Simponi
CHU Amiens-Picardie
2020 Phase 4 EUCTR2020-004391-18-FR France;
Guy's and St Thomas' NHS Foundation Trust
2017 Phase 4 EUCTR2017-001374-42-GB United Kingdom;
Helse More og Romsdal Hospital Trust
2016 Phase 4 EUCTR2016-001409-18-NO Norway;
Janssen Biologics B.V.
2015 Phase 2 EUCTR2013-002042-36-FR Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-PL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002042-36-BG Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-NL Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-HU Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-DE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-CZ Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
2014 - EUCTR2013-002042-36-BE Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
Janssen Biologics BV
2019 Phase 3 EUCTR2017-004496-31-PL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2019 Phase 3 EUCTR2017-004496-31-NL Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-FR Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-ES Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
2018 Phase 3 EUCTR2017-004496-31-BE Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
MSD
2014 Phase 4 EUCTR2013-004583-56-GB United Kingdom;
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
2014 Phase 4 EUCTR2014-003262-25-PT Portugal;
UCD
2015 Phase 4 EUCTR2015-004724-62-IE Ireland;
University Medical Centre Ljubljana, Department of gastroenterology
2020 Phase 4 EUCTR2019-003987-37-SI Slovenia;
Simponi (Golimumab)
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
Simponi®
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Simponi® (Golimumab)
MSD Belgium BVBA/SPRL
2014 - EUCTR2014-000656-29-BE Belgium;
Simulect
Cerimon Pharmaceuticals, Inc.
2007 Phase 2 EUCTR2006-006319-54-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-006319-54-CZ Belgium;Czech Republic;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-SK Belgium;Czech Republic;Slovakia;United Kingdom;
2007 Phase 2 EUCTR2006-004303-19-GB Belgium;Czech Republic;Slovakia;United Kingdom;
2007 - EUCTR2006-006319-54-BE Belgium;United Kingdom;
2007 - EUCTR2006-004303-19-CZ Belgium;Czech Republic;United Kingdom;
2007 - EUCTR2006-004303-19-BE Belgium;Czech Republic;United Kingdom;
Single dose-group A
Pfizer
2005 Phase 1 NCT00928681 Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Smartject Device delivery of Golimumab
Merck Sharp & Dohme Corp.
2014 Phase 4 NCT02155335 Belgium;
Smoking cigarettes
Meir Medical Center
2010 Phase 1/Phase 2 NCT01040910 Israel;
Smoking of cannabis
Meir Medical Center
2010 Phase 1/Phase 2 NCT01040910 Israel;
Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate
Bridge Biotherapeutics, Inc.
2021 Phase 2 EUCTR2020-003556-33-PL Korea, Republic of;New Zealand;Poland;Ukraine;United States;
Sodium Picosulfate/Magnesium Citrate Laxative
American University of Beirut Medical Center
2018 Phase 4 NCT03581149 Lebanon;
Sotrastaurin (INN) acetate
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Spesolimab
BOEHRINGER-INGELHEIM ITALIA S.P.A.
2018 Phase 2 EUCTR2018-000334-35-IT Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim
2018 Phase 2/Phase 3 NCT03482635 Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2017 Phase 2 NCT03123120 Denmark;Germany;Ireland;Netherlands;Norway;Spain;United Kingdom;
2017 Phase 2 NCT03100864 Belgium;Germany;United Kingdom;
Boehringer Ingelheim Denmark A/S
2019 Phase 2;Phase 3 EUCTR2017-004230-28-DK Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim International GmbH
2019 Phase 2;Phase 3 EUCTR2017-004230-28-HU Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim LImited
2018 Phase 2 EUCTR2018-000334-35-GB Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Limited
2018 Phase 2;Phase 3 EUCTR2017-004230-28-GB Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim Norway KS
2019 Phase 2 EUCTR2018-000334-35-NO Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim Pharma GmbH & Co. KG
2018 Phase 2 EUCTR2018-000334-35-DE Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH & Co KG
2018 Phase 2;Phase 3 EUCTR2017-004230-28-AT Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
Boehringer Ingelheim RCV GmbH&Co. KG
2019 Phase 2 EUCTR2018-000334-35-PL Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-000334-35-AT Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
SCS Boehringer Ingelheim Comm. V
2018 Phase 2 EUCTR2018-000334-35-BE Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
Spesolimab IV infusion
Boehringer Ingelheim
2018 Phase 2 NCT03648541 Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States;
Spesolimab SC solution for injection
Boehringer Ingelheim
2018 Phase 2 NCT03648541 Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom;United States;
Standard 2 hours-infusion
Asan Medical Center
2011 Phase 4 NCT01346826 Korea, Republic of;
Standard Therapy
Merck Sharp & Dohme Corp.
2007 - NCT00705484 Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Standardized FMT
The Second Hospital of Nanjing Medical University
2012 Phase 2/Phase 3 NCT01790061 China;
Standardized FODMAP
Vendsyssel Hospital
2018 - NCT02469220 Denmark;
Standardized anthocyanin-rich extract
University of Zurich
2019 Phase 2 NCT04000139 Switzerland;
Stasis
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
2020 Phase 0 ChiCTR2000037261 China;
Stelara
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Sterile saline for injection
Bristol-Myers Squibb
2008 Phase 2 NCT00656890 Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States;
Steroids
Medical University of Graz
2018 - NCT03460847 Austria;
Stool samples
University Hospital, Bordeaux
2020 - NCT04272307 France;
Sucrosomial Iron
American University of Beirut Medical Center
2019 Phase 3 NCT05225545 Lebanon;
Sugar Extract
Oslo University Hospital
2011 Phase 2/Phase 3 NCT01496053 Norway;
Sulphsalazine, Pentasa, Asacol, Colazide, Depentum
University of Nottingham
2005 Phase 4 EUCTR2005-000695-40-GB United Kingdom;
Suspension de microbiote fécal
CHU Nantes
2018 Phase 3 EUCTR2017-004967-11-FR France;
Synergy-1
University of Alberta
2016 - NCT02865707 Canada;
Synergy1
University of Alberta
2007 - NCT02093767 Canada;
Sübetaholzwurzel 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
Süßholzwurzel 1ml/10ml
Steigerwald Arzneimittelwerk GmbH
2014 - EUCTR2013-000891-13-DE Germany;
TA-650
Mitsubishi Tanabe Pharma Corporation
2012 Phase 3 NCT01585155 Japan;
TA-650 (Infliximab)
Mitsubishi Tanabe Pharma Corporation
- Phase 3 JPRN-JapicCTI-060298 -
TD-1473
Theravance Biopharma
2016 Phase 1 NCT02818686 Georgia;Moldova, Republic of;Romania;United States;
Theravance Biopharma Ireland Limited
2021 Phase 3 EUCTR2018-002135-19-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-002135-19-IT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 2;Phase 3 EUCTR2018-002136-24-IT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
TD-1473 Dose A
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-1473 Dose B
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-1473 Dose C
Theravance Biopharma
2020 Phase 2/Phase 3 NCT03920254 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
2019 Phase 2/Phase 3 NCT03758443 Australia;Bulgaria;Canada;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United States;
TD-3504
Theravance Biopharma
2017 Phase 1 NCT03103412 United States;
THRX-139060
Theravance Biopharma Ireland Limited
2021 Phase 3 EUCTR2018-002135-19-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002135-19-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-SK Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PT Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-PL Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-HU Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-GR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-FR Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-ES Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-DE Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2019 Phase 2;Phase 3 EUCTR2018-002136-24-BG Australia;Bulgaria;Canada;Croatia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
TJ301
I-Mab Biopharma HongKong Limited
2018 Phase 2 NCT03235752 Australia;China;Korea, Republic of;Taiwan;
TLL018
Hangzhou Highlightll Pharmaceutical Co., Ltd
2021 Phase 2 NCT05121402 -
TOFACINITIB
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2021 Phase 4 EUCTR2020-003006-31-IT Italy;
TOP1288
Topivert Pharma Ltd
2017 Phase 1 NCT03071081 United Kingdom;
2016 Phase 2 NCT02888379 Bulgaria;Czech Republic;Czechia;Hungary;Latvia;Lithuania;Poland;Ukraine;United Kingdom;
2015 Phase 1 NCT02463045 United Kingdom;
TP05
Tillotts Pharma AG
2015 Phase 3 EUCTR2013-000366-11-RO Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-SK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;
2014 Phase 3 EUCTR2013-000366-11-LV Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-LT Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-HU Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3 EUCTR2013-000366-11-BG Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 NCT01903252 Netherlands;Switzerland;
2013 Phase 3 EUCTR2013-000366-11-SE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-PL Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine;
2013 Phase 3 EUCTR2013-000366-11-IE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-GB Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-FI Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-DK Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-CZ Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 3 EUCTR2013-000366-11-BE Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 1 NCT02306798 -
2013 - EUCTR2013-000366-11-ES Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine;
TP05 Coating A
Tillotts Pharma AG
2011 Phase 1 NCT02306772 -
TP05 Coating B
Tillotts Pharma AG
2011 Phase 1 NCT02306772 -
TP05 Coating D
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TP05 Coating E
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TP05 Coating H
Tillotts Pharma AG
2012 Phase 1 NCT02306785 -
TPMT genotyping
ZonMw: The Netherlands Organisation for Health Research and Development
2007 - NCT00521950 Netherlands;
TREMFYA®
Janssen-Cilag International NV
2019 Phase 2 EUCTR2018-001510-15-PL Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
2019 Phase 2 EUCTR2018-001510-15-DE Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
TSO
ParaTech A/S
2018 Phase 2 EUCTR2017-004772-65-DK Denmark;
TYK2 Inhibitor
Bristol-Myers Squibb International Corporation
2021 Phase 2 EUCTR2019-004878-26-NL Australia;Canada;Germany;Netherlands;United Kingdom;United States;
2021 Phase 2 EUCTR2019-004878-26-DE Australia;Canada;Germany;Netherlands;United Kingdom;United States;
Tacrolimus
Astellas Pharma Inc
2006 Phase 3 NCT00643071 Japan;
2006 Phase 3 NCT00347048 Japan;
Chiba University Hospital
2013 - JPRN-UMIN000010776 Japan;
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
2013 Phase 4 JPRN-UMIN000010612 Japan;
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
2010 Phase 3 JPRN-UMIN000003785 Japan;
Department of lower gastroenterology, Hyogo College of Medicine
2010 Phase 4 JPRN-UMIN000003952 Japan;
Juntendo University
2011 - JPRN-UMIN000005824 Japan;
Keio University Gastroenterology and Hepatology
2016 - JPRN-UMIN000024936 Japan;
Kitasato University Kitasato Institute Hospital
2014 - JPRN-UMIN000013694 Japan;
Medical College of Wisconsin
2017 Phase 3 NCT02954159 United States;
Osaka City University, Graduate School of Medicine,Department of Gastroenterology
2013 - JPRN-UMIN000004201 Japan;
Osaka Medical College
2014 - JPRN-UMIN000015912 Japan;
Saitama Medical Center, Saitama Medical University
2011 - JPRN-UMIN000005033 Japan;
Yokohama City University Medical Center
2014 Phase 2 JPRN-UMIN000013716 Japan;
Tauroursoursodeoxycholic acid, brand name Tudcabil
Washington University School of Medicine
2019 Phase 1 NCT04114292 United States;
Telotristat Etiprate
Lexicon Pharmaceuticals
2012 Phase 2 NCT01456052 Lithuania;Poland;Slovakia;United States;
Telotristat etiprate
Lexicon Pharmaceuticals, Inc.
2012 - EUCTR2011-003532-32-LT Belgium;Lithuania;Poland;Slovakia;United States;
2011 - EUCTR2011-003532-32-SK Belgium;Lithuania;Poland;Slovakia;United States;
Terbinafine
Hamilton Health Sciences Corporation
2016 Phase 2 NCT02606032 Canada;
Tetracycline
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
2013 Phase 3 JPRN-UMIN000009811 Japan;
Hokkaido University Hospital
2016 - JPRN-UMIN000024520 Japan;
Japan UC Antibiotics-therapy Study Group(JUCASG)
2003 Phase 2 JPRN-C000000078 Japan;
Shiga University of Medical Science
2015 - JPRN-UMIN000017844 Japan;
Thalidomide
IRCCS Burlo Garofolo
2008 Phase 3 NCT00720538 Italy;
Thalidomide Pharmion
ISTITUTO PER L INFANZIA BURLO GAROFOLO
2006 - EUCTR2005-005414-20-IT Italy;
The Colonic Transendoscopic enteral Tubing.
The Second Hospital of Nanjing Medical University
2019 - NCT03917095 China;
Threonine
Nestlé
2015 - NCT02423460 Canada;
Tilpisertib
Gilead Sciences
2019 Phase 2 NCT04130919 Australia;Austria;Canada;France;Germany;Italy;Poland;Switzerland;United States;
To be confirmed
Gilead Sciences, Inc.
2020 Phase 2 EUCTR2019-001430-33-GB Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
To be requested
Landos Biopharma Inc.
2020 Phase 2 EUCTR2018-005086-39-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HU Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 2 EUCTR2018-005086-39-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Tofacitinib
Kawai Norisuke
2021 Phase 3 JPRN-jRCT2071210075 Australia;Canada;Japan;United States;
PFIZER INC.
2013 - EUCTR2011-004578-27-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
PFIZER LIMITED
2013 Phase 3 EUCTR2011-004580-79-IT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-IT Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer
2021 Phase 3 NCT04624230 Australia;Canada;Israel;Japan;Poland;Spain;United States;
2020 - NCT04424303 France;
2020 - NCT04338204 Sweden;
2012 Phase 3 NCT01465763 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 NCT01458951 Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc
2012 Phase 3 EUCTR2011-004580-79-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2013 Phase 3 EUCTR2011-004580-79-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004581-14-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004579-35-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004578-27-HR Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004580-79-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004581-14-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-NL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004579-35-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-SK Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-LV Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-GB Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-ES Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004578-27-AT Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004580-79-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004579-35-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004578-27-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Postgraduate Institute of Medical Education and Research
2021 - NCT05112263 -
University of Miami
2020 Phase 3 NCT04505410 United States;
Tofacitinib 10 MG [Xeljanz]
McMaster University
2021 Phase 2 NCT04925973 Canada;
Tofacitinib citrate
PFIZER INC
2018 Phase 3;Phase 4 EUCTR2017-002274-39-IT Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2018 Phase 3;Phase 4 EUCTR2017-002274-39-NL Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-GB Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-CZ Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3;Phase 4 EUCTR2017-002274-39-BE Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002274-39-AT Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3;Phase 4 EUCTR2017-002274-39-HU Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-002274-39-ES Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Pfizer Inc.
2017 Phase 3;Phase 4 EUCTR2017-002274-39-SK Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Phase III Formulation)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercial formulation - debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercial formulation – debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-AT Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (Proposed commercialFormulation - debossed)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
2012 Phase 3 EUCTR2011-004581-14-DE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Tofacitinib citrate (clinical trial image)
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
2012 Phase 3 EUCTR2011-004581-14-NL Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-HU Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-GB Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-EE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-DK Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-BE Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc.
2012 Phase 3 EUCTR2011-004581-14-SK Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2011-004581-14-CZ Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
2012 Phase 3 EUCTR2011-004581-14-PL Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Traditional treatments
The Second Hospital of Nanjing Medical University
2012 Phase 2/Phase 3 NCT01790061 China;
Tralokinumab
ASTRAZENECA
2011 - EUCTR2011-004812-40-IT Czech Republic;Germany;Italy;Netherlands;United Kingdom;
AstraZeneca
2012 Phase 2 NCT01482884 Czech Republic;France;Germany;Italy;Netherlands;Poland;United Kingdom;
AstraZeneca AB
2012 Phase 2 EUCTR2011-004812-40-GB Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-NL Czech Republic;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-DE Czech Republic;Germany;Italy;Netherlands;United Kingdom;
2012 - EUCTR2011-004812-40-CZ Czech Republic;Italy;Netherlands;United Kingdom;
Treatment Algorithm A
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Treatment Algorithm B
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Treatment Algorithm C
Alimentiv Inc.
2020 Phase 4 NCT04259138 Belgium;Canada;France;Netherlands;Poland;Ukraine;United Kingdom;United States;
Trexan inj 25 mg/ml
GETAID, Jean Minjoz Hospital
2009 - EUCTR2006-003607-40-FI Austria;Belgium;Finland;Netherlands;
Trichuris suis eggs
University of Aarhus
2012 - NCT03079700 -
Trichuris suis ova
New York University School of Medicine
2012 - NCT01433471 United States;
ParaTech A/S
2018 Phase 2 NCT03565939 Denmark;
Trichuris suis ova (TSO)
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 2 NCT01953354 United States;
UCB4940
UCB Biopharma SPRL
2017 Phase 2 EUCTR2016-000420-26-PL Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2017 Phase 2 EUCTR2016-000420-26-BG Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-ES Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
2016 Phase 2 EUCTR2016-000420-26-CZ Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
UCMSC group
Affiliated Hospital to Academy of Military Medical Sciences
2015 Phase 1/Phase 2 NCT02442037 China;
UR-12746-S
Palau Pharma S.A.
2009 Phase 2 EUCTR2008-004610-27-SK Belgium;Hungary;Slovakia;Spain;
2009 - EUCTR2008-004610-27-HU Belgium;Hungary;Spain;
2008 - EUCTR2008-004610-27-BE Belgium;Hungary;Spain;
UTTR1147A
Genentech, Inc.
2019 Phase 2 NCT03650413 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 NCT03558152 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2016 Phase 1 NCT02749630 Canada;Germany;United Kingdom;
UTTR1147A, IL22-Fc, IL-22Fc
Genentech, Inc.
2019 Phase 2 EUCTR2017-004997-32-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-DE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004997-32-IE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
UTTR1147A/RO7021610 (Active)
GENENTECH, INC.
2019 Phase 2 EUCTR2017-004997-32-IT Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Genentech, Inc.
2019 Phase 2 EUCTR2017-004997-32-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004997-32-DE Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-NL Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-IE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-HU Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GR Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-GB Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-DE Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-BG Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Roche Farma, S.A por delegación de Genentech, Inc.
2018 Phase 2 EUCTR2017-004997-32-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002350-36-ES Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Umbilical Cord Mesenchymal Stem Cells
Qingdao University
2010 Phase 1/Phase 2 NCT01221428 China;
Umbilical cord blood mononuclear cells
Shandong Qilu Stem Cells Engineering Co., Ltd.
2021 - NCT04882683 China;
Unknown
F. Hoffmann-La Roche Ltd
2015 Phase 3 EUCTR2013-004435-72-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Upadacitinib
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2016-000642-62-IT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-IT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2020 Phase 3 EUCTR2016-000642-62-SE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2016-000642-62-FR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-SK Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-PL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-NL Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-LT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-IE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-HR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GR Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-GB Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-ES Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-DE Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-CZ Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2016-000642-62-AT Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-NO Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-LV Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-HU Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000642-62-FI Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 2;Phase 3 EUCTR2016-000641-31-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000674-38-BE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-SE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-PT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-LT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-HR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-FI Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2017 Phase 2;Phase 3 EUCTR2016-000641-31-CZ Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GR Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2016-000674-38-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-SK Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-PL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-NL Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-IE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-HU Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-GB Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-EE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
2016 Phase 2;Phase 3 EUCTR2016-000641-31-AT Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-000674-38-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-NO Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
- Phase 2;Phase 3 EUCTR2016-000641-31-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AbbVie GK
2018 Phase 3 JPRN-JapicCTI-184131 Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
Upadacitinib (ABT-494)
AbbVie
2018 Phase 3 NCT03653026 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 NCT03006068 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib - Direct compression-yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib - Wet Granulation-Yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Upadacitinib -Direct compression-yellow
AbbVie Deutschland GmbH & Co. KG
- Phase 3 EUCTR2016-000674-38-DE Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Updacitinib (ABT-494)
AbbVie
2016 Phase 3 NCT02819635 Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;Egypt;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Urbason
GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
2017 Phase 4 EUCTR2016-001170-15-ES Spain;
Ursodeoxycholic acid
The 900th Hospital of PLA
2018 Phase 4 ChiCTR2000038316 China;
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
Ursodiol (ursodeoxycholic acid, UDCA)
Stanford University
2019 Phase 2/Phase 3 NCT03724175 United States;
Ursofalk
UMC Utrecht
2009 - EUCTR2009-010921-38-NL Netherlands;
Ustekinumab
Janssen Cilag S.A.S.
2018 - NCT03606499 France;
Janssen Pharmaceutical K.K.
2021 - NCT04963725 Japan;
2015 Phase 3 JPRN-JapicCTI-163122 Japan, Asia except Japan, North America, Europe, Oceania;
Janssen Scientific Affairs, LLC
2021 - NCT04372108 United States;
Janssen-Cilag International NV
2016 Phase 3 EUCTR2014-005606-38-PL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-SK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-NL Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-HU Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DK Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-DE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-CZ Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BG Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
2015 Phase 3 EUCTR2014-005606-38-AT Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Nishikawa Kazuko
2021 Phase 3 JPRN-jRCT2041200098 Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom Of Great Britain And Northern Irela;United States Of America;
Ustekinumab Dose Based on BSA and Body Weight
Janssen Research & Development, LLC
2021 Phase 3 NCT04630028 Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
Ustekinumab IV
Janssen Research & Development, LLC
2015 Phase 3 NCT02407236 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
Ustekinumab IV Infusion
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Ustekinumab SC
Janssen Research & Development, LLC
2015 Phase 3 NCT02407236 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
Ustekinumab SC Injection
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Usual current care
Hospital Galdakao-Usansolo
2020 - NCT04188990 Spain;
V565
VHsquared Ltd.
2017 Phase 1 NCT03705117 United Kingdom;
VB-201
Vascular Biogenics Ltd.
2013 - EUCTR2012-003974-18-BG Bulgaria;Hungary;
2012 - EUCTR2012-003974-18-HU Bulgaria;Hungary;
Vascular Biogenics Ltd. operating as VBL Therapeutics
2013 Phase 2 NCT01839214 Bulgaria;Hungary;Poland;
VE202
Vedanta Biosciences, Inc.
2021 Phase 2 EUCTR2021-001280-24-LT Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-001280-24-HU Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
VEDULIZUMAB
ALIMENTIV INC.
2021 Phase 4 EUCTR2019-002485-12-IT Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
VSL#3
VSL Pharmaceuticals
2006 - NCT00951548 Italy;
VSL#3 (Original De Simone formulation)
Charles University, Czech Republic
2014 - NCT01765439 Czech Republic;Czechia;
VSL#3®
VSL Pharmaceuticals
2017 - NCT03415711 Italy;
VTX002
Oppilan Pharma Ltd
2021 Phase 2 NCT05156125 Czechia;Georgia;Hungary;Poland;Ukraine;United States;
Oppilan Pharma Ltd.
2022 Phase 2 EUCTR2021-003050-23-PL Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
VTX002 is not biologic
Oppilan Pharma Ltd.
2022 Phase 2 EUCTR2021-003050-23-LT Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-003050-23-HU Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
2021 Phase 2 EUCTR2021-003050-23-CZ Belarus;Czech Republic;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Russian Federation;Ukraine;United States;
Vaccine Vivotif + Vaccine Dukoral + oats
Haukeland University Hospital
2008 Phase 2 NCT00751933 Norway;
Valganciclovir
CHU de Saint Etienne
2019 Phase 4 EUCTR2019-001032-54-FR France;
Centre Hospitalier Universitaire de Saint Etienne
2021 Phase 3 NCT04064697 France;
Vaminolac
Aarhus University Hospital
2015 - NCT02084550 Denmark;
Vaminolac, komb.
Department of Medicine and Endocrinology
2015 Phase 3 EUCTR2014-000784-41-DK Denmark;
Vamorolone suspension for oral dosing
ReveraGen BioPharma, Inc.
2020 Phase 1/Phase 2 NCT04348890 -
Vancomycin
Ari M Grinspan
2021 Early Phase 1 NCT04968951 United States;
University of Dundee
2006 - NCT00355602 United Kingdom;
Vancomycin Pre-Treat
Seres Therapeutics, Inc.
2016 Phase 1 NCT02618187 United States;
Vancomycin Pre-Treatment
KoBioLabs
2021 Phase 2 NCT04898348 -
Seres Therapeutics, Inc.
2018 Phase 2 NCT03759041 Canada;United States;
Vatelizumab
Sanofi aventis Recherche&Développement
2013 Phase 2 EUCTR2012-002013-19-BE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-PL Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-IT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-DE Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
2013 - EUCTR2012-002013-19-AT Austria;Belgium;Canada;France;Germany;Italy;Poland;United States;
Sanofi-aventis recherche & développement
2014 - EUCTR2013-001012-30-DE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 Phase 2 EUCTR2013-001012-30-BE Austria;Belgium;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-PL Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-IT Austria;Canada;Germany;Italy;Poland;United States;
2013 - EUCTR2013-001012-30-AT Austria;Canada;Germany;Italy;Poland;United States;
Vedolizumab
AstraZeneca
2018 Phase 2 NCT04718818 Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States;
CHU de Saint Etienne
2019 Phase 4 EUCTR2019-001032-54-FR France;
Fujiya Mikihiro
2021 Phase 4 JPRN-jRCTs011200009 Japan;
GENENTECH, INC.
2018 Phase 2 EUCTR2017-002350-36-IT Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Geert D'Haens
2015 Phase 4 NCT02646657 Belgium;Hungary;Netherlands;
Genentech, Inc.
2018 Phase 2 NCT03558152 Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Guy's & St Thomas NHS Foundation Trust
2018 Phase 4 EUCTR2018-002794-21-GB United Kingdom;
Guy's and St Thomas' NHS Foundation Trust
2019 Phase 4 NCT04006080 United Kingdom;
MILLENNIUM PHARMACEUTICALS, INC.
2009 Phase 3 EUCTR2008-002784-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-002782-32-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
Medical College of Wisconsin
2017 Phase 3 NCT02954159 United States;
Millennium Pharmaceuticals, Inc.
2009 Phase 3 NCT00783718 Canada;Puerto Rico;United States;
2007 Phase 2 NCT01177228 -
2007 Phase 2 NCT00619489 Canada;
Naganuma Makoto
2021 - JPRN-jRCT1031200329 Japan;
Shaare Zedek Medical Center
2017 - NCT02862132 Denmark;Finland;Ireland;Israel;Slovenia;United Kingdom;United States;
Shikamura Mitsuhiro
2021 Phase 3 JPRN-jRCT2071210030 Australia;Belgium;Bosnia;Canada;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 JPRN-jRCT2031200371 Japan;
Stanford University
2020 - NCT03802214 Canada;United States;
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2021 Phase 3 EUCTR2020-004300-34-IT Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda
2021 Phase 3 NCT04779307 United States;
2021 Phase 3 NCT04738942 Japan;
2019 - NCT03824561 Japan;
2018 Phase 2 NCT03196427 Belgium;Canada;France;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 4 NCT02559713 United States;
2017 Phase 2 NCT03138655 Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 4 NCT02760615 United States;
2016 Phase 4 NCT02743806 Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
2015 Phase 3 NCT02497469 Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 - NCT02674308 Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 3 NCT02039505 Japan;
2009 Phase 3 NCT00790933 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;Korea, Republic of;Malaysia;United States;
Takeda Development Center Americas, Inc.
2021 Phase 3 EUCTR2020-004300-34-SK Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-LT Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HU Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-HR Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-GR Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004300-34-ES Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-CZ Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004300-34-BE Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
Takeda Pharmaceutical Company Limited
2019 - JPRN-JapicCTI-194603 Japan;
University of Pennsylvania
2017 Phase 4 NCT03237260 United States;
Yonsei University
2021 Phase 3 NCT04919252 Korea, Republic of;
ooi makoto
2021 Phase 3 JPRN-jRCT1051210145 Japan;
Vedolizumab 108 mg SC
Takeda
2015 Phase 3 NCT02611830 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Vedolizumab 300 mg IV
Takeda
2015 Phase 3 NCT02611830 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Vedolizumab IV
Academic Medical Center/ Gastroenterology
2015 Phase 4 EUCTR2014-005443-40-BE Belgium;Hungary;Netherlands;
Eli Lilly and Company
2021 Phase 3 NCT04469062 -
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda
2022 Phase 4 NCT04804540 -
2017 Phase 4 NCT03029143 Canada;United States;
2017 Phase 3 NCT03221036 China;
Takeda Development Centre Europe Limited
2016 Phase 4 EUCTR2016-000678-40-CZ Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
Takeda Development Centre Europe, Ltd.
2018 Phase 2 EUCTR2017-002231-41-PL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-NL Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-002231-41-BE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-HU Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-GB Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2017-002231-41-DE Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-PL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HU Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-HR Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000939-33-ES Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-SK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LV Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-LT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-GB Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-EE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DK Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-DE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-CZ Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BG Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-000939-33-BE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 2 EUCTR2017-002231-41-FR Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
Vedolizumab IV, Placebo IV, Placebo SC
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab IV, Placebo SC
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab Injection
Mayo Clinic
2017 Early Phase 1 NCT03309865 United States;
Rennes University Hospital
2019 Phase 4 NCT03679546 France;
Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV
Takeda Pharmaceutical Company Limited
2015 Phase 3 JPRN-JapicCTI-163222 Japan, Japan, Refer to Other section;
Vedolizumab SC
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
2016 Phase 3 EUCTR2015-000482-31-IT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-IT Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda
2016 Phase 3 NCT02620046 Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Takeda Development Centre Europe, Ltd.
2016 Phase 3 EUCTR2015-000482-31-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BG Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000482-31-BE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-SE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-NL Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-LT Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HU Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-HR Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-GB Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-ES Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DK Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-DE Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-CZ Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BG Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-000480-14-BE Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Takeda Pharmaceutical Company Limited
2016 Phase 3 JPRN-JapicCTI-163220 Japan, Refer to Othersection;
Vedolizumab intravenous injection
Takeda
2014 Phase 2 NCT02913508 -
Vedolizumab subcutaneous injection
Takeda
2014 Phase 2 NCT02913508 -
Vedolizumab, Ustekinumab, or Tofacitinib
Asan Medical Center
2022 - NCT05186623 Korea, Republic of;
Vidofludimus calcium
Immunic AG
2020 Phase 2 EUCTR2017-003703-22-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2017-003703-22-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-PL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2017-003703-22-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-NL Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2018 Phase 2 EUCTR2017-003703-22-ES Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
Vidofludimus calcium dihydrate
Immunic AG
2018 Phase 2 EUCTR2017-003703-22-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Vigantol Oel TM
Imperial College London
2008 Phase 4 EUCTR2007-006692-37-GB United Kingdom;
2008 - EUCTR2008-001467-10-GB United Kingdom;
Visilizumab
Abbott
2006 Phase 2 NCT00307827 Canada;Croatia;Ireland;Italy;Poland;Russian Federation;Serbia;Spain;Switzerland;United States;
Facet Biotech
2007 Phase 3 NCT00502294 -
2006 Phase 2/Phase 3 NCT00279435 Australia;Austria;Belgium;Canada;Croatia;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Ukraine;United States;
2006 Phase 2/Phase 3 NCT00279422 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Norway;Slovakia;Ukraine;United States;
2004 Phase 1/Phase 2 NCT00267306 United States;
2002 Phase 2/Phase 3 NCT00032305 United States;
PDL BioPharma , Inc.
2006 - EUCTR2005-003482-17-IT Greece;Ireland;Italy;Spain;United Kingdom;
PDL BioPharma, Inc
PDL BioPharma, Inc.
2006 - NCT00355901 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
Visilizumab (Nuvion)
PDL BioPharma, Inc
2007 - EUCTR2005-003707-37-BE Austria;Belgium;
2007 - EUCTR2005-003707-37-AT Austria;Belgium;
2006 Phase 2;Phase 3 EUCTR2005-002063-87-SK Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
2006 Phase 2 EUCTR2005-003481-42-IE Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-004105-28-NL France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003481-42-ES Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-DE Belgium;Czech Republic;Germany;Hungary;
PDL BioPharma, Inc.
2007 - EUCTR2005-004105-28-GR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-004105-28-FR France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2007 - EUCTR2005-003482-17-GR Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003482-17-GB Greece;Ireland;Italy;Spain;United Kingdom;
2007 - EUCTR2005-003481-42-GR Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 Phase 2 EUCTR2005-004105-28-IE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 Phase 2 EUCTR2005-003482-17-IE Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-004105-28-GB France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-004105-28-DE France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
2006 - EUCTR2005-003482-17-ES Greece;Ireland;Italy;Spain;United Kingdom;
2006 - EUCTR2005-003481-42-HU Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-DE Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-003481-42-CZ Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
2006 - EUCTR2005-002063-87-CZ Belgium;Czech Republic;Germany;Hungary;
Protein Design Labs, Inc
2006 Phase 2 EUCTR2005-003481-42-SK Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
2006 - EUCTR2005-003481-42-AT Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
Protein Design Labs, Inc.
2006 - EUCTR2005-002063-87-HU Belgium;Czech Republic;Germany;Hungary;
2006 - EUCTR2005-002063-87-BE Belgium;Czech Republic;Germany;Hungary;
2005 - EUCTR2005-002063-87-AT Austria;Belgium;Czech Republic;Germany;Hungary;
Vitamin B2
Novartis Pharma Services AG
2007 Phase 2 EUCTR2007-002542-38-DK Denmark;Germany;
Vitamin D
Stanford University
2021 Phase 1 NCT04828031 United States;
University Hospital of North Norway
2013 Phase 1/Phase 2 NCT01846026 Norway;
Vitamin D drops
Second Affiliated Hospital of Wenzhou Medical University
2020 Early Phase 1 NCT04309058 China;
Vitamin D3
Boston Children's Hospital
2020 Phase 2 NCT04331639 United States;
2017 Phase 3 NCT03162432 United States;
Massachusetts General Hospital
2020 - NCT04225819 United States;
University Hospital, Basel, Switzerland
2022 Phase 3 NCT04991324 -
University of California, San Francisco
2012 - NCT01877577 United States;
University of Chicago
2012 - NCT01640496 United States;
Vitamin E 800IU
University Health Network, Toronto
2002 Phase 2 NCT00152841 Canada;
Vitamin K
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Warfarin
Janssen Research & Development, LLC
2018 Phase 1 NCT03358706 Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
Water
411th Hospital of PLA
2013 - ChiCTR-TRC-13003530 China;
The Jikei University School of MedicineDivision of Gastroenterology and Hepatology
2009 - JPRN-UMIN000008967 Japan;
Wharton Jelly Mesenchymal stem cells
Hanan Jafar
2017 Phase 1/Phase 2 NCT03299413 Jordan;
XELJANZ -
PFIZER INC
- Phase 3 EUCTR2018-002378-30-IT Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Xeljanz
DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA
2019 Phase 4 EUCTR2018-004890-28-IT Italy;
Erasmus Medical Center
2019 Phase 4 EUCTR2018-004587-61-NL Netherlands;
F. Hoffmann-La Roche Ltd
2020 Phase 3 EUCTR2019-004652-11-SI Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Xeljanz 5 mg film-coated tablets
Academic Medical Center
2017 Phase 3 EUCTR2016-002691-27-NL Netherlands;
Xeljanz 5mg film-coated tablets
Amsterdam UMC, location AMC
2020 Phase 2 EUCTR2020-002695-12-NL Netherlands;
Z-206
Zeria Pharmaceutical Co., Ltd.
2013 Phase 3 JPRN-JapicCTI-132135 -
- Phase 2 JPRN-JapicCTI-121943 -
ZEPOSIA® (ozanimod)
Celgene International II Sàrl
2016 Phase 3 EUCTR2015-001600-64-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001600-64-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-SK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001600-64-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-001600-64-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Zessly
University Medical Center Groningen
2021 Phase 4 EUCTR2020-001811-26-BE Belgium;Netherlands;
2020 Phase 4 EUCTR2020-001811-26-NL Netherlands;
Zoenasa-1:4
Altheus Therapeutics, Inc.
2012 Phase 2 NCT01586533 United States;
[124I]IB PF 06687234
Pfizer
2020 Phase 1 NCT03414788 United States;
[18F]FSPG
Asan Foundation
2018 Phase 2 NCT03546868 Korea, Republic of;
hydrocortisone acetate suppository with Sephure suppository applicator
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-DE Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States;
idrocortisone acetato in supposta con appli
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-IT Germany;Hong Kong;India;Italy;Philippines;Poland;Russian Federation;Spain;Ukraine;United States;
idrocortisone acetato in supposta con applicatore per supposte Sephure
Cristcot HCA LLC
2020 Phase 3 EUCTR2019-003596-19-IT Germany;Hong Kong;India;Italy;Philippines;Poland;Russian Federation;Spain;Ukraine;United States;
mesalazine pellets
Dr. Falk Pharma GmbH
2005 Phase 3 EUCTR2004-001218-15-SK Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 Phase 3 EUCTR2004-001216-31-SK Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovakia;Slovenia;
2005 - EUCTR2004-001218-15-SI Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001218-15-LV Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-LT Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-HU Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-EE Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001218-15-DE Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-SI Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;Slovenia;
2005 - EUCTR2004-001216-31-LV Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-LT Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-HU Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-EE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-DE Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;
2005 - EUCTR2004-001216-31-CZ Czech Republic;Estonia;Germany;Hungary;Latvia;Lithuania;